Significant New Use Rules on Certain Chemical Substances (24-3.5e), 102046-102074 [2024-29275]
Download as PDF
102046
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
ddrumheller on DSK120RN23PROD with PROPOSALS1
equipment or pollution prevention
process modifications;’’ section 8.26,
‘‘Civil or criminal penalties for failure to
comply;’’ section 8.27, ‘‘Special facilitywide permit provisions;’’ and section
8.28, ‘‘Delay of testing;’’ as described in
section II of this preamble. The EPA has
made, and will continue to make, these
materials generally available through
www.regulations.gov and at the EPA
Region 2 Office (please contact the
person identified in the FOR FURTHER
INFORMATION CONTACT section of this
preamble for more information).
VI. Statutory and Executive Order
Reviews
Under the CAA, the Administrator is
required to approve a SIP submission
that complies with the provisions of the
CAA and applicable Federal regulations.
42 U.S.C. 7410(k); 40 CFR 52.02(a).
Thus, in reviewing SIP submissions, the
EPA’s role is to approve state choices,
provided that they meet the criteria of
the CAA. Accordingly, this action
merely proposes to approve State law as
meeting Federal requirements and does
not impose additional requirements
beyond those imposed by State law. For
that reason, this proposed action:
• Is not a ‘‘significant regulatory
action’’ subject to review by the Office
of Management and Budget under
Executive Orders 12866 (58 FR 51735,
October 4, 1993) and 14094 (88 FR
21879, April 11, 2023);
• Does not impose an information
collection burden under the provisions
of the Paperwork Reduction Act (44
U.S.C. 3501 et seq.);
• Is certified as not having a
significant economic impact on a
substantial number of small entities
under the Regulatory Flexibility Act (5
U.S.C. 601 et seq.);
• Does not contain any unfunded
mandate or significantly or uniquely
affect small governments, as described
in the Unfunded Mandates Reform Act
of 1995 (Pub. L. 104–4);
• Does not have federalism
implications as specified in Executive
Order 13132 (64 FR 43255, August 10,
1999);
• Is not subject to Executive Order
13045 (62 FR 19885, April 23, 1997)
because it approves a state program;
• Is not a significant regulatory action
subject to Executive Order 13211 (66 FR
28355, May 22, 2001); and
• Is not subject to requirements of
section 12(d) of the National
Technology Transfer and Advancement
Act of 1995 (15 U.S.C. 272 note) because
application of those requirements would
be inconsistent with the Clean Air Act.
In addition, this proposed SIP will not
apply on any Indian reservation land or
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
in any other area where EPA or an
Indian Tribe has demonstrated that a
Tribe has jurisdiction. In those areas of
Indian country, the rules do not have
Tribal implications and will not impose
substantial direct costs on Tribal
governments or preempt Tribal law as
specified by Executive Order 13175 (65
FR 67249, November 9, 2000).
Executive Order 12898 (Federal
Actions to Address Environmental
Justice in Minority Populations and
Low-Income Populations, 59 FR 7629,
Feb. 16, 1994) directs Federal agencies
to identify and address
‘‘disproportionately high and adverse
human health or environmental effects’’
of their actions on communities with EJ
concerns to the greatest extent
practicable and permitted by law.
Executive Order 14096 (Revitalizing Our
Nation’s Commitment to Environmental
Justice for All, 88 FR 25251, April 26,
2023) builds on and supplements E.O.
12898 and defines EJ as, among other
things, the just treatment and
meaningful involvement of all people,
regardless of income, race, color,
national origin, or Tribal affiliation, or
disability in agency decision-making
and other Federal activities that affect
human health and the environment.
The NJDEP considered EJ as part of its
SIP submittal given that the CAA and
applicable implementing regulations
neither prohibit nor require an
evaluation. The EPA’s review of the
NJDEP’s EJ considerations is described
above in the section titled,
‘‘Environmental Justice
Considerations.’’ The consideration was
done for the purpose of providing
additional context and information
about this rulemaking to the public, not
as a basis of the action. The EPA is
taking action under the CAA on bases
independent of the consideration of EJ.
Due to the nature of the action being
taken here, this action is expected to
have a neutral to positive impact on the
air quality of the affected area. In
addition, there is no information in the
record upon which this decision is
based that is inconsistent with the
stated goal of E.O. 12898/14096 of
achieving EJ for communities with EJ
concerns.
List of Subjects in 40 CFR Part 52
Environmental protection, Air
pollution control, Ammonia,
Incorporation by reference,
Intergovernmental relations, Nitrogen
oxides, Particulate matter, Reporting
and recordkeeping requirements, Sulfur
dioxide, Volatile organic compounds.
PO 00000
Frm 00031
Fmt 4702
Sfmt 4702
Authority: 42 U.S.C. 7401 et seq.
Lisa Garcia,
Regional Administrator, Region 2.
[FR Doc. 2024–29525 Filed 12–16–24; 8:45 am]
BILLING CODE 6560–50–P
ENVIRONMENTAL PROTECTION
AGENCY
40 CFR Part 721
[EPA–HQ–OPPT–2024–0079; FRL–12386–
01–OCSPP]
RIN 2070–AB27
Significant New Use Rules on Certain
Chemical Substances (24–3.5e)
Environmental Protection
Agency (EPA).
ACTION: Proposed rule.
AGENCY:
EPA is proposing significant
new use rules (SNURs) under the Toxic
Substances Control Act (TSCA) for
certain chemical substances that were
the subject of premanufacture notices
(PMNs) and are also subject to an Order
issued by EPA pursuant to TSCA. The
SNURs require persons who intend to
manufacture (defined by statute to
include import) or process any of these
chemical substances for an activity that
is proposed as a significant new use by
this rulemaking to notify EPA at least 90
days before commencing that activity.
The required notification initiates EPA’s
evaluation of the conditions of that use
for that chemical substance. In addition,
the manufacture or processing for the
significant new use may not commence
until EPA has conducted a review of the
required notification, made an
appropriate determination regarding
that notification, and taken such actions
as required by that determination.
DATES: Comments must be received on
or before January 16, 2025.
ADDRESSES: Submit your comments,
identified by docket identification (ID)
number EPA–HQ–OPPT–2024–0079, at
https://www.regulations.gov. Follow the
online instructions for submitting
comments. Do not submit electronically
any information you consider to be
Confidential Business Information (CBI)
or other information whose disclosure is
restricted by statute. Additional
instructions on commenting and visiting
the docket, along with more information
about dockets generally, is available at
https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
For technical information: Jordan
Garbin, New Chemicals Division
(7405M), Office of Pollution Prevention
and Toxics, Environmental Protection
SUMMARY:
E:\FR\FM\17DEP1.SGM
17DEP1
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
Agency, 1200 Pennsylvania Ave. NW,
Washington, DC 20460–0001; telephone
number: (202) 564–4156; email address:
garbin.jordan@epa.gov.
For general information on SNURs:
William Wysong, New Chemicals
Division (7405M), Office of Pollution
Prevention and Toxics, Environmental
Protection Agency, 1200 Pennsylvania
Ave. NW, Washington, DC 20460–0001;
telephone number: (202) 564–4163;
email address: wysong.william@epa.gov.
For general information on TSCA: The
TSCA-Hotline, ABVI-Goodwill, 422
South Clinton Ave., Rochester, NY
14620; telephone number: (202) 554–
1404; email address: TSCA-Hotline@
epa.gov.
SUPPLEMENTARY INFORMATION:
I. Executive Summary
A. What is the Agency’s authority for
taking this action?
TSCA section 5(a)(2) (15 U.S.C.
2604(a)(2)) authorizes EPA to determine
that a use of a chemical substance is a
‘‘significant new use.’’ EPA must make
this determination by rule after
considering all relevant factors,
including the factors in TSCA section
5(a)(2) (see also the discussion in Unit
II.).
B. What action is the Agency taking?
EPA is proposing SNURs for the
chemical substances discussed in Unit
III. These SNURs, if finalized as
proposed, would require persons who
intend to manufacture or process any of
these chemical substances for an
activity that is designated as a
significant new use to notify EPA at
least 90 days before commencing that
activity.
ddrumheller on DSK120RN23PROD with PROPOSALS1
C. Does this action apply to me?
1. General Applicability
This action applies to you if you
manufacture, process, or use the
chemical substances contained in this
proposed rule. The following list of
North American Industrial
Classification System (NAICS) codes is
not intended to be exhaustive, but rather
provides a guide to help readers
determine whether this document
applies to them. Potentially affected
entities may include:
• Manufacturers or processors of one
or more subject chemical substances
(NAICS codes 325 and 324110), e.g.,
chemical manufacturing and petroleum
refineries.
2. Applicability to Importers and
Exporters
This action may also apply to certain
entities through pre-existing import
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
certification and export notification
requirements under TSCA (https://
www.epa.gov/tsca-import-exportrequirements).
Chemical importers are subject to
TSCA section 13 (15 U.S.C. 2612), the
requirements in 19 CFR 12.118 through
12.127, 19 CFR 127.28, and the EPA
policy in support of import certification
at 40 CFR part 707, subpart B. Chemical
importers must certify that the shipment
of the chemical substance complies with
all applicable rules and orders under
TSCA, including regulations issued
under TSCA sections 5, 6, 7 and Title
IV.
Pursuant to 40 CFR 721.20, any
persons who export or intend to export
a chemical substance that is the subject
of this proposed rule on or after January
16, 2025 are subject to TSCA section
12(b) (15 U.S.C. 2611(b)) and must
comply with the export notification
requirements in 40 CFR part 707,
subpart D.
D. What are the incremental economic
impacts of this action?
EPA has evaluated the potential costs
of establishing SNUN reporting
requirements for potential
manufacturers (including importers)
and processors of the chemical
substances subject to these proposed
SNURs. This analysis, which is
available in the docket, is briefly
summarized here.
1. Estimated Costs for SNUN
Submissions
If a SNUN is submitted, costs are an
estimated $45,000 per SNUN
submission for large business submitters
and $14,500 for small business
submitters. These estimates include the
cost to prepare and submit the SNUN
(including registration for EPA’s Central
Data Exchange (CDX)), and the payment
of a user fee. Businesses that submit a
SNUN would be subject to either a
$37,000 user fee required by 40 CFR
700.45(c)(2)(ii) and (d), or, if they are a
small business as defined at 13 CFR
121.201, a reduced user fee of $6,480
(40 CFR 700.45(c)(1)(ii) and (d)) per
fiscal year 2022. The costs of
submission for SNUNs will not be
incurred by any company unless a
company decides to pursue a significant
new use as defined in these SNURs.
Additionally, these estimates reflect the
costs and fees as they are known at the
time of this rulemaking.
2. Estimated Costs for Export
Notifications
EPA has also evaluated the potential
costs associated with the export
notification requirements under TSCA
PO 00000
Frm 00032
Fmt 4702
Sfmt 4702
102047
section 12(b) and the implementing
regulations at 40 CFR part 707, subpart
D. For persons exporting a substance
that is the subject of a SNUR, a one-time
notice to EPA must be provided for the
first export or intended export to a
particular country. The total costs of
export notification will vary by
chemical, depending on the number of
required notifications (i.e., the number
of countries to which the chemical is
exported). While EPA is unable to make
any estimate of the likely number of
export notifications for the chemical
substances covered by these SNURs, as
stated in the accompanying economic
analysis, the estimated cost of the export
notification requirement on a per unit
basis is approximately $106.
E. What should I consider as I prepare
my comments for EPA?
1. Submitting CBI
Do not submit CBI to EPA through
email or https://www.regulations.gov. If
you wish to include CBI in your
comment, please follow the applicable
instructions at https://www.epa.gov/
dockets/commenting-epa-dockets#rules
and clearly mark the information that
you claim to be CBI. Information so
marked will not be disclosed except in
accordance with procedures set forth in
40 CFR parts 2 and 703.
2. Tips for Preparing Your Comments
When preparing and submitting your
comments, see the commenting tips at
https://www.epa.gov/dockets/
commenting-epa-dockets.
II. Background
This unit provides general
information about SNURs. For
additional information about EPA’s new
chemical program go to https://
www.epa.gov/reviewing-new-chemicalsunder-toxic-substances-control-act-tsca.
A. Significant New Use Determination
Factors
TSCA section 5(a)(2) states that EPA’s
determination that a use of a chemical
substance is a significant new use must
be made after consideration of all
relevant factors, including:
• The projected volume of
manufacturing and processing of a
chemical substance.
• The extent to which a use changes
the type or form of exposure of human
beings or the environment to a chemical
substance.
• The extent to which a use increases
the magnitude and duration of exposure
of human beings or the environment to
a chemical substance.
• The reasonably anticipated manner
and methods of manufacturing,
E:\FR\FM\17DEP1.SGM
17DEP1
102048
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
processing, distribution in commerce,
and disposal of a chemical substance.
In determining what would constitute
a significant new use for the chemical
substances that are the subject of these
SNURs, EPA considered relevant
information about the toxicity of the
chemical substances, and potential
human exposures and environmental
releases that may be associated with the
substances, in the context of the four
bulleted TSCA section 5(a)(2) factors
listed in this unit and discussed in Unit
III.
These proposed SNURs include PMN
substances that are subject to orders
issued under TSCA section 5(e)(1)(A), as
required by the determinations made
under TSCA section 5(a)(3)(B). The
TSCA orders require protective
measures to limit exposures or
otherwise mitigate the potential
unreasonable risk. The proposed SNURs
identify as significant new uses any
manufacturing, processing, use,
distribution in commerce, or disposal
that does not conform to the restrictions
imposed by the underlying TSCA
orders, consistent with TSCA section
5(f)(4).
B. Rationale and Objectives of the
SNURs
ddrumheller on DSK120RN23PROD with PROPOSALS1
1. Rationale
Under TSCA, no person may
manufacture a new chemical substance
or manufacture or process a chemical
substance for a significant new use until
EPA makes a determination as described
in TSCA section 5(a) and takes any
required action. The issuance of a SNUR
is not a risk determination itself, only a
notification requirement for ‘‘significant
new uses,’’ so that the Agency has the
opportunity to review the SNUN for the
significant new use and make a TSCA
section 5(a)(3) risk determination.
During review of the PMNs submitted
that are the subject to these proposed
SNURs, EPA concluded that regulation
was warranted under TSCA section 5(e),
pending the development of information
sufficient to make reasoned evaluations
of the health or environmental effects of
the chemical substances. Based on the
findings outlined in Unit III., TSCA
section 5(e) Orders requiring the use of
appropriate exposure controls were
negotiated with the PMN submitters. As
a general matter, EPA believes it is
necessary to follow the TSCA Orders
with a SNUR that identifies the absence
of those protective measures as
significant new uses to ensure that all
manufacturers and processors—not just
the original submitter—are held to the
same standard.
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
2. Objectives
EPA is proposing these SNURs
because the Agency wants:
• To identify as significant new uses
any manufacturing, processing, use,
distribution in commerce, or disposal
that does not conform to the restrictions
imposed by the underlying TSCA
Orders, consistent with TSCA section
5(f)(4).
• To have an opportunity to review
and evaluate data submitted in a SNUN
before the submitter begins
manufacturing or processing a listed
chemical substance for the described
significant new use.
• To be obligated to make a
determination under TSCA section
5(a)(3) regarding the use described in
the SNUN, under the conditions of use.
The Agency will either determine under
TSCA section 5(a)(3)(C) that the
significant new use is not likely to
present an unreasonable risk, including
an unreasonable risk to a potentially
exposed or susceptible subpopulation
identified as relevant by the
Administrator under the conditions of
use, or make a determination under
TSCA section 5(a)(3)(A) or (B) and take
the required regulatory action associated
with the determination, before
manufacture or processing for the
significant new use of the chemical
substance can occur.
Issuance of a proposed SNUR for a
chemical substance does not signify that
the chemical substance is listed on the
TSCA Chemical Substance Inventory
(TSCA Inventory). Guidance on how to
determine if a chemical substance is on
the TSCA Inventory is available at
https://www.epa.gov/tsca-inventory.
C. Significant New Uses Claimed as CBI
EPA is proposing to establish certain
significant new uses which have been
claimed as CBI subject to Agency
confidentiality regulations at 40 CFR
part 2 and 40 CFR part 703. Absent a
final determination or other disposition
of the confidentiality claim under these
regulations, EPA is required to keep this
information confidential. EPA
promulgated a procedure at 40 CFR
721.11 to deal with the situation where
a specific significant new use is CBI.
Under these procedures. a manufacturer
or processor may request EPA to
identify the confidential significant new
use under the rule. The manufacturer or
processor must show that it has a bona
fide intent to manufacture or process the
chemical substance. If EPA concludes
that the person has shown a bona fide
intent to manufacture or process the
chemical substance, EPA will identify
the confidential significant new use to
PO 00000
Frm 00033
Fmt 4702
Sfmt 4702
that person. Since most of the chemical
identities of the chemical substances
subject to these SNURs are also CBI,
manufacturers and processors can
combine the bona fide submission
under the procedure in 40 CFR 721.11
into a single step.
D. Applicability of General Provisions
General provisions for SNURs appear
in 40 CFR part 721, subpart A. These
provisions describe persons subject to
SNURs, recordkeeping requirements,
exemptions to reporting requirements,
and applicability of the rule to uses
occurring before the effective date of the
rule. Pursuant to 40 CFR 721.1(c),
persons subject to SNURs must comply
with the same requirements and EPA
regulatory procedures as submitters of
PMNs under TSCA section 5(a)(1)(A). In
particular, these requirements include
the information submission
requirements of TSCA sections 5(b) and
5(d)(1), the exemptions authorized by
TSCA sections 5(h)(1), 5(h)(2), 5(h)(3),
and 5(h)(5) and the regulations at 40
CFR part 720. In addition, provisions
relating to user fees appear at 40 CFR
part 700.
Once EPA receives a SNUN, EPA
must either determine that the
significant new use is not likely to
present an unreasonable risk of injury
under the conditions of use for the
chemical substance or take such
regulatory action as is associated with
an alternative determination under
TSCA section 5 before the manufacture
(including import) or processing for the
significant new use can commence. If
EPA determines that the significant new
use of the chemical substance is not
likely to present an unreasonable risk,
EPA is required under TSCA section
5(g) to make public, and submit for
publication in the Federal Register, a
statement of EPA’s findings.
As discussed in Unit I.C.2., persons
who export or intend to export a
chemical substance identified in a
proposed or final SNUR are subject to
the export notification provisions of
TSCA section 12(b), and persons who
import a chemical substance identified
in a final SNUR are subject to the TSCA
section 13 import certification
requirements. See also https://
www.epa.gov/tsca-import-exportrequirements.
E. Applicability of the Proposed SNURs
to Uses Occurring Before the Effective
Date of the Final Rule
To establish a significant new use,
EPA must determine that the use is not
ongoing. The chemical substances
subject to this proposed rule have
undergone premanufacture review and
E:\FR\FM\17DEP1.SGM
17DEP1
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
received determinations under TSCA
section 5(a)(3)(C). TSCA Orders have
been issued for these chemical
substances and the PMN submitters are
required by the TSCA Orders to submit
a SNUN before undertaking activities
that would be designated as significant
new uses in these SNURs. Additionally,
the identities of many of the chemical
substances subject to this proposed rule
have been claimed as confidential per
40 CFR 720.85, further reducing the
likelihood that another party would
manufacture or process the substances
for an activity that would be designated
as a significant new use. Based on this,
the Agency believes that it is highly
unlikely that any of the significant new
uses identified in Unit III. are ongoing.
When the chemical substances
identified in Unit III. are added to the
TSCA Inventory, EPA recognizes that,
before the rule is effective, other persons
might engage in a use that has been
identified as a significant new use.
Persons who begin manufacture or
processing of the chemical substances
for a significant new use identified on
or after the designated cutoff date
specified in Unit III.A. would have to
cease any such activity upon the
effective date of the final rule. To
resume their activities, these persons
would have to first comply with all
applicable SNUR notification
requirements and EPA would have to
take action under TSCA section 5
allowing manufacture or processing to
proceed.
F. Important Information About SNUN
Submissions
1. SNUN Submissions
SNUNs must be submitted on EPA
Form No. 7710–25, generated using ePMN software, and submitted to the
Agency in accordance with the
procedures set forth in 40 CFR 720.40
and 721.25. E–PMN software is
available electronically at https://
www.epa.gov/reviewing-new-chemicalsunder-toxic-substances-control-act-tsca.
ddrumheller on DSK120RN23PROD with PROPOSALS1
2. Development and Submission of
Information
EPA recognizes that TSCA section 5
does not require development of any
particular new information (e.g.,
generating test data) before submission
of a SNUN. There is an exception: If a
person is required to submit information
for a chemical substance pursuant to a
rule, order or consent agreement under
TSCA section 4, then TSCA section
5(b)(1)(A) requires such information to
be submitted to EPA at the time of
submission of the SNUN.
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
In the absence of a rule, TSCA order,
or consent agreement under TSCA
section 4 covering the chemical
substance, persons are required only to
submit information in their possession
or control and to describe any other
information known to or reasonably
ascertainable by them (see 40 CFR
720.50). However, upon review of PMNs
and SNUNs, the Agency has the
authority to require appropriate testing.
To assist with EPA’s analysis of the
SNUN, submitters are encouraged, but
not required, to provide the potentially
useful information identified for the
chemical substance in Unit III.C.
EPA strongly encourages persons,
before performing any testing, to consult
with the Agency pertaining to protocol
selection. Furthermore, pursuant to
TSCA section 4(h), which pertains to
reduction of testing in vertebrate
animals, EPA encourages consultation
with the Agency on the use of
alternative test methods and strategies
(also called New Approach
Methodologies, or NAMs), if available,
to generate the recommended test data.
EPA encourages dialog with Agency
representatives to help determine how
best the submitter can meet both the
data needs and the objective of TSCA
section 4(h). For more information on
alternative test methods and strategies
to reduce vertebrate animal testing, visit
https://www.epa.gov/assessing-andmanaging-chemicals-under-tsca/
alternative-test-methods-and-strategiesreduce.
The potentially useful information
described in Unit III. may not be the
only means of providing information to
evaluate the chemical substance
associated with the significant new
uses. However, submitting a SNUN
without any test data may increase the
likelihood that EPA will take action
under TSCA sections 5(e) or 5(f). EPA
recommends that potential SNUN
submitters contact EPA early enough so
that they will be able to conduct the
appropriate tests.
SNUN submitters should be aware
that EPA will be better able to evaluate
SNUNs that provide detailed
information on the human exposure and
environmental release that may result
from the significant new use of the
chemical substances.
III. Chemical Substances Subject to
These Proposed SNURs
A. What is the designated cutoff date for
ongoing uses?
EPA designates December 17, 2024 as
the cutoff date for determining whether
the new use is ongoing. This
PO 00000
Frm 00034
Fmt 4702
Sfmt 4702
102049
designation is explained in more detail
in Unit II.E.
B. What information is provided for
each chemical substance?
For each chemical substance
identified in Unit III.C., EPA provides
the following information:
• PMN number (the proposed CFR
citation assigned in the regulatory text
section of the proposed rule).
• Chemical name (generic name, if
the specific name is claimed as CBI).
• Chemical Abstracts Service Registry
Number (CASRN) (if assigned for nonconfidential chemical identities).
• Basis for the action (effective date of
and basis for the TSCA Order).
• Potentially useful information.
The regulatory text section of the
proposed rule specifies the activities
designated as significant new uses.
Certain new uses, including production
volume limits and other uses designated
in the proposed rules, may be claimed
as CBI.
These proposed rules include PMN
substances that are subject to orders
issued under TSCA section 5(e)(1)(A), as
required by the determinations made
under TSCA section 5(a)(3)(B). Those
TSCA Orders require protective
measures to limit exposures or
otherwise mitigate the potential
unreasonable risk. The proposed SNURs
identify as significant new uses any
manufacturing, processing, use,
distribution in commerce, or disposal
that does not conform to the restrictions
imposed by the underlying TSCA
Orders, consistent with TSCA section
5(f)(4).
C. Which chemical substances are
subject to these proposed rules?
The substances subject to the
proposed rules in this document are as
follows:
PMN Number (Proposed CFR Citation):
P–18–127 (40 CFR 721.12043)
Chemical Name: Heptane, 2-methoxy2-methyl-.
CASRN: 76589–16–7.
Effective Date of TSCA Order:
December 15, 2023.
Basis for TSCA Order: The PMN states
that the use will be as a fragrance for
household and consumer products,
mainly laundry detergents. Based on
submitted test data on the PMN
substance, EPA has identified concerns
for skin sensitization. Based on
comparison to analogous chemical
substances, EPA has also identified
concerns for systemic and
developmental effects. Based on
submitted test data on the PMN
substance, EPA predicts toxicity to
E:\FR\FM\17DEP1.SGM
17DEP1
102050
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
ddrumheller on DSK120RN23PROD with PROPOSALS1
aquatic organisms may occur at
concentrations that exceed 210 ppb. The
Order was issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence
of sufficient information to permit a
reasoned evaluation, the substance may
present an unreasonable risk of injury to
human health and the environment. To
protect against these risks, the Order
requires:
• Manufacture of the PMN substance
only by import into the United States in
a solution of no greater than 5% by
weight (i.e., no domestic manufacture);
• Processing of the PMN substance
only in a solution of no greater than 5%
by weight of the PMN substance;
• Processing for use or use of the
PMN substance in consumer products
only if the concentration of the PMN
substance is less than 1% by weight;
• No release of the PMN substance, or
any waste stream containing the PMN
substance, in surface water
concentrations that exceed 210 ppb;
• Use of personal protective
equipment where there is a potential for
dermal exposure; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of
developmental toxicity, specific target
organ toxicity, and pulmonary effects
testing may be potentially useful to
characterize the health and
environmental effects of the PMN
substance. Although the Order does not
require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
based on submission of this or other
relevant information.
PMN Number (Proposed CFR Citation):
P–18–325 (40 CFR 721.12044)
Chemical Name: Benzenesulfonic
acid, alkyl-, compd. with 1,1′iminobis[2-propanol] (1:1) (generic).
CASRN: Not available.
Effective Date of TSCA Order: January
9, 2024.
Basis for TSCA Order: The PMN states
that the use will be as an industrial
crosslinking catalyst. Based on the
structure of the anion, EPA identified
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
concerns for lung toxicity (surfactant
effects). Based on test data for the
neutral form of the cation and analogues
for the anion, EPA also identified
concerns for skin and eye irritation, and
systemic and reproductive effects. Based
on comparison to analogous anionic
surfactants, EPA predicts toxicity to
aquatic organisms may occur at
concentrations that exceed 0.4 ppb. The
Order was issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence
of sufficient information to permit a
reasoned evaluation, the substance may
present an unreasonable risk of injury to
human health and the environment. To
protect against these risks, the Order
requires:
• No manufacture, processing, or use
of the PMN substance in any manner
that results in inhalation exposure to the
PMN substance;
• No processing for use or use of the
PMN substance other than as an
industrial cross-linking catalyst;
• No release of the PMN substances,
or any waste stream containing the PMN
substances, into waters of the United
States;
• Use of personal protective
equipment where there is a potential for
dermal exposure; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of skin
irritation/corrosion, eye irritation/
corrosion, pulmonary effects, specific
target organ toxicity, and aquatic
toxicity testing may be potentially
useful to characterize the health and
environmental effects of the PMN
substance. Although the Order does not
require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
based on submission of this or other
relevant information.
PMN Number (Proposed CFR Citation):
P–20–14 (40 CFR 721.12045)
Chemical Name: Sugars, polymer
with alkanetriamine (generic).
CASRN: Not available.
Effective Date of TSCA Order: January
27, 2023.
PO 00000
Frm 00035
Fmt 4702
Sfmt 4702
Basis for TSCA Order: The PMN states
that the generic (non-confidential) use
will be as a water resistant resin
additive. Based on comparison to
analogous chemical substances, EPA has
identified concerns for systemic effects
(body weight). Based on potential
chelation to nutrient metals, EPA has
also identified concerns for
developmental and systemic effects.
Based on submitted test data on the
PMN substance, EPA predicts toxicity to
aquatic organisms may occur at
concentrations that exceed 191 ppb. The
Order was issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence
of sufficient information to permit a
reasoned evaluation, the substance may
present an unreasonable risk of injury to
human health and the environment. To
protect against these risks, the Order
requires:
• No use of the PMN substance in a
consumer product;
• No release of the PMN substance, or
any waste stream containing the PMN
substance, in surface water
concentrations that exceed 191 ppb;
• Use of personal protective
equipment where there is a potential for
dermal exposure; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of
reproductive toxicity and specific target
organ toxicity testing may be potentially
useful to characterize the health and
environmental effects of the PMN
substance. Although the Order does not
require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
based on submission of this or other
relevant information.
PMN Number (Proposed CFR Citation):
P–21–86 (40 CFR 721.12046)
Chemical Name: Isooctadecanamide,
N,N-bis(2-ethylhexyl)-.
CASRN: 1616494–50–8.
Effective Date of TSCA Order:
February 6, 2024.
Basis for TSCA Order: The PMN states
that the generic (non-confidential) use
will be as an automotive engine
E:\FR\FM\17DEP1.SGM
17DEP1
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
ddrumheller on DSK120RN23PROD with PROPOSALS1
additive. Based on test data for the
metabolite, EPA has identified concerns
for systemic effects. The Order was
issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence
of sufficient information to permit a
reasoned evaluation, the substance may
present an unreasonable risk of injury to
human health. To protect against these
risks, the Order requires:
• No processing for use of the PMN
substance in a consumer product where
the concentration of the PMN substance
in the consumer product formulation
exceeds the confidential percentage
listed in the Order;
• No use of the PMN substance in a
consumer product where the
concentration of the PMN substance
exceeds the confidential percentage
listed in the Order;
• Use of personal protective
equipment where there is a potential for
dermal exposure; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of
metabolism or pharmacokinetics and
specific target organ toxicity testing may
be potentially useful to characterize the
health effects of the PMN substance.
Although the Order does not require
these tests, the Order’s restrictions
remain in effect until the Order is
modified or revoked by EPA based on
submission of this or other relevant
information.
PMN Number (Proposed CFR Citation):
P–21–164 (40 CFR 721.12047)
Chemical Name: 2-Butanone, oxime,
reaction products with
trimethoxymethylsilane.
CASRN: 2639393–45–4.
Effective Date of TSCA Order:
November 13, 2023.
Basis for TSCA Order: The PMN states
that the use will be as a crosslinker for
waterproofing. Based on comparison to
analogous chemical substances, EPA has
identified concerns for irritation to skin
and eyes and systemic effects. Based on
test data for hydrolysis products, EPA
has also identified concerns for acute
toxicity, skin irritation, eye corrosion,
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
respiratory tract irritation and corrosion,
skin sensitization, systemic effects,
developmental effects, neurotoxicity
and carcinogenicity. Based on test data
for hydrolysis products, EPA predicts
toxicity to aquatic organisms may occur
at concentrations that exceed 102 ppb.
The Order was issued under TSCA
sections 5(a)(3)(B)(ii)(I) and
5(e)(1)(A)(ii)(I), based on a finding that
in the absence of sufficient information
to permit a reasoned evaluation, the
substance may present an unreasonable
risk of injury to human health and the
environment. To protect against these
risks, the Order requires:
• No use of the PMN substance unless
at 4% or less by weight in formulation;
• No loading or unloading of the
PMN substance for manufacture,
processing, or use unless under a gas
(e.g., nitrogen) blanket;
• Application of the PMN substance
for use only by roll, brush, or dip
coating;
• Use of personal protective
equipment where there is a potential for
dermal exposure;
• Use of a NIOSH-certified
combination particulate and gas/vapor
respirator with an APF of at least 50
where there is a potential for inhalation
exposure;
• Disposal of the PMN substance, or
waste streams containing the PMN
substance, only by incineration;
• No release of the PMN substance, or
any waste stream containing the PMN
substance, into waters of the United
States; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of acute
toxicity, carcinogenicity, eye damage,
pulmonary effects, skin irritation,
specific target organ toxicity, and
aquatic toxicity testing may be
potentially useful to characterize the
health and environmental effects of the
PMN substance. Although the Order
does not require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
based on submission of this or other
relevant information.
PO 00000
Frm 00036
Fmt 4702
Sfmt 4702
102051
PMN Number (Proposed CFR Citation):
P–21–170 (40 CFR 721.12048)
Chemical Name: 2,6-Bis(dialkyl)-4-[2(1-alkyl-4(1H)pyridinylidene)alkylidene]-2,5cycloalkyladien-1-one (generic).
CASRN: Not available.
Effective Date of TSCA Order: January
27, 2024.
Basis for TSCA Order: The PMN states
that the use will be as a color indicator
for frying oil breakdown. Based on
comparison to analogous chemical
substances, EPA has identified concerns
for irritation to skin and eyes, skin
sensitization, neurotoxicity, systemic
effects (respiratory tract, lung, liver,
kidney, spleen, and body weight
effects), reproductive and
developmental effects, genotoxicity,
carcinogenicity, and acute toxicity
(mortality). Based on OECD Toolbox
results, EPA identified concerns for skin
sensitization and based on information
provided in the SDS, EPA has also
identified concerns for acute toxicity
and irritation to skin, eyes, and
respiratory tract. Based on comparison
to analogous chemical substances, EPA
predicts toxicity to aquatic organisms
may occur at concentrations that exceed
1 ppb. The Order was issued under
TSCA sections 5(a)(3)(B)(ii)(I) and
5(e)(1)(A)(ii)(I), based on a finding that
in the absence of sufficient information
to permit a reasoned evaluation, the
substance may present an unreasonable
risk of injury to human health and the
environment. To protect against these
risks, the Order requires:
• Manufacture of the PMN substance
only below an annual volume of 10 kg;
• No manufacture, processing, or use
of the PMN substance resulting in
releases to air except with the use of a
HEPA filtration system;
• No processing for use or use of the
PMN substance other than as a color
indicator for frying oil breakdown;
• No processing for use or use of the
PMN substance where the concentration
of the PMN substance in the final
product exceeds 0.008%;
• No release of the PMN substance, or
any waste stream containing the PMN
substance, into waters of the United
States;
• Use of a NIOSH-certified particulate
respirator with an APF of at least 10
where there is a potential for inhalation
exposure;
• Use of personal protective
equipment where there is a potential for
dermal exposure; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
E:\FR\FM\17DEP1.SGM
17DEP1
102052
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of
biodegradation, bioaccumulation, log P,
and aquatic toxicity testing may be
potentially useful to characterize the
physical/chemical properties and
environmental fate/effects of the PMN
substance. Although the Order does not
require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
based on submission of this or other
relevant information.
ddrumheller on DSK120RN23PROD with PROPOSALS1
PMN Number (Proposed CFR Citation):
P–21–184 (40 CFR 721.12049)
Chemical Name: Fatty acids, soya,
reaction products with ammoniaethanolamine reaction by-products.
CASRN: 2378512–59–3.
Effective Date of TSCA Order:
November 16, 2023.
Basis for TSCA Order: The PMN states
that the generic (non-confidential) use
will be in asphalt emulsion
applications. Based on comparison to
analogous chemical substances, EPA has
identified concerns for acute toxicity,
skin and eye irritation/corrosion, skin
sensitization, point-of-contact effects,
lung effects, and systemic effects. Based
on the surfactant-like properties of the
PMN substance and its use as an
emulsifier, EPA has also identified
concerns for lung effects (surfactancy).
Based on information in the SDS, EPA
has also identified concerns for skin
irritation, eye corrosion, and respiratory
irritation. Based on comparison to
analogous aliphatic amines, EPA
predicts toxicity to aquatic organisms
may occur at concentrations that exceed
2 ppb. The Order was issued under
TSCA sections 5(a)(3)(B)(ii)(I) and
5(e)(1)(A)(ii)(I), based on a finding that
in the absence of sufficient information
to permit a reasoned evaluation, the
substance may present an unreasonable
risk of injury to human health and the
environment. To protect against these
risks, the Order requires:
• No manufacture, processing, or use
of the PMN substance in any manner
that results in the generation of vapor,
mist, dust, or aerosol;
• No processing for use or use of the
PMN substance in a consumer product;
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
• Use of personal protective
equipment where there is a potential for
dermal exposure;
• No release of the PMN substance, or
any waste stream containing the PMN
substance, in surface water
concentrations that exceed 2 ppb; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of acute
toxicity, specific target organ toxicity,
pulmonary effects, skin irritation/
corrosion, eye damage, neurotoxicity,
skin sensitization, and aquatic toxicity
testing may be potentially useful to
characterize the health and
environmental effects of the PMN
substance. Although the Order does not
require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
based on submission of this or other
relevant information.
PMN Numbers (Proposed CFR
Citations): P–22–3 (40 CFR 721.12050),
P–22–4 (40 CFR 721.12051), P–22–5 (40
CFR 721.12052), and P–22–6 (40 CFR
721.12053)
Chemical Names: 1,5Pentanediamine, 2-methyl-,
hydrochloride (1:2) (P–22–3), 1,5Pentanediamine, 2-methyl-,
hydrochloride (1:1) (P–22–4), Formic
acid, compd. with 2-methyl-1,5pentanediamine (2:1) (P–22–5), and
Formic acid, compd. with 2-methyl-1,5pentanediamine (1:1) (P–22–6).
CASRNs: 34813–63–3 (P–22–3),
1840915–04–9 (P–22–4), 1836131–73–7
(P–22–5), and 1836131–75–9 (P–22–6).
Effective Date of TSCA Order:
December 4, 2023.
Basis for TSCA Order: The PMNs state
that the uses will be as clay stabilizers
for oil and gas fracking. Based on
submitted test data on the P–22–3
substance, comparison to analogous
chemical substances, structure and
expected acidity or basicity of
components, physical/chemical
properties of components, and
information provided in the SDS, EPA
has identified concerns for acute
toxicity, irritation or corrosion to skin,
eyes, and respiratory tract, and systemic
PO 00000
Frm 00037
Fmt 4702
Sfmt 4702
effects. Based on submitted test data for
the P–22–3 substance, EPA predicts
toxicity to aquatic organisms may occur
at concentrations that exceed 570 ppb.
The Order was issued under TSCA
sections 5(a)(3)(B)(ii)(I) and
5(e)(1)(A)(ii)(I), based on a finding that
in the absence of sufficient information
to permit a reasoned evaluation, the
substances may present an unreasonable
risk of injury to human health and the
environment. To protect against these
risks, the Order requires:
• No processing for use or use of the
PMN substances in consumer products;
• No manufacture, processing, or use
of the PMN substances in any manner
that results in inhalation exposure to the
PMN substances;
• Use of personal protective
equipment where there is a potential for
dermal exposure;
• No release of the PMN substances,
or any waste stream containing the PMN
substances, in surface water
concentrations that exceed 570 ppb
combined; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of eye
irritation/corrosion, skin irritation/
corrosion, specific target organ toxicity,
pulmonary effects, and aquatic toxicity
testing may be potentially useful to
characterize the health and
environmental effects of the PMN
substances. Although the Order does not
require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
based on submission of this or other
relevant information.
PMN Number (Proposed CFR Citation):
P–22–11 (40 CFR 721.12054)
Chemical Name: Alkadiene,
homopolymer, hydroxy-terminated,
bis[N-[2-[(1-oxo-2-propen-1yl)oxylethyl]carbamates] (generic).
CASRN: Not available.
Effective Date of TSCA Order:
November 27, 2023.
Basis for TSCA Order: The PMN states
that the generic (non-confidential) use
will be as a functionalized rubber in the
resin side of two component epoxy
E:\FR\FM\17DEP1.SGM
17DEP1
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
ddrumheller on DSK120RN23PROD with PROPOSALS1
modified acrylic adhesive and as a
functionalized rubber in the resin side
of two component acrylic adhesive.
Based on test data on one or both of the
two components in the formulation,
EPA has identified concerns for skin
sensitization, and systemic,
reproductive, and developmental
effects. Based on the weight of the
scientific evidence, EPA has also
identified concerns for respiratory
sensitization. Based on information in
the SDS, EPA has also identified
concerns for skin sensitization and
reproductive toxicity. The Order was
issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence
of sufficient information to permit a
reasoned evaluation, the substance may
present an unreasonable risk of injury to
human health. To protect against these
risks, the Order requires:
• No use of the PMN substance in a
consumer product;
• No manufacture, processing, or use
of the PMN substance in any manner
that results in inhalation exposure;
• Use of personal protective
equipment where there is a potential for
dermal exposure; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of skin
sensitization, developmental toxicity,
reproductive toxicity, and specific target
organ toxicity testing may be potentially
useful to characterize the health effects
of the PMN substance. Although the
Order does not require these tests, the
Order’s restrictions remain in effect
until the Order is modified or revoked
by EPA based on submission of this or
other relevant information.
PMN Number (Proposed CFR Citation):
P–22–25 (40 CFR 721.12055)
Chemical Name: Oxirane, 2(chloromethyl)-, homopolymer, ether
with dialkyl-alkanediol (2:1) (generic).
CASRN: Not available.
Effective Date of TSCA Order:
February 20, 2024.
Basis for TSCA Order: The PMN states
that the use will be as a chemical
intermediate. Based on comparison to
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
analogous chemical substances and
structural alerts, EPA has identified
concerns for acute toxicity, irritation to
the respiratory tract, skin, and eyes,
systemic effects, genetic toxicity, and
carcinogenicity. The Order was issued
under TSCA sections 5(a)(3)(B)(ii)(I) and
5(e)(1)(A)(ii)(I), based on a finding that
in the absence of sufficient information
to permit a reasoned evaluation, the
substance may present an unreasonable
risk of injury to human health. To
protect against these risks, the Order
requires:
• No exceedance of the confidential
annual production volume listed in the
Order;
• No manufacture, processing, or use
of the PMN substance in any manner
that results in the generation of a vapor,
mist, dust, or aerosol;
• Use of the PMN substance only as
a chemical intermediate;
• Disposal of the PMN substance, or
waste streams containing the PMN
substance, only by hazardous waste
incineration;
• No release of the PMN substance, or
any waste stream containing the PMN
substance, into waters of the United
States;
• Use of personal protective
equipment where there is a potential for
dermal exposure; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of acute
toxicity, specific target organ toxicity,
pulmonary effects, eye irritation, skin
irritation, genetic toxicity, and
carcinogenicity testing may be
potentially useful to characterize the
health effects of the PMN substance.
Although the Order does not require
these tests, the Order’s restrictions
remain in effect until the Order is
modified or revoked by EPA based on
submission of this or other relevant
information.
PMN Number (Proposed CFR Citation):
P–22–49 (40 CFR 721.12056)
Chemical Name: Aryl, polymer with
formaldehyde, glycidyl ether, reaction
products with amino alkyl-alkane
diamine, cyclohexanediamine and
PO 00000
Frm 00038
Fmt 4702
Sfmt 4702
102053
alkylene (alkylcyclohexanamine)
(generic).
CASRN: Not available.
Effective Date of TSCA Order: January
11, 2024.
Basis for TSCA Order: The PMN states
that the use will be as a hardener in
coatings for oil and gas, power, and
chemical/petrochemical industries for
tank and pipe linings and for asset
protection, in coatings in wastewater
applications industries for tank and
pipe linings and for asset protection, in
coatings used in manufacturing
industries for tank and pipe linings and
for asset protection, and in OEM
automotive and heavy industrial
machinery coatings. Based on submitted
test data on the PMN substance, EPA
has identified concerns for acute
toxicity. Based on residual data, EPA
has also identified concerns for
irritation to the skin, eye, and
respiratory tract, skin and respiratory
sensitization, systemic, developmental,
and reproductive effects, corrosion to all
tissues, and genetic toxicity. Based on
submitted test data on the PMN
substance and comparison to analogous
polycationic polymers, EPA predicts
toxicity to aquatic organisms may occur
at concentrations that exceed 2 ppb. The
Order was issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence
of sufficient information to permit a
reasoned evaluation, the substance may
present an unreasonable risk of injury to
human health or the environment. To
protect against these risks, the Order
requires:
• No release of the PMN substance, or
any waste stream containing the PMN
substance, in surface water
concentrations that exceed 2 ppb;
• Use of a NIOSH-certified particulate
respirator with an APF of at least 1,000
where there is a potential for inhalation
exposure;
• No use of the PMN substance in a
consumer product;
• Use of personal protective
equipment where there is a potential for
dermal exposure; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
E:\FR\FM\17DEP1.SGM
17DEP1
102054
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
ddrumheller on DSK120RN23PROD with PROPOSALS1
determined that the results of skin
irritation, skin corrosion, eye irritation,
eye corrosion, specific target organ
toxicity, pulmonary effects, and aquatic
toxicity testing may be potentially
useful to characterize the health and
environmental effects of the PMN
substance. Although the Order does not
require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
based on submission of this or other
relevant information.
PMN Number (Proposed CFR Citation):
P–22–50 (40 CFR 721.12057)
Chemical Name: Alkene, alkoxy-,
polymer with alkoxyalkene (generic).
CASRN: Not available.
Effective Date of TSCA Order: January
8, 2024.
Basis for TSCA Order: The PMN states
that the generic (non-confidential) use
will be as a lubricant. Based on
comparison to analogous chemical
substances, EPA has identified concerns
for skin, eye, and respiratory tract
irritation and systemic effects. Based on
comparison to analogous neutral
organics, EPA predicts toxicity to
aquatic organisms may occur at
concentrations that exceed 32 ppb. The
Order was issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence
of sufficient information to permit a
reasoned evaluation, the substance may
present an unreasonable risk of injury to
human health and the environment. To
protect against these risks, the Order
requires:
• No processing for use or use of the
PMN substance in a consumer product;
• No manufacture, processing, or use
of the PMN substance in any manner
that results in inhalation exposure to the
PMN substance;
• No processing for use or use of the
PMN substance other than for the
confidential use listed in the Order;
• No release of the PMN substance, or
any waste stream containing the PMN
substance, into waters of the United
States;
• Use of personal protective
equipment where there is a potential for
dermal exposure; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of specific
target organ toxicity, skin irritation, eye
irritation, pulmonary effects, and
aquatic toxicity testing may be
potentially useful to characterize the
health and environmental effects of the
PMN substance. Although the Order
does not require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
based on submission of this or other
relevant information.
PMN Number (Proposed CFR Citation):
P–22–58 (40 CFR 721.12058)
Chemical Name:
Methanesulfonamide, 1,1,1-trifluoro-N[(trifluoromethyl)sulfonyl]-, sodium salt
(1:1).
CASRN: 91742–21–1.
Effective Date of TSCA Order:
February 13, 2024.
Basis for TSCA Order: The PMN states
that the generic (non-confidential) use
will be as a process chemical. Based on
submitted test data on the PMN
substance, EPA has identified concerns
for acute toxicity and serious eye
damage. Based on comparison to
analogous chemical substances, EPA has
also identified concerns for respiratory
tract and skin irritation, neurotoxicity,
systemic, reproductive, and
developmental effects. Based on
comparison to analogous chemical
substances, EPA has also identified
concerns for respiratory, systemic, and
neurological effects for the potential
incineration product of the anion. Based
on submitted test data on the PMN
substance and comparison to analogous
substances, EPA predicts toxicity to
aquatic organisms may occur at
concentrations that exceed 140 ppb. The
Order was issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence
of sufficient information to permit a
reasoned evaluation, the substance may
present an unreasonable risk of injury to
human health and the environment. To
protect against these risks, the Order
requires:
• No manufacture of the PMN
substance other than in an enclosed
process;
• No processing or use of the PMN
substance other than in a manner that
does not generate a vapor, mist, dust, or
aerosol that results in inhalation
exposure to workers;
• No use of the PMN substance other
than for the confidential use listed in
the Order;
• No use of the PMN substance other
than in the form of a liquid;
PO 00000
Frm 00039
Fmt 4702
Sfmt 4702
• No release of the PMN substance, or
any waste stream containing the PMN
substance, in surface water
concentrations that exceed 100 ppb;
• Use of a NIOSH-certified
combination particulate and gas/vapor
respirator with an APF of at least 50
where there is a potential for inhalation
exposure;
• Use of personal protective
equipment where there is a potential for
dermal exposure; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of specific
target organ toxicity, pulmonary effects,
reproductive toxicity, developmental
toxicity, neurotoxicity, sediment
toxicity, and aquatic toxicity testing
may be potentially useful to characterize
the health and environmental effects of
the PMN substance. Although the Order
does not require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
based on submission of this or other
relevant information.
PMN Number (Proposed CFR Citation):
P–22–75 (40 CFR 721.12059)
Chemical Name: 1H-Isoindole1,3(2H)-dione, 3a,4,7,7a-tetrahydro-2-(2hydroxyethyl)-.
CASRN: 15458–48–7.
Effective Date of TSCA Order: January
19, 2024.
Basis for TSCA Order: The PMN states
that the use will be as a monomer used
to produce an unsaturated polyester
resin. Based on comparison to
analogous chemical substances, EPA has
identified concerns for acute toxicity,
skin and eye irritation, and systemic
effects. Based on comparison to
analogous imides, EPA predicts toxicity
to aquatic organisms may occur at
concentrations that exceed 21 ppb. The
Order was issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence
of sufficient information to permit a
reasoned evaluation, the substance may
present an unreasonable risk of injury to
human health and the environment. To
protect against these risks, the Order
requires:
E:\FR\FM\17DEP1.SGM
17DEP1
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
• Manufacture of the PMN substance
only at or below an annual volume of
3,000 kg;
• No domestic manufacture of the
PMN substance (i.e., import only);
• No use of the PMN substance other
than as a monomer used to produce an
unsaturated polyester resin;
• Use of personal protective
equipment where there is a potential for
dermal exposure; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of acute
toxicity, eye irritation, skin irritation,
pulmonary effects, specific target organ
toxicity, and aquatic toxicity testing
may be potentially useful to characterize
the health and environmental effects of
the PMN substance. Although the Order
does not require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
based on submission of this or other
relevant information.
ddrumheller on DSK120RN23PROD with PROPOSALS1
PMN Number (Proposed CFR Citation):
P–22–78 (40 CFR 721.12060)
Chemical Name: Oxirane, 2-methyl-,
polymer with oxirane, mono-isoalkyl
ethers, phosphates, salt (generic).
CASRN: Not available.
Effective Date of TSCA Order:
November 27, 2023.
Basis for TSCA Order: The PMN states
that the use will be as a dispersing agent
for pesticide formulations. Based on
structure, EPA has identified concerns
for lung effects (surfactancy). Based on
comparison to analogous chemical
substances, EPA has also identified
concerns for skin irritation and systemic
effects. Based on comparison to
analogous anionic surfactants, EPA
predicts toxicity to aquatic organisms
may occur at concentrations that exceed
23 ppb. The Order was issued under
TSCA sections 5(a)(3)(B)(ii)(I) and
5(e)(1)(A)(ii)(I), based on a finding that
in the absence of sufficient information
to permit a reasoned evaluation, the
substance may present an unreasonable
risk of injury to human health and the
environment. To protect against these
risks, the Order requires:
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
• No processing for use or use of the
PMN substance other than as a
dispersing agent for pesticide
formulations;
• No manufacture or processing of the
PMN substance in any manner that
results in the generation of a vapor,
mist, dust, or aerosol;
• Use of personal protective
equipment where there is a potential for
dermal exposure;
• No release of the PMN substance, or
any waste stream containing the PMN
substance, in surface water
concentrations that exceed 23 ppb; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of
pulmonary effects, skin irritation,
specific target organ toxicity, and
aquatic toxicity testing may be
potentially useful to characterize the
health and environmental effects of the
PMN substance. Although the Order
does not require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
based on submission of this or other
relevant information.
PMN Number (Proposed CFR Citation):
P–22–80 (40 CFR 721.12061)
Chemical Name: Poly(oxy-1,2ethanediyl), .alpha.-(2-aminoethyl).omega.-(2-aminoethoxy)- and Poly(oxy1,2-ethanediyl), .alpha.,.alpha.′,(iminodi-2,1- ethanediyl)bis[.omega.-(2aminoethoxy)-.
CASRNs: 24991–53–5 and 90350–34–
8.
Effective Date of TSCA Order:
December 1, 2023.
Basis for TSCA Order: The PMN states
that the use will be as an industrial
intermediate used in the manufacture of
polyamides as a monomer. Based on the
pH of the PMN substance, EPA has
identified concerns for skin, eye, and
respiratory tract corrosion. Based on
comparison to analogous chemical
substances, EPA has also identified
concerns for acute toxicity and skin
sensitization. Based on comparison to
analogous polycationic polymers, EPA
predicts toxicity to aquatic organisms
may occur at concentrations that exceed
PO 00000
Frm 00040
Fmt 4702
Sfmt 4702
102055
0.7 ppb. The Order was issued under
TSCA sections 5(a)(3)(B)(ii)(I) and
5(e)(1)(A)(ii)(I), based on a finding that
in the absence of sufficient information
to permit a reasoned evaluation, the
substance may present an unreasonable
risk of injury to human health and the
environment. To protect against these
risks, the Order requires:
• No manufacture, processing, or use
of the PMN substance in any manner
that results in inhalation exposure;
• No release of the PMN substance, or
any waste stream containing the PMN
substance, in surface water
concentrations that exceed 0.7 ppb;
• Use of personal protective
equipment where there is a potential for
dermal exposure; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of acute
toxicity, skin corrosion, eye corrosion,
pulmonary effects, skin sensitization,
and aquatic toxicity testing may be
potentially useful to characterize the
health and environmental effects of the
PMN substance. Although the Order
does not require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
based on submission of this or other
relevant information.
PMN Number (Proposed CFR Citation):
P–22–82 (40 CFR 721.12062)
Chemical Name: Alkenoic acid, alkyl,
carbopolycyclic alkyl ester, polymer
with trihalo (trihaloalkyl) alkyl alkyl
alkenoate (generic).
CASRN: Not available.
Effective Date of TSCA Order:
November 3, 2023.
Basis for TSCA Order: The PMN states
that the generic (non-confidential) use
will be as a component of photoresist.
Based on test data on the degradation
product and an analogue of the
degradation product, EPA has identified
concerns for neurotoxicity,
reproductive, developmental, and
systemic effects. Based on the potential
incineration product, EPA has also
identified concerns for systemic effects,
and neurotoxicity. The Order was
issued under TSCA sections
E:\FR\FM\17DEP1.SGM
17DEP1
102056
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
ddrumheller on DSK120RN23PROD with PROPOSALS1
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence
of sufficient information to permit a
reasoned evaluation, the substance may
present an unreasonable risk of injury to
human health. To protect against these
risks, the Order requires:
• No manufacture of the PMN
substance other than by import into the
United States (i.e., no domestic
manufacture) in a liquid formulation;
• No processing or use of the PMN
substance other than in a liquid
formulation;
• Use of the PMN substance only for
the confidential use listed in the Order;
• No release of the PMN substance, or
any waste stream containing the PMN
substance, into waters of the United
States;
• Disposal of the PMN substance, or
waste streams containing the PMN
substance, only by incineration;
• Use of personal protective
equipment where there is a potential for
dermal exposure; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of
pulmonary effects, reproductive and
developmental effects, and
neurotoxicity testing may be potentially
useful to characterize the health effects
of the PMN substance. Although the
Order does not require these tests, the
Order’s restrictions remain in effect
until the Order is modified or revoked
by EPA based on submission of this or
other relevant information.
PMN Number (Proposed CFR Citation):
P–22–121 (40 CFR 721.12063)
Chemical Name: Polychloroalkene
(generic).
CASRN: Not available.
Effective Date of TSCA Order:
February 6, 2024.
Basis for TSCA Order: The PMN states
that the generic (non-confidential) use
will be as a process intermediate. Based
on submitted test data on the PMN
substance and information in the SDS,
EPA has identified concerns for acute
toxicity (oral) and skin sensitization.
Based on test data for analogues, EPA
identified concerns for acute toxicity
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
(oral, inhalation), skin irritation, eye
corrosion, respiratory irritation,
genotoxicity, carcinogenicity, and
systemic effects. Based on submitted
acute test data and comparison to
analogous chemical substances, EPA
predicts toxicity to aquatic organisms
may occur at concentrations that exceed
0.15 ppb. The Order was issued under
TSCA sections 5(a)(3)(B)(ii)(I) and
5(e)(1)(A)(ii)(I), based on a finding that
in the absence of sufficient information
to permit a reasoned evaluation, the
substance may present an unreasonable
risk of injury to human health and the
environment. To protect against these
risks, the Order requires:
• No domestic manufacture of the
PMN substance (i.e., import only);
• No processing, use, loading, or
unloading of the PMN substance unless
under a gas (e.g., nitrogen) blanket or in
a closed system except that sampling
may occur outside the closed system
resulting in exposures;
• No use of the PMN substance other
than for the confidential use listed in
the Order;
• Use of a NIOSH-certified
combination particulate and gas/vapor
respirator with an APF of at least 50
where there is a potential for inhalation
exposure;
• Use of personal protective
equipment where there is a potential for
dermal exposure;
• No release of the PMN substance, or
any waste stream containing the PMN
substance, in surface water
concentrations that exceed 0.15 ppb;
and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results
carcinogenicity, eye irritation/corrosion,
genetic toxicity, pulmonary effects, skin
irritation, specific target organ toxicity,
toxicokinetics, and aquatic toxicity
testing may be potentially useful to
characterize the health and
environmental effects of the PMN
substance. Although the Order does not
require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
PO 00000
Frm 00041
Fmt 4702
Sfmt 4702
based on submission of this or other
relevant information.
PMN Number (Proposed CFR Citation):
P–22–145 (40 CFR 721.12064)
Chemical Name: Alkanoic acid,
trialkyl-, diester with carbomonocycle
bis(alkyleneoxy)]bis[alkanediol]
(generic).
CASRN: Not available.
Effective Date of TSCA Order:
February 21, 2024.
Basis for TSCA Order: The PMN states
that the use will be as a reactive-diluent
in a polyol component of a 2K
(Isocyanate-Polyol) Urethane coating
system for interior concrete floor sealant
or interior/exterior paver sealer. Based
on the physical/chemical properties of
the PMN substance (as described in the
New Chemical Program’s PBT category
at 64 FR 60194; November 1999) and
test data on structurally similar
substances, the PMN substance is a
potentially persistent, bioaccumulative,
and toxic (PBT) chemical. EPA
estimates that the PMN substance will
persist in the environment for more than
six months and estimates a
bioconcentration factor of greater than
or equal to 5,000. Based on test data for
a potential hydrolysis product, EPA has
identified concerns for acute toxicity
and systemic, reproductive, and
developmental effects. Based on
comparison to analogous esters, EPA
predicts toxicity to aquatic organisms
may occur at concentrations that exceed
0.14 ppb. The Order was issued under
TSCA sections 5(a)(3)(B)(ii)(I) and
5(e)(1)(A)(ii)(I), based on a finding that
in the absence of sufficient information
to permit a reasoned evaluation, the
substance may present an unreasonable
risk of injury to human health and the
environment. To protect against these
risks, the Order requires:
• No use of the PMN substance in any
manner that generates a spray, mist,
vapor, or aerosol containing the PMN
substance unless the concentration of
the PMN substance is less than 5.7% by
weight;
• No processing for use or use of the
PMN substance in a consumer product;
• No release of the PMN substance, or
any waste stream containing the PMN
substance, into waters of the United
States;
• Disposal of the PMN substance, or
waste streams containing the PMN
substance, only by incineration;
• Use of personal protective
equipment where there is a potential for
dermal exposure; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
E:\FR\FM\17DEP1.SGM
17DEP1
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
ddrumheller on DSK120RN23PROD with PROPOSALS1
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of acute
toxicity, reproductive toxicity,
developmental toxicity, specific target
organ toxicity, toxicokinetics, and
aquatic toxicity testing may be
potentially useful to characterize the
health and environmental effects of the
PMN substance. Although the Order
does not require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
based on submission of this or other
relevant information.
PMN Number (Proposed CFR Citation):
P–22–175 (40 CFR 721.12065)
Chemical Name: Modified
Silsesquioxane, alkoxy-terminated
(generic).
CASRN: Not available.
Effective Date of TSCA Order: January
30, 2024.
Basis for TSCA Order: The PMN states
that the use will be as a curable binder
resin for composite stone articles
(engineered stone). Based on
comparison to analogous alkoxysilanes
and other analogous chemical
substances, EPA has identified concerns
for lung toxicity. Based on the reactivity
of the PMN substance and the low
molecular weight fraction content, EPA
has also identified concerns for
irritation to the skin, eyes, and
respiratory tract. Based on comparison
with analogous chemical substances,
EPA has also identified concerns for
hematological effects (i.e., increased
neutrophils, eosinophils, lymphocytes)
associated with lung toxicity. Based on
comparison to analogous alkoxysilanes,
EPA predicts toxicity to aquatic
organisms may occur at concentrations
that exceed 7 ppb. The Order was issued
under TSCA sections 5(a)(3)(B)(ii)(I) and
5(e)(1)(A)(ii)(I), based on a finding that
in the absence of sufficient information
to permit a reasoned evaluation, the
substance may present an unreasonable
risk of injury to human health and the
environment. To protect against these
risks, the Order requires:
• No domestic manufacture of the
PMN substance (i.e., import only);
• Use of the PMN substance only if
the concentration of the PMN substance
does not exceed 10% by weight in
formulation;
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
• Use of a NIOSH-certified respirator
with an APF of at least 10 where there
is a potential for inhalation exposure;
• No release of the PMN substance, or
any waste stream containing the PMN
substance, in surface water
concentrations that exceed 7 ppb;
• Use of personal protective
equipment where there is a potential for
dermal exposure; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of skin
irritation, eye irritation, specific target
organ toxicity, and aquatic toxicity
testing may be potentially useful to
characterize the health and
environmental effects of the PMN
substance. Although the Order does not
require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
based on submission of this or other
relevant information.
PMN Number (Proposed CFR Citation):
P–23–18 (40 CFR 721.12066)
Chemical Name: Vegetable oil,
polymer with pimelin ketone,
oxymethylene and
polymethylenepolyphenylene
isocyanate (generic).
CASRN: Not applicable.
Effective Date of TSCA Order:
February 23, 2024.
Basis for TSCA Order: The PMN states
that the use will be as an industrial
adhesive. Based on the weight of the
scientific evidence, EPA has identified
concerns for skin and respiratory
sensitization and lung toxicity for the
PMN substance and the low molecular
weight fraction. Based on test data for
residuals and comparison to analogous
chemical substances of the residuals,
EPA has also identified acute toxicity,
irritation to the skin, eyes, and
respiratory tract, skin sensitization,
respiratory sensitization, neurotoxicity,
lung effects, systemic effects,
reproductive and developmental effects,
genetic toxicity, and carcinogenicity for
the residuals. The Order was issued
under TSCA sections 5(a)(3)(B)(ii)(I) and
5(e)(1)(A)(ii)(I), based on a finding that
in the absence of sufficient information
PO 00000
Frm 00042
Fmt 4702
Sfmt 4702
102057
to permit a reasoned evaluation, the
substance may present an unreasonable
risk of injury to human health. To
protect against these risks, the Order
requires:
• No manufacture, processing, or use
of the PMN substance in any manner
that results in inhalation exposure to the
PMN substance;
• No processing for use or use of the
PMN substance in a consumer product;
• Use of personal protective
equipment where there is a potential for
dermal exposure; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of skin
irritation, skin sensitization, and
pulmonary effects testing may be
potentially useful to characterize the
health effects of the PMN substance.
Although the Order does not require
these tests, the Order’s restrictions
remain in effect until the Order is
modified or revoked by EPA based on
submission of this or other relevant
information.
PMN Number (Proposed CFR Citation):
P–23–20 (40 CFR 721.12067)
Chemical Name: Silsesquioxanes, 3mercaptopropyl, polymers with silicic
acid (H4SiO4) tetra-Et ester,
[(trimethylsilyl)oxy]-terminated.
CASRN: 2796383–42–9.
Effective Date of TSCA Order:
November 21, 2023.
Basis for TSCA Order: The PMN states
that the generic (non-confidential) use
will be as an additive/intermediate.
Based on comparison to analogous
chemical substances and alkoxysilanes,
EPA has identified concerns for lung
effects. Based on analogue data for the
hydrolysis product, EPA has also
identified concerns for skin
sensitization and systemic effects. Based
on comparison to analogous
alkoxysilanes and thiols, EPA predicts
toxicity to aquatic organisms may occur
at concentrations that exceed 3 ppb. The
Order was issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence
of sufficient information to permit a
reasoned evaluation, the substance may
E:\FR\FM\17DEP1.SGM
17DEP1
102058
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
ddrumheller on DSK120RN23PROD with PROPOSALS1
present an unreasonable risk of injury to
human health and the environment. To
protect against these risks, the Order
requires:
• Use of the PMN substance only for
the confidential use listed in the Order;
• No manufacture, processing, or use
of the PMN substance in any manner
that results in inhalation exposure to the
PMN substance;
• Use of personal protective
equipment where there is a potential for
dermal exposure;
• No release of the PMN substance, or
any waste stream containing the PMN
substance, in surface water
concentrations that exceed 3 ppb; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of specific
target organ toxicity, pulmonary effects,
skin sensitization, and aquatic toxicity
testing may be potentially useful to
characterize the health and
environmental effects of the PMN
substance. Although the Order does not
require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
based on submission of this or other
relevant information.
PMN Number (Proposed CFR Citation):
P–23–36 (40 CFR 721.12068).
Chemical Name: Castor oil, polymer
with dicyclopentadiene, maleic
anhydride, 2-methyl-1,3-propanediol,
3a,4,7,7a-tetrahydro-2-(2-hydroxyethyl)1H-isoindole-1,3(2H)-dione and
triethylene glycol.
CASRN: 2794200–69–2.
Effective Date of TSCA Order: January
19, 2024.
Basis for TSCA Order: The PMN states
that the use will be as a resin used in
an electrical insulation coating to
insulate electrical components (motors)
in automobiles. Based on test data for
the expected hydrolysis product and an
analogue of the expected hydrolysis
product, EPA has identified concerns
for skin irritation, eye irritation,
systemic effects, and reproductive/
developmental effects. Based on
comparison to analogous nonionic
polymers, EPA predicts toxicity to
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
aquatic organisms may occur at
concentrations that exceed 27 ppb. The
Order was issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence
of sufficient information to permit a
reasoned evaluation, the substance may
present an unreasonable risk of injury to
human health and the environment. To
protect against these risks, the Order
requires:
• No processing for use or use of the
PMN substance in a consumer product;
• No manufacture, processing, or use
of the PMN substance in any manner
that generates a vapor, mist, dust, or
aerosol;
• Use of personal protective
equipment where there is a potential for
dermal exposure;
• No release of the PMN substance, or
any waste stream containing the PMN
substance, in surface water
concentrations that exceed 27 ppb; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of skin
irritation, eye irritation, specific target
organ toxicity, toxicokinetics, and
aquatic toxicity testing may be
potentially useful to characterize the
health and environmental effects of the
PMN substance. Although the Order
does not require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
based on submission of this or other
relevant information.
PMN Numbers (Proposed CFR
Citations): P–23–37 (40 CFR 721.12069),
P–23–44 (40 CFR 721.12070), P–23–80
(40 CFR 721.12071), and P–23–93 (40
CFR 721.12072)
Chemical Names: Monoaromatic
cyclic alkylene sulfonium fluoroalkyl
sulfonic acid salt (generic) (P–23–37 and
P–23–44), Aromatic sulfonium tricyclo
fluoroalkyl sulfonic acid salt (generic)
(P–23–80), and Aromatic
dibenzothiophenium fluoroalkyl
carbopolycycle sulfonic acid salt
(generic) (P–23–93).
CASRNs: Not available.
Effective Date of TSCA Order:
December 22, 2023.
PO 00000
Frm 00043
Fmt 4702
Sfmt 4702
Basis for TSCA Order: The PMNs state
that the generic (non-confidential) use
of the PMN substances will be as
photoacid generators (PAGs) for use in
electronics industry. Based on the
physical/chemical properties of the
PMN substances (as described in the
New Chemical Program’s PBT category
at 64 FR 60194; November 1999) and
test data on structurally similar
substances, the PMN substance are
potentially persistent, bioaccumulative,
and toxic (PBT) chemicals. EPA
estimates that the PMN substances will
persist in the environment for more than
six months and have unknown
bioaccumulation. Based on comparison
to analogous chemical compounds, EPA
has identified concerns for acute
toxicity, irritation to the skin and
respiratory tract, neurological effects,
and systemic effects for the cation of the
PMN substances, as well as eye
corrosion for P–23–44, P–23–80, and P–
23–93. Based on comparison to
analogous chemical substances, EPA has
also identified concerns for genetic
toxicity for the PMN substances, and
skin sensitization and portal-of-entry
(respiratory) effects for P–23–93. Based
on the photoreactivity of the PMN
substances, EPA has also identified
concerns for photosensitization. Based
on comparison to analogous
compounds, EPA has also identified
concerns for systemic and reproductive
effects for the anion of P–23–44 and P–
23–93. Based on data on a potential
incineration product, EPA identified
concerns for local and systemic effects
via inhalation exposure. Based on a lack
of scientific data, there is unknown
toxicity to aquatic organisms. The Order
was issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence
of sufficient information to permit a
reasoned evaluation, the substances may
present an unreasonable risk of injury to
human health or the environment. To
protect against these risks, the Order
requires:
• No manufacture of the PMN
substances beyond the time limits
specified in the Order without submittal
to EPA the results of certain testing
described in the Testing section of the
Order;
• Use of personal protective
equipment where there is a potential for
dermal exposure;
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS;
• No modification of the processing
or use of the PMN substances in any
way that generates a vapor, dust, mist,
or aerosol in a non-enclosed process;
E:\FR\FM\17DEP1.SGM
17DEP1
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
ddrumheller on DSK120RN23PROD with PROPOSALS1
• Use of the PMN substances only for
the confidential uses listed in the Order;
• No domestic manufacture of the
PMN substances (i.e., import only);
• Import of the PMN substances only
in solution or in sealed containers
weighing 5 kilograms or less; and
• No exceedance of the confidential
annual importation volumes listed the
Order.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
about the physical/chemical properties,
fate, bioaccumulation, environmental
hazard, and human health effects of the
PMN substances may be potentially
useful in support of a request by the
PMN submitter to modify the Order, or
if a manufacturer or processor is
considering submitting a SNUN for a
significant new use that will be
designated by this SNUR. The submitter
has agreed not to exceed the time limits
specified in the Order without
performing the required Tier I and Tier
II testing outlined in the Testing section
of the Order.
PMN Number (Proposed CFR Citation):
P–23–64 (40 CFR 721.12073)
Chemical Name: Alkanediol,
substituted, polymer with
diisocyanatoalkane, substituted
heterocycle-modified (generic).
CASRN: Not available.
Effective Date of TSCA Order:
February 21, 2024.
Basis for TSCA Order: The PMN states
that the generic (non-confidential) use
will be as a component in aerospace
coatings. Based on comparison to
analogous chemical substances, EPA has
identified concerns for pulmonary
effects, systemic effects, and skin
sensitization. The Order was issued
under TSCA sections 5(a)(3)(B)(ii)(I) and
5(e)(1)(A)(ii)(I), based on a finding that
in the absence of sufficient information
to permit a reasoned evaluation, the
substance may present an unreasonable
risk of injury to human health. To
protect against these risks, the Order
requires:
• No processing for use or use of the
PMN substance in consumer products;
• No manufacture, processing, or use
of the PMN substance in any manner
that results in the generation of a vapor,
mist, dust, or aerosol;
• Use of personal protective
equipment where there is a potential for
dermal exposure; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of
pulmonary effects and specific target
organ toxicity testing may be potentially
useful to characterize the health effects
of the PMN substance. Although the
Order does not require these tests, the
Order’s restrictions remain in effect
until the Order is modified or revoked
by EPA based on submission of this or
other relevant information.
PMN Number (Proposed CFR Citation):
P–23–72 (40 CFR 721.12074)
Chemical Name: Halosubstituted
carbopolycycle, polymer with
substituted carbomonocycles and
oxybis[alkanol] (generic).
CASRN: Not available.
Effective Date of TSCA Order:
February 22, 2024.
Basis for TSCA Order: The PMN states
that the use will be as a UV resin for
offset lithographic printing on plastic
substrates. Based on the physical/
chemical properties of the PMN
substance (as described in the New
Chemical Program’s PBT category at 64
FR 60194; November 1999) and test data
on structurally similar substances, the
PMN substance is a potentially
persistent, bioaccumulative, and toxic
(PBT) chemical. EPA estimates that the
PMN substance will persist in the
environment for more than six months
and estimates a bioaccumulation factor
of greater than or equal to 5,000. Based
on test data for hydrolysis products of
the low molecular weight fraction of the
PMN substance, EPA has identified
concerns for genetic toxicity,
carcinogenicity, and systemic,
reproductive, and developmental
effects. Based on comparison to
analogous esters, EPA predicts toxicity
to aquatic organisms may occur at
concentrations that exceed 0.4 ppb. The
Order was issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence
of sufficient information to permit a
reasoned evaluation, the substance may
present an unreasonable risk of injury to
human health and the environment. To
protect against these risks, the Order
requires:
• No processing for use or use of the
PMN substance in a consumer product;
PO 00000
Frm 00044
Fmt 4702
Sfmt 4702
102059
• No processing for use or use of the
PMN substance other than in an
enclosed roll-coating lithographic
printing machine;
• No processing for use or use of the
PMN substance in a final coating
formulation that exceeds 40% by
weight;
• Disposal of the PMN substance only
by landfill;
• No release of the PMN substance, or
any waste stream containing the PMN
substance, into waters of the United
States;
• Use of a NIOSH-certified respirator
with an APF of at least 10 where there
is a potential for inhalation exposure;
• Use of personal protective
equipment where there is a potential for
dermal exposure; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of
carcinogenicity, developmental toxicity,
genetic toxicity, reproductive toxicity,
specific target organ toxicity,
toxicokinetics, and aquatic toxicity
testing may be potentially useful to
characterize the health and
environmental effects of the PMN
substance. Although the Order does not
require these tests, the Order’s
restrictions remain in effect until the
Order is modified or revoked by EPA
based on submission of this or other
relevant information.
PMN Number (Proposed CFR Citation):
P–23–94 (40 CFR 721.12075)
Chemical Name: Polymer of
benzenedicarboxylic acid, substitutedbenzenedicarboxylic acid, branchedalkyldiol, alkyldiol and triisocyanate
(generic).
CASRN: Not available.
Effective Date of TSCA Order: January
9, 2024.
Basis for TSCA Order: The PMN states
that the use will be as a reactive
polymer for use in surface pretreatment. Based on test data for the
feedstock residual, EPA has identified
concerns for lung effects for the
residual. Based on OECD QSAR Toolbox
results and the structural alert for
diisocyanates, EPA has also identified
E:\FR\FM\17DEP1.SGM
17DEP1
102060
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
ddrumheller on DSK120RN23PROD with PROPOSALS1
concerns for dermal and respiratory
sensitization. The Order was issued
under TSCA sections 5(a)(3)(B)(ii)(I) and
5(e)(1)(A)(ii)(I), based on a finding that
in the absence of sufficient information
to permit a reasoned evaluation, the
substance may present an unreasonable
risk of injury to human health. To
protect against these risks, the Order
requires:
• No processing for use or use of the
PMN substance in a consumer product;
• No manufacture, processing, or use
of the PMN substance in any manner
that results in inhalation exposure to the
PMN substance;
• Use of personal protective
equipment where there is a potential for
dermal exposure; and
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
may be potentially useful in support of
a request by the PMN submitter to
modify the Order, or if a manufacturer
or processor is considering submitting a
SNUN for a significant new use that will
be designated by this SNUR. EPA has
determined that the results of specific
target organ toxicity, pulmonary effects,
and skin sensitization testing may be
potentially useful to characterize the
health effects of the PMN substance.
Although the Order does not require
these tests, the Order’s restrictions
remain in effect until the Order is
modified or revoked by EPA based on
submission of this or other relevant
information.
PMN Number (Proposed CFR Citation):
P–23–172 (40 CFR 721.12076)
Chemical Name: Sulfonium,
tricarbocyclic-, alkylcarbomonocyclicpolyfluoro-heteropolycyclic-alkyl
sulfonate (1:1), polymer with alkylaryl
and carbomonocyclic alkylalkanoate, diMe 2,2′-(1,2-diazenediyl)bis[2alkylalkanoate]-initiated (generic).
CASRN: Not available.
Effective Date of TSCA Order: January
29, 2024.
Basis for TSCA Order: The PMN states
that the generic (non-confidential) use
of the PMN substance will be for
photolithography. Based on the
physical/chemical properties of the
PMN substance (as described in the
New Chemical Program’s PBT category
at 64 FR 60194; November 1999) and
test data on structurally similar
substances, the PMN substance is a
potentially persistent, bioaccumulative,
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
and toxic (PBT) chemical. EPA
estimates that the PMN substance will
persist in the environment for more than
six months and estimates unknown
bioaccumulation. Based on comparison
to analogous sulfonium compounds,
EPA has identified concerns for acute
toxicity, irritation to the skin and
respiratory tract, eye corrosion,
neurological effects, and systemic
effects for the sulfonium cation. Based
on comparison to analogous chemical
substances, EPA has also identified
concerns for genetic toxicity. Based on
the photoreactivity of the PMN
substance, EPA has also identified
concerns for photosensitization. Based
on a potential incineration product
(trifluroacetate), EPA has also identified
concerns for local, neurological,
developmental and systemic effects via
inhalation exposure. The Order was
issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence
of sufficient information to permit a
reasoned evaluation, the substance may
present an unreasonable risk of injury to
human health or the environment. To
protect against these risks, the Order
requires:
• No manufacture of the PMN
substance beyond the time limits
specified in the Order without submittal
to EPA the results of certain testing
described in the Testing section of the
Order;
• Use of personal protective
equipment where there is a potential for
dermal exposure;
• Establishment of a hazard
communication program, including
human health precautionary statements
on each label and in the SDS;
• No modification of the processing
of the PMN substance in any way that
generates a vapor, dust, mist, or aerosol
in a non-enclosed process;
• Use of the PMN substance only for
the confidential use listed in the Order;
• No domestic manufacture of the
PMN substance (i.e., import only);
• Import of the PMN substance only
in solution or in sealed containers
weighing 5 kilograms or less; and
• No exceedance of the confidential
annual importation volume listed the
Order.
The proposed SNUR would designate
as a ‘‘significant new use’’ the absence
of these protective measures.
Potentially Useful Information: EPA
has determined that certain information
about the physical/chemical properties,
fate, bioaccumulation, environmental
hazard, and human health effects of the
PMN substance may be potentially
useful in support of a request by the
PMN submitter to modify the Order, or
PO 00000
Frm 00045
Fmt 4702
Sfmt 4702
if a manufacturer or processor is
considering submitting a SNUN for a
significant new use that will be
designated by this SNUR. The submitter
has agreed not to exceed the time limits
specified in the Order without
performing the required Tier I and Tier
II testing outlined in the Testing section
of the Order.
IV. Statutory and Executive Order
Reviews
Additional information about these
statutes and Executive Orders can be
found at https://www.epa.gov/lawsregulations-and-executive-orders.
A. Executive Order 12866: Regulatory
Planning and Review and Executive
Order 14094: Modernizing Regulatory
Review
This action proposes to establish
SNURs for new chemical substances
that were the subject of PMNs. The
Office of Management and Budget
(OMB) has exempted these types of
actions from review under Executive
Order 12866 (58 FR 51735, October 4,
1993), as amended by Executive Order
14094 (88 FR 21879, April 11, 2023).
B. Paperwork Reduction Act (PRA)
According to the PRA (44 U.S.C. 3501
et seq.), an agency may not conduct or
sponsor, and a person is not required to
respond to a collection of information
that requires OMB approval under PRA,
unless it has been approved by OMB
and displays a currently valid OMB
control number. The OMB control
numbers for EPA’s regulations in title 40
of the CFR, after appearing in the
Federal Register, are listed in 40 CFR
part 9, and included on the related
collection instrument or form, if
applicable.
The information collection
requirements related to SNURs have
already been approved by OMB
pursuant to PRA under OMB control
number 2070–0038 (EPA ICR No. 1188).
This action does not impose any burden
requiring additional OMB approval. If
an entity were to submit a SNUN to the
Agency, the annual burden is estimated
to average between 30 and 170 hours
per submission. This burden estimate
includes the time needed to review
instructions, search existing data
sources, gather and maintain the data
needed, and complete, review, and
submit the required SNUN.
EPA always welcomes your feedback
on the burden estimates. Send any
comments about the accuracy of the
burden estimate, and any suggested
methods for improving the collection
instruments or instruction or
minimizing respondent burden,
E:\FR\FM\17DEP1.SGM
17DEP1
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
ddrumheller on DSK120RN23PROD with PROPOSALS1
including through the use of automated
collection techniques.
C. Regulatory Flexibility Act (RFA)
I certify that this action will not have
a significant economic impact on a
substantial number of small entities
under the RFA (5 U.S.C. 601 et seq.).
The requirement to submit a SNUN
applies to any person (including small
or large entities) who intends to engage
in any activity described in the final
rule as a ‘‘significant new use.’’ Because
these uses are ‘‘new,’’ based on all
information currently available to EPA,
EPA has concluded that no small or
large entities presently engage in such
activities.
A SNUR requires that any person who
intends to engage in such activity in the
future must first notify EPA by
submitting a SNUN. Although some
small entities may decide to pursue a
significant new use in the future, EPA
cannot presently determine how many,
if any, there may be. However, EPA’s
experience to date is that, in response to
the promulgation of SNURs covering
over 1,000 chemicals, the Agency
receives only a small number of notices
per year. For example, the number of
SNUNs received was 16 in Federal fiscal
year (FY) FY2018, five in FY2019, seven
in FY2020, 13 in FY2021, 11 in FY2022,
and 15 in FY2023, and only a fraction
of these submissions were from small
businesses.
In addition, the Agency currently
offers relief to qualifying small
businesses by reducing the SNUN
submission fee from $37,000 to $6,480.
This lower fee reduces the total
reporting and recordkeeping cost of
submitting a SNUN to about $14,500 per
SNUN submission for qualifying small
firms. Therefore, the potential economic
impacts of complying with these
proposed SNURs are not expected to be
significant or adversely impact a
substantial number of small entities. In
a SNUR that published in the Federal
Register of June 2, 1997 (62 FR 29684)
(FRL–5597–1), the Agency presented its
general determination that SNURs are
not expected to have a significant
economic impact on a substantial
number of small entities, which was
provided to the Chief Counsel for
Advocacy of the Small Business
Administration.
D. Unfunded Mandates Reform Act
(UMRA)
This action does not contain an
unfunded mandate of $100 million or
more (in 1995 dollars) in any one year
as described in UMRA, 2 U.S.C. 1531–
1538, and does not significantly or
uniquely affect small governments.
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
Based on EPA’s experience with
proposing and finalizing SNURs, State,
local, and Tribal governments have not
been impacted by SNURs, and EPA does
not have any reasons to believe that any
State, local, or Tribal government will
be impacted by these SNURs. In
addition, the estimated costs of this
action to the private sector do not
exceed $183 million or more in any one
year (the 1995 dollars are adjusted to
2023 dollars for inflation using the GDP
implicit price deflator). The estimated
costs for this action are discussed in
Unit I.D.
E. Executive Order 13132: Federalism
This action will not have federalism
implications as specified in Executive
Order 13132 (64 FR 43255, August 10,
1999), because it is not expected to have
a substantial direct effect on States, on
the relationship between the national
government and the States, or on the
distribution of power and
responsibilities among the various
levels of government. Accordingly, the
requirements of Executive Order 13132
do not apply to this action.
F. Executive Order 13175: Consultation
and Coordination With Indian Tribal
Governments
This action will not have Tribal
implications as specified in Executive
Order 13175 (65 FR 67249, November 9,
2000), because it is not expected to have
substantial direct effects on Indian
Tribes, significantly or uniquely affect
the communities of Indian Tribal
governments and does not involve or
impose any requirements that affect
Indian Tribes. Accordingly, the
requirements of Executive Order 13175
do not apply to this action.
G. Executive Order 13045: Protection of
Children From Environmental Health
Risks and Safety Risks
This action is not subject to Executive
Order 13045 (62 FR 19885, April 23,
1997), because it does not concern an
environmental health or safety risk.
Since this action does not concern a
human health risk, EPA’s 2021 Policy
on Children’s Health also does not
apply. Although the establishment of
these SNURs do not address an existing
children’s environmental health
concern because the chemical uses
involved are not ongoing uses, SNURs
require that persons notify EPA at least
90 days before commencing
manufacture (defined by statute to
include import) or processing of any of
these chemical substances for an
activity that is designated as a
significant new use by this rulemaking.
This notification allows EPA to assess
PO 00000
Frm 00046
Fmt 4702
Sfmt 4702
102061
the intended uses to identify potential
risks and take appropriate actions before
the activities commence.
H. Executive Order 13211: Actions
Concerning Regulations That
Significantly Affect Energy Supply,
Distribution, or Use
This action is not a ‘‘significant
energy action’’ as defined in Executive
Order 13211 (66 FR 28355, May 22,
2001), because it is not likely to have a
significant adverse effect on the supply,
distribution, or use of energy.
I. National Technology Transfer and
Advancement Act (NTTAA)
This action does not involve any
technical standards subject to NTTAA
section 12(d) (15 U.S.C. 272 note).
J. Executive Order 12898: Federal
Actions To Address Environmental
Justice in Minority Populations and
Low-Income Populations and Executive
Order 14096: Revitalizing Our Nation’s
Commitment to Environmental Justice
for All
EPA believes that this type of action
does not concern human health or
environmental conditions and therefore
cannot be evaluated with respect to the
potentially disproportionate and
adverse effects on communities with
environmental justice concerns in
accordance with Executive Orders
12898 (59 FR 7629, February 16, 1994)
and 14096 (88 FR 25251, April 26,
2023). Although this action does not
concern human health or environmental
conditions, the premanufacture
notifications required by these SNURs
will allow EPA to assess the intended
uses to identify potential
disproportionate risks and take
appropriate actions before the activities
commence.
List of Subjects in 40 CFR part 721
Environmental protection, Chemicals,
Hazardous substances, Reporting and
recordkeeping requirements.
Kevin DeBell,
Acting Director, Office of Pollution Prevention
and Toxics.
Therefore, for the reasons stated in the
preamble, EPA proposes to amend 40
CFR chapter I as follows:
PART 721—SIGNIFICANT NEW USES
OF CHEMICAL SUBSTANCES
1. The authority citation for part 721
continues to read as follows:
■
Authority: 15 U.S.C. 2604, 2607, and
2625(c).
E:\FR\FM\17DEP1.SGM
17DEP1
102062
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
2. Add §§ 721.12043 through
721.12076 to Subpart E to read as
follows:
■
Subpart E—Significant New Uses for
Specific Chemical Substances
Sec.
ddrumheller on DSK120RN23PROD with PROPOSALS1
*
*
*
*
*
721.12043 Heptane, 2-methoxy-2-methyl-.
721.12044 Benzenesulfonic acid, alkyl-,
compd. with 1,1′-iminobis[2-propanol]
(1:1) (generic).
721.12045 Sugars, polymer with
alkanetriamine (generic).
721.12046 Isooctadecanamide, N,N-bis(2ethylhexyl)-.
721.12047 2-Butanone, oxime, reaction
products with trimethoxymethylsilane.
721.12048 2,6-Bis(dialkyl)-4-[2-(1-alkyl4(1H)-pyridinylidene)alkylidene]-2,5cycloalkyladien-1-one (generic).
721.12049 Fatty acids, soya, reaction
products with ammonia-ethanolamine
reaction by-products.
721.12050 1,5-Pentanediamine, 2-methyl-,
hydrochloride (1:2).
721.12051 1,5-Pentanediamine, 2-methyl-,
hydrochloride (1:1).
721.12052 Formic acid, compd. with 2methyl-1,5- pentanediamine (2:1).
721.12053 Formic acid, compd. with 2methyl-1,5-pentanediamine (1:1).
721.12054 Alkadiene, homopolymer,
hydroxy-terminated, bis[N-[2-[(1-oxo-2propen-1-yl)oxylethyl]carbamates]
(generic).
721.12055 Oxirane, 2-(chloromethyl)-,
homopolymer, ether with dialkylalkanediol (2:1) (generic).
721.12056 Aryl, polymer with
formaldehyde, glycidyl ether, reaction
products with amino alkyl-alkane
diamine, cyclohexanediamine and
alkylene (alkylcyclohexanamine)
(generic).
721.12057 Alkene, alkoxy-, polymer with
alkoxyalkene (generic).
721.12058 Methanesulfonamide, 1,1,1trifluoro-N-[(trifluoromethyl)sulfonyl]-,
sodium salt (1:1).
721.12059 1H-Isoindole-1,3(2H)-dione,
3a,4,7,7a-tetrahydro-2-(2-hydroxyethyl).
721.12060 Oxirane, 2-methyl-, polymer
with oxirane, mono-isoalkyl ethers,
phosphates, salt (generic).
721.12061 Poly(oxy-1,2-ethanediyl),
.alpha.-(2-aminoethyl)-.omega.-(2aminoethoxy)- and Poly(oxy-1,2ethanediyl), .alpha.,.alpha.′,-(iminodi2,1- ethanediyl)bis[.omega.-(2aminoethoxy)-.
721.12062 Alkenoic acid, alkyl,
carbopolycyclic alkyl ester, polymer
with trihalo (trihaloalkyl) alkyl alkyl
alkenoate (generic).
721.12063 Polychloroalkene (generic).
721.12064 Alkanoic acid, trialkyl-, diester
with carbomonocycle
bis(alkyleneoxy)]bis[alkanediol]
(generic).
721.12065 Modified Silsesquioxane,
alkoxy-terminated (generic).
721.12066 Vegetable oil, polymer with
pimelin ketone, oxymethylene and
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
polymethylenepolyphenylene isocyanate
(generic).
721.12067 Silsesquioxanes, 3mercaptopropyl, polymers with silicic
acid (H4SiO4) tetra-Et ester,
[(trimethylsilyl)oxy]-terminated.
721.12068 Castor oil, polymer with
dicyclopentadiene, maleic anhydride, 2methyl-1,3-propanediol, 3a,4,7,7atetrahydro-2-(2-hydroxyethyl)-1Hisoindole-1,3(2H)-dione and triethylene
glycol.
721.12069 Monoaromatic cyclic alkylene
sulfonium fluoroalkyl sulfonic acid salt
(generic).
721.12070 Monoaromatic cyclic alkylene
sulfonium fluoroalkyl sulfonic acid salt
(generic).
721.12071 Aromatic sulfonium tricyclo
fluoroalkyl sulfonic acid salt (generic).
721.12072 Aromatic dibenzothiophenium
fluoroalkyl carbopolycycle sulfonic acid
salt (generic).
721.12073 Alkanediol, substituted, polymer
with diisocyanatoalkane, substituted
heterocycle-modified (generic).
721.12074 Halosubstituted carbopolycycle,
polymer with substituted
carbomonocycles and oxybis[alkanol]
(generic).
721.12075 Polymer of benzenedicarboxylic
acid, substituted-benzenedicarboxylic
acid, branched-alkyldiol, alkyldiol and
triisocyanate (generic).
721.12076 Sulfonium, tricarbocyclic-,
alkylcarbomonocyclic-polyfluoroheteropolycyclic-alkyl sulfonate (1:1),
polymer with alkylaryl and
carbomonocyclic alkylalkanoate, di-Me
2,2′-(1,2-diazenediyl)bis[2alkylalkanoate]-initiated (generic).
*
*
*
§ 721.12043
*
*
Heptane, 2-methoxy-2-methyl-.
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
as Heptane, 2-methoxy-2-methyl- (PMN
P–18–127; CASRN 76589–16–7) is
subject to reporting under this section
for the significant new uses described in
paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (3), and (c). When
determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (d), (f), (g)(1), (3), and (5). For
purposes of § 721.72(g)(1), this
substance may cause: skin sensitization
and specific target organ toxicity. For
purposes of § 721.72(g)(3), this
PO 00000
Frm 00047
Fmt 4702
Sfmt 4702
substance may be: toxic to aquatic life.
Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(f). It is a significant
new use to manufacture the substance
unless by import into the United States
in a solution of no greater than 5% by
weight (i.e., no domestic manufacture).
It is a significant new use to process the
substance unless in a solution of no
greater than 5% by weight of the
substance. It is a significant new use to
process for use or use the substance in
consumer products unless the
concentration of the substance is less
than 1% by weight.
(iv) Release to water. Requirements as
specified in § 721.90(a)(4), (b)(4), and
(c)(4), where N=210.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i), and (k) are
applicable to manufacturers, importers,
and processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
§ 721.12044 Benzenesulfonic acid, alkyl-,
compd. with 1,1′-iminobis[2-propanol] (1:1)
(generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as benzenesulfonic acid,
alkyl-, compd. with 1,1′-iminobis[2propanol] (1:1) (PMN P–18–325) is
subject to reporting under this section
for the significant new uses described in
paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1) and (3), (b), and (c). When
determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible. For purposes
of § 721.63(b), the concentration is set at
1.0%.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (f), and (g)(1), (3) and (5). For
E:\FR\FM\17DEP1.SGM
17DEP1
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
purposes of § 721.72(e), the
concentration is set at 1.0%. For
purposes of § 721.72(g)(1), this
substance may cause: skin irritation, eye
irritation, and specific target organ
toxicity. For purposes § 721.72(g)(3),
this substance may be: toxic to aquatic
life. Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(k). It is a
significant new use to manufacture,
process, or use the substance in any
manner that results in inhalation
exposure to the substance. It is a
significant new use to process for use or
use the substance other than as an
industrial cross-linking catalyst.
(iv) Release to water. Requirements as
specified in § 721.90(a)(1), (b)(1), and
(c)(1).
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i), and (k) are
applicable to manufacturers, importers,
and processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
ddrumheller on DSK120RN23PROD with PROPOSALS1
§ 721.12045 Sugars, polymer with
alkanetriamine (generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as sugars, polymer with
alkanetriamine (PMN P–20–14) is
subject to reporting under this section
for the significant new uses described in
paragraph (a)(2) of this section. The
requirements of this section do not
apply to quantities of the substance after
they have been completely reacted or
cured.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1) and (3), (b), and (c). When
determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible. For purposes
of § 721.63(b), the concentration is set at
1.0%.
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (f), (g)(1), (3), and (5). For
purposes of § 721.72(e), the
concentration is set at 1.0%. For
purposes of § 721.72(g)(1), this
substance may cause: reproductive
toxicity and specific target organ
toxicity. For purposes of § 721.72(g)(3),
this substance may be: toxic to aquatic
life. Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(o).
(iv) Release to water. Requirements as
specified in § 721.90(a)(4), (b)(4), and
(c)(4), where N=191.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i), and (k) are
applicable to manufacturers, importers,
and processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
§ 721.12046 Isooctadecanamide, N,Nbis(2-ethylhexyl)-.
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
as isooctadecanamide, N,N-bis(2ethylhexyl)- (PMN P–21–86; CASRN
1616494–50–8) is subject to reporting
under this section for the significant
new uses described in paragraph (a)(2)
of this section. The requirements of this
section do not apply to quantities of the
substance after they have been entrained
in a polymer.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1) and (3), (b), and (c). When
determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible. For purposes
of § 721.63(b), the concentration is set at
1.0%.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (f), (g)(1), and (5). For purposes
of § 721.72(e), the concentration is set at
PO 00000
Frm 00048
Fmt 4702
Sfmt 4702
102063
1.0%. For purposes of § 721.72(g)(1),
this substance may cause: specific target
organ toxicity. Alternative hazard and
warning statements that meet the
criteria of the Globally Harmonized
System and OSHA Hazard
Communication Standard may be used.
(iii) Industrial, commercial, and
consumer activities. It is a significant
new use to process the substance for use
in a consumer product where the
concentration of the substance in the
consumer product formulation exceeds
the confidential percentage listed in the
Order. It is a significant new use to use
the substance in a consumer product
where the concentration of the
substance exceeds the confidential
percentage listed in the Order.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i) are applicable to
manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
§ 721.12047 2-Butanone, oxime, reaction
products with trimethoxymethylsilane.
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
as 2-butanone, oxime, reaction products
with trimethoxymethylsilane (PMN P–
21–164; CASRN 2639393–45–4) is
subject to reporting under this section
for the significant new uses described in
paragraph (a)(2) of this section. The
requirements of this section do not
apply to quantities of the substance after
they have been completely reacted or
cured.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (3) through (6), and (c).
When determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1) and (4),
engineering control measures (e.g.,
enclosure or confinement of the
operation, general and local ventilation)
or administrative control measures (e.g.,
workplace policies and procedures)
shall be considered and implemented to
prevent exposure, where feasible. For
purposes of § 721.63(a)(5), respirators
must provide a National Institute for
Occupational Safety and Health
(NIOSH) assigned protection factor
(APF) of at least 50.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
E:\FR\FM\17DEP1.SGM
17DEP1
102064
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
through (d), (f), (g)(1), (3), and (5). For
purposes of § 721.72(g)(1), this
substance may cause: acute toxicity,
carcinogenicity, serious eye damage,
reproductive toxicity, skin irritation,
skin sensitization, and specific target
organ toxicity. For purposes of
§ 721.72(g)(3), this substance may be:
toxic to aquatic life. Alternative hazard
and warning statements that meet the
criteria of the Globally Harmonized
System and OSHA Hazard
Communication Standard may be used.
(iii) Industrial, commercial, and
consumer activities. It is a significant
new use to load or unload the substance
for manufacture, processing, or use in
any manner unless under a gas (e.g.
nitrogen) blanket. It is a significant new
use to use the substance unless at 4%
or less by weight in formulation. It is a
significant new use to apply the
substance for use unless by roll, brush,
or dip coating.
(iv) Disposal. Requirements as
specified in § 721.85(a)(1), (b)(1), and
(c)(1).
(v) Release to water. Requirements as
specified in § 721.90(a)(1), (b)(1), and
(c)(1).
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (k) are applicable
to manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
ddrumheller on DSK120RN23PROD with PROPOSALS1
§ 721.12048 2,6-Bis(dialkyl)-4-[2-(1-alkyl4(1H)-pyridinylidene)alkylidene]-2,5cycloalkyladien-1-one (generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as 2,6-bis(dialkyl)-4-[2-(1alkyl-4(1H)-pyridinylidene)alkylidene]2,5-cycloalkyladien-1-one (generic)
(PMN P–21–170) is subject to reporting
under this section for the significant
new uses described in paragraph (a)(2)
of this section.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (3) through (6), and (c).
When determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1) and (4),
engineering control measures (e.g.,
enclosure or confinement of the
operation, general and local ventilation)
or administrative control measures (e.g.,
workplace policies and procedures)
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
shall be considered and implemented to
prevent exposure, where feasible. For
purposes of § 721.63(a)(5), respirators
must provide a National Institute for
Occupational Safety and Health
(NIOSH) assigned protection factor
(APF) of at least 10.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (d), (f), (g)(1), (3), and (5). For
purposes of § 721.72(g)(1), this
substance may cause: acute toxicity,
skin irritation, eye irritation, skin
sensitization, genetic toxicity,
carcinogenicity, reproductive toxicity,
and specific target organ toxicity. For
purposes of § 721.72(g)(3), this
substance may be: toxic to aquatic life.
Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(k), (t). It is a
significant new use to manufacture the
substance in excess of an annual volume
of 10 kg. It is a significant new use to
process for use or use the substance
other than as a color indicator for frying
oil breakdown. It is a significant new
use to manufacture, process, or use the
substance in any manner that results in
the release of the substance to air except
with the use of a HEPA filtration
system.
(iv) Release to water. Requirements as
specified in § 721.90(a)(1), (b)(1), and
(c)(1).
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i), and (k) are
applicable to manufacturers, importers,
and processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
§ 721.12049 Fatty acids, soya, reaction
products with ammonia-ethanolamine
reaction by-products.
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
as fatty acids, soya, reaction products
with ammonia-ethanolamine reaction
by-products (PMN P–21–184; CASRN
2378512–59–3) is subject to reporting
under this section for the significant
new uses described in paragraph (a)(2)
of this section.
(2) The significant new uses are:
PO 00000
Frm 00049
Fmt 4702
Sfmt 4702
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (3), and (c). When
determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (d), (f), (g)(1), (3), and (5). For
purposes of § 721.72(g)(1), this
substance may cause: acute toxicity,
skin corrosion, skin irritation, serious
eye damage, eye irritation, skin
sensitization, and specific target organ
toxicity. For purposes of § 721.72(g)(3),
this substance may be: toxic to aquatic
life. Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(o), and (y)(1) and
(2). It is a significant new use to
manufacture, process, or use the
substance in any manner that results in
the generation of vapor, mist, aerosol, or
dust.
(iv) Release to water. Requirements as
specified in § 721.90(a)(4), (b)(4), and
(c)(4), where N=2.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i), and (k) are
applicable to manufacturers, importers,
and processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
§ 721.12050 1,5-Pentanediamine,
2-methyl-, hydrochloride (1:2).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
as 1,5-pentanediamine, 2-methyl-,
hydrochloride (1:2) (PMN P–22–3;
CASRN 34813–63–3) is subject to
reporting under this section for the
significant new uses described in
paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (3), (b), and (c). When
determining which persons are
E:\FR\FM\17DEP1.SGM
17DEP1
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible. For purposes
of § 721.63(b), the concentration is set at
1.0%.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (f), (g)(1), (3), and (5). For
purposes of § 721.72(e), the
concentration is set at 1.0%. For
purposes of § 721.72(g)(1), this
substance may cause: acute toxicity,
skin irritation, and eye irritation. For
purposes of § 721.72(g)(3), this
substance may be: toxic to aquatic life.
Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(o). It is a
significant new use to manufacture,
process, or use the substance in any
manner that results in inhalation
exposure to the substance.
(iv) Release to water. Requirements as
specified in § 721.90(a)(4), (b)(4), and
(c)(4), where N=570 of P–22–3, P–22–4,
P–22–5, and P–22–6 combined.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i), and (k) are
applicable to manufacturers, importers,
and processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
ddrumheller on DSK120RN23PROD with PROPOSALS1
§ 721.12051 1,5-Pentanediamine,
2-methyl-, hydrochloride (1:1).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
as 1,5-pentanediamine, 2-methyl-,
hydrochloride (1:1) (PMN P–22–4;
CASRN 1840915–04–9) is subject to
reporting under this section for the
significant new uses described in
paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (3), (b), and (c). When
determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible. For purposes
of § 721.63(b), the concentration is set at
1.0%.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (f), (g)(1), (3), and (5). For
purposes of § 721.72(e), the
concentration is set at 1.0%. For
purposes of § 721.72(g)(1), this
substance may cause: acute toxicity,
skin irritation, eye irritation, serious eye
damage, skin corrosion, and specific
target organ toxicity. For purposes of
§ 721.72(g)(3), this substance may be:
toxic to aquatic life. Alternative hazard
and warning statements that meet the
criteria of the Globally Harmonized
System and OSHA Hazard
Communication Standard may be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(o). It is a
significant new use to manufacture,
process, or use the substance in any
manner that results in inhalation
exposure to the substance.
(iv) Release to water. Requirements as
specified in § 721.90(a)(4), (b)(4), and
(c)(4), where N=570 of P–22–3, P–22–4,
P–22–5, and P–22–6 combined.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i), and (k) are
applicable to manufacturers, importers,
and processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
§ 721.12052 Formic acid, compd. with 2methyl-1,5- pentanediamine (2:1).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
as formic acid, compd. with 2-methyl1,5- pentanediamine (2:1) (PMN P–22–
5; CASRN 1836131–73–7) is subject to
reporting under this section for the
significant new uses described in
paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1) and (3), (b), and (c). When
determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
PO 00000
Frm 00050
Fmt 4702
Sfmt 4702
102065
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible. For purposes
of § 721.63(b), the concentration is set at
1.0%.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (f), (g)(1), (3), and (5). For
purposes of § 721.72(e), the
concentration is set at 1.0%. For
purposes of § 721.72(g)(1), this
substance may cause: acute toxicity,
skin irritation, eye irritation, and
specific target organ toxicity. For
purposes of § 721.72(g)(3), this
substance may be: toxic to aquatic life.
Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(o). It is a
significant new use to manufacture,
process, or use the substance in any
manner that results in inhalation
exposure to the substance.
(iv) Release to water. Requirements as
specified in § 721.90(a)(4), (b)(4), and
(c)(4), where N=570 of P–22–3, P–22–4,
P–22–5, and P–22–6 combined.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i), and (k) are
applicable to manufacturers, importers,
and processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
§ 721.12053 Formic acid, compd. with 2methyl-1,5-pentanediamine (1:1).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
as formic acid, compd. with 2-methyl1,5-pentanediamine (1:1) (PMN P–22–6;
CASRN 1836131–75–9) is subject to
reporting under this section for the
significant new uses described in
paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1) and (3), (b), and (c). When
determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
E:\FR\FM\17DEP1.SGM
17DEP1
102066
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible. For purposes
of § 721.63(b), the concentration is set at
1.0%.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (f), (g)(1), (3), and (5). For
purposes of § 721.72(e), the
concentration is set at 1.0%. For
purposes of § 721.72(g)(1), this
substance may cause: acute toxicity,
skin corrosion, skin irritation, serious
eye damage, eye irritation, and specific
target organ toxicity. For purposes of
§ 721.72(g)(3), this substance may be:
toxic to aquatic life. Alternative hazard
and warning statements that meet the
criteria of the Globally Harmonized
System and OSHA Hazard
Communication Standard may be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(o). It is a
significant new use to manufacture,
process, or use the substance in any
manner that results in inhalation
exposure to the substance.
(iv) Release to water. Requirements as
specified in § 721.90(a)(4), (b)(4), and
(c)(4), where N=570 of P–22–3, P–22–4,
P–22–5, and P–22–6 combined.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i), and (k) are
applicable to manufacturers, importers,
and processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
ddrumheller on DSK120RN23PROD with PROPOSALS1
§ 721.12054 Alkadiene, homopolymer,
hydroxy-terminated, bis[N-[2-[(1-oxo-2propen-1- yl)oxylethyl]carbamates]
(generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as alkadiene, homopolymer,
hydroxy-terminated, bis[N-[2-[(1-oxo-2propen-1-yl)oxylethyl]carbamates]
(PMN P–22–11) is subject to reporting
under this section for the significant
new uses described in paragraph (a)(2)
of this section.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (3), and (c). When
determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (d), (f), (g)(1), and (5). For
purposes of § 721.72(g)(1), this
substance may cause: skin sensitization,
respiratory sensitization, reproductive
toxicity, and specific target organ
toxicity. Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(o). It is a
significant new use to manufacture,
process, or use the substance in any
manner that results in inhalation
exposure to the substance.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i) are applicable to
manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
§ 721.12055 Oxirane, 2-(chloromethyl)-,
homopolymer, ether with dialkyl-alkanediol
(2:1) (generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as oxirane, 2-(chloromethyl), homopolymer, ether with dialkylalkanediol (2:1) (PMN P–22–25) is
subject to reporting under this section
for the significant new uses described in
paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (3), (b), and (c). When
determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible. For purposes
of § 721.63(b), the concentration is set at
0.1%.
PO 00000
Frm 00051
Fmt 4702
Sfmt 4702
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (f), (g)(1), and (5). For purposes
of § 721.72(e), the concentration is set at
0.1%. For purposes of § 721.72(g)(1),
this substance may cause: acute toxicity,
skin irritation, eye irritation, genetic
toxicity, carcinogenicity, and specific
target organ toxicity. Alternative hazard
and warning statements that meet the
criteria of the Globally Harmonized
System and OSHA Hazard
Communication Standard may be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(g), (t), (y)(1), and
(2). It is a significant new use to
manufacture, process, or use the
substance in any manner that generates
a vapor, mist, aerosol, or dust.
(iv) Disposal. It is a significant new
use to dispose of the substance, or waste
streams containing the substance, other
than by hazardous waste incineration.
(v) Release to water. Requirements as
specified in § 721.90(a)(1), (b)(1), and
(c)(1).
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (k) are applicable
to manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
§ 721.12056 Aryl, polymer with
formaldehyde, glycidyl ether, reaction
products with amino alkyl-alkane diamine,
cyclohexanediamine and alkylene
(alkylcyclohexanamine) (generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as aryl, polymer with
formaldehyde, glycidyl ether, reaction
products with amino alkyl-alkane
diamine, cyclohexanediamine and
alkylene (alkylcyclohexanamine) (PMN
P–22–49) is subject to reporting under
this section for the significant new uses
described in paragraph (a)(2) of this
section. The requirements of this section
do not apply to quantities of the
substance after they have been
completely reacted or cured.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (3) through (6), and (c).
When determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1) and (4),
engineering control measures (e.g.,
E:\FR\FM\17DEP1.SGM
17DEP1
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
enclosure or confinement of the
operation, general and local ventilation)
or administrative control measures (e.g.,
workplace policies and procedures)
shall be considered and implemented to
prevent exposure, where feasible. For
purposes of § 721.63(a)(5), respirators
must provide a National Institute for
Occupational Safety and Health
(NIOSH) assigned protection factor
(APF) of at least 1,000.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (d), (f), (g)(1), (3), and (5). For
purposes of § 721.72(g)(1), this
substance may cause: acute toxicity,
skin irritation, eye irritation, skin
corrosion, serious eye damage,
respiratory sensitization, skin
sensitization, genetic toxicity,
reproductive toxicity, and specific target
organ toxicity. For purposes of
§ 721.72(g)(3), this substance may be:
toxic to aquatic life. Alternative hazard
and warning statements that meet the
criteria of the Globally Harmonized
System and OSHA Hazard
Communication Standard may be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(o).
(iv) Release to water. Requirements as
specified in § 721.90(a)(4), (b)(4), and
(c)(4), where N=2.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i), and (k) are
applicable to manufacturers, importers,
and processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
ddrumheller on DSK120RN23PROD with PROPOSALS1
§ 721.12057 Alkene, alkoxy-, polymer with
alkoxyalkene (generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as alkene, alkoxy-, polymer
with alkoxyalkene (PMN P–22–50) is
subject to reporting under this section
for the significant new uses described in
paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1) and (3), (b), and (c). When
determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible. For purposes
of § 721.63(b), the concentration is set at
1.0%.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (f), (g)(1), (3), and (5). For
purposes of § 721.72(e), the
concentration is set at 1.0%. For
purposes of § 721.72(g)(1), this
substance may cause: skin irritation, eye
irritation, and specific target organ
toxicity. For purposes of § 721.72(g)(3),
this substance may be: toxic to aquatic
life. Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(k) and (o). It is a
significant new use to manufacture,
process, or use the substance in any
manner that results in inhalation
exposure to the substance.
(iv) Release to water. Requirements as
specified in § 721.90(a)(1), (b)(1), and
(c)(1).
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i), and (k) are
applicable to manufacturers, importers,
and processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
§ 721.12058 Methanesulfonamide, 1,1,1trifluoro-N-[(trifluoromethyl)sulfonyl]-,
sodium salt (1:1).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
as Methanesulfonamide, 1,1,1-trifluoroN-[(trifluoromethyl)sulfonyl]-, sodium
salt (1:1) (PMN P–22–58; CASRN
91742–21–1) is subject to reporting
under this section for the significant
new uses described in paragraph (a)(2)
of this section. The requirements of this
section do not apply to quantities of the
substance after they have been
incorporated into an article.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (3) through (6), (b), and
(c). When determining which persons
are reasonably likely to be exposed as
required for § 721.63(a)(1) and (4),
engineering control measures (e.g.,
enclosure or confinement of the
PO 00000
Frm 00052
Fmt 4702
Sfmt 4702
102067
operation, general and local ventilation)
or administrative control measures (e.g.,
workplace policies and procedures)
shall be considered and implemented to
prevent exposure, where feasible. For
purposes of § 721.63(a)(5), respirators
must provide a National Institute for
Occupational Safety and Health
(NIOSH) assigned protection factor
(APF) of at least 50. For purposes of
§ 721.63(b), the concentration is set at
1.0%.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (f), (g)(1), (3), and (5). For
purposes of § 721.72(e), the
concentration is set at 1.0%. For
purposes of § 721.72(g)(1), this
substance may cause: acute toxicity,
serious eye damage, skin irritation,
reproductive toxicity, and specific target
organ toxicity. For purposes of
§ 721.72(g)(3), this substance may be:
toxic to aquatic life. Alternative hazard
and warning statements that meet the
criteria of the Globally Harmonized
System and OSHA Hazard
Communication Standard may be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(b), (k), (v)(2), and
(y)(1) and (2). It is a significant new use
to process the substance in a manner
that generates a vapor, mist, aerosol, or
dust that results in inhalation to
workers.
(iv) Release to water. Requirements as
specified in § 721.90(a)(4), (b)(4), and
(c)(4), where N=100.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i), and (k) are
applicable to manufacturers, importers,
and processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
§ 721.12059 1H-Isoindole-1,3(2H)-dione,
3a,4,7,7a-tetrahydro-2-(2-hydroxyethyl)-.
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
as 1H-Isoindole-1,3(2H)-dione,
3a,4,7,7a-tetrahydro-2-(2-hydroxyethyl)(PMN P–22–75; CASRN 15458–48–7) is
subject to reporting under this section
for the significant new uses described in
paragraph (a)(2) of this section. The
requirements of this section do not
apply to quantities of the substance after
they have been completely reacted or
cured.
(2) The significant new uses are:
E:\FR\FM\17DEP1.SGM
17DEP1
102068
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (3), (b), and (c). When
determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible. For purposes
of § 721.63(b), the concentration is set at
1.0%.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (f), (g)(1), (3), and (5). For
purposes of § 721.72(e), the
concentration is set at 1.0%. For
purposes of § 721.72(g)(1), this
substance may cause: acute toxicity,
skin irritation, eye irritation, and
specific target organ toxicity. For
purposes of § 721.72(g)(3), this
substance may be: toxic to aquatic life.
Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(f), (k), and (t). It is
a significant new use to manufacture the
substance in excess of an annual volume
of 3,000 kg. It is a significant new use
to use the substance other than as a
monomer used to produce an
unsaturated polyester resin.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i) are applicable to
manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
ddrumheller on DSK120RN23PROD with PROPOSALS1
§ 721.12060 Oxirane, 2-methyl-, polymer
with oxirane, mono-isoalkyl ethers,
phosphates, salt (generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as oxirane, 2-methyl-,
polymer with oxirane, mono-isoalkyl
ethers, phosphates, salt (PMN P–22–78)
is subject to reporting under this section
for the significant new uses described in
paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
§ 721.63(a)(1) and (3), (b), and (c). When
determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible. For purposes
of § 721.63(b), the concentration is set at
1.0%.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (f), (g)(1), (3), and (5). For
purposes of § 721.72(e), the
concentration is set at 1.0%. For
purposes of § 721.72(g)(1), this
substance may cause: skin irritation and
specific target organ toxicity. For
purposes of § 721.72(g)(3), this
substance may be: toxic to aquatic life.
Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(k). It is a
significant new use to manufacture or
process the substance in a manner that
generates a vapor, mist, aerosol, or dust.
It is a significant new use to process for
use or use the substance other than as
a dispersing agent for pesticide
formulations.
(iv) Release to water. Requirements as
specified in § 721.90(a)(4), (b)(4), and
(c)(4), where N=23.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i), and (k) are
applicable to manufacturers, importers,
and processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
and 90350–34–8) is subject to reporting
under this section for the significant
new uses described in paragraph (a)(2)
of this section. The requirements of this
section do not apply to quantities of the
substance after they have been
completely reacted or destroyed.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (3), and (c). When
determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (d), (f), (g)(1), (3), and (5). For
purposes of § 721.72(g)(1), this
substance may cause: acute toxicity,
skin corrosion, serious eye damage, and
skin sensitization. For purposes of
§ 721.72(g)(3), this substance may be:
toxic to aquatic life. Alternative hazard
and warning statements that meet the
criteria of the Globally Harmonized
System and OSHA Hazard
Communication Standard may be used.
(iii) Industrial, commercial, and
consumer activities. It is a significant
new use to manufacture, process, or use
the substance in any manner that results
in inhalation exposure to the substance.
(iv) Release to water. Requirements as
specified in § 721.90(a)(4), (b)(4), and
(c)(4), where N=0.7.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i), and (k) are
applicable to manufacturers, importers,
and processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
§ 721.12061 Poly(oxy-1,2-ethanediyl),
.alpha.-(2-aminoethyl)-.omega.-(2aminoethoxy)- and Poly(oxy-1,2-ethanediyl),
.alpha.,.alpha.′,-(iminodi-2,1ethanediyl)bis[.omega.-(2-aminoethoxy)-.
§ 721.12062 Alkenoic acid, alkyl,
carbopolycyclic alkyl ester, polymer with
trihalo (trihaloalkyl) alkyl alkyl alkenoate
(generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
as poly(oxy-1,2-ethanediyl), .alpha.-(2aminoethyl)-.omega.-(2-aminoethoxy)and poly(oxy-1,2-ethanediyl),
.alpha.,.alpha.′,-(iminodi-2,1ethanediyl)bis[.omega.-(2-aminoethoxy)(PMN P–22–80; CAS Nos. 24991–53–5
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as alkenoic acid, alkyl,
carbopolycyclic alkyl ester, polymer
with trihalo (trihaloalkyl) alkyl alkyl
alkenoate (PMN P–22–82) is subject to
reporting under this section for the
significant new uses described in
PO 00000
Frm 00053
Fmt 4702
Sfmt 4702
E:\FR\FM\17DEP1.SGM
17DEP1
ddrumheller on DSK120RN23PROD with PROPOSALS1
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
paragraph (a)(2) of this section. The
requirements of this section do not
apply to quantities of the substance after
they have been entrained in dried
photoresist.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (3), (b), and (c). When
determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible. For purposes
of § 721.63(b), the concentration is set at
1.0%.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (f), (g)(1), and (5). For purposes
of § 721.72(e), the concentration is set at
1.0%. For purposes of § 721.72(g)(1),
this substance may cause: reproductive
toxicity and specific target organ
toxicity. Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(f), (k), (v)(1), (2)
and (4), (w)(1), (2) and (4), and (x)(1), (2)
and (4). It is a significant new use to
manufacture the substance other than by
import into the United States (i.e., no
domestic manufacture) in a liquid
formulation.
(iv) Disposal. Requirements as
specified in § 721.85(a)(1), (b)(1), and
(c)(1).
(v) Release to water. Requirements as
specified in § 721.90(a)(1), (b)(1), and
(c)(1).
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (k) are applicable
to manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
§ 721.12063
Polychloroalkene (generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as polychloroalkene (PMN
P–22–121) is subject to reporting under
this section for the significant new uses
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
described in paragraph (a)(2) of this
section. The requirements of this section
do not apply to quantities of the
substance after they have been
completely reacted.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (3) through (6), and (c).
When determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1) and (4),
engineering control measures (e.g.,
enclosure or confinement of the
operation, general and local ventilation)
or administrative control measures (e.g.,
workplace policies and procedures)
shall be considered and implemented to
prevent exposure, where feasible. For
purposes of § 721.63(a)(5), respirators
must provide a National Institute for
Occupational Safety and Health
(NIOSH) assigned protection factor
(APF) of at least 50.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (d), (f), (g)(1), (3), and (5). For
purposes of § 721.72(g)(1), this
substance may cause: acute toxicity,
skin irritation, serious eye damage, skin
sensitization, genetic toxicity,
carcinogenicity, and specific target
organ toxicity. For purposes of
§ 721.72(g)(3), this substance may be:
toxic to aquatic life. Alternative hazard
and warning statements that meet the
criteria of the Globally Harmonized
System and OSHA Hazard
Communication Standard may be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(f) and (k). It is a
significant new use to process, use,
load, or unload the substance unless
under a gas (e.g., nitrogen) blanket or in
a closed system except that sampling
may occur outside the closed system
resulting in exposures.
(iv) Release to water. Requirements as
specified in § 721.90(a)(4), (b)(4), and
(c)(4), where N=0.15.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i), and (k) are
applicable to manufacturers, importers,
and processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
PO 00000
Frm 00054
Fmt 4702
Sfmt 4702
102069
§ 721.12064 Alkanoic acid, trialkyl-, diester
with carbomonocycle
bis(alkyleneoxy)]bis[alkanediol] (generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as alkanoic acid, trialkyl-,
diester with carbomonocycle
bis(alkyleneoxy)]bis[alkanediol] (PMN
P–22–145) is subject to reporting under
this section for the significant new uses
described in paragraph (a)(2) of this
section.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (3), (b), and (c). When
determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible. For purposes
of § 721.63(b), the concentration is set at
1.0%.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (f), (g)(1), (3), and (5). For
purposes of § 721.72(e), the
concentration is set at 1.0%. For
purposes of § 721.72(g)(1), this
substance may cause: acute toxicity,
reproductive toxicity, and specific target
organ toxicity. For purposes of
§ 721.72(g)(3), this substance may be:
toxic to aquatic life. Alternative hazard
and warning statements that meet the
criteria of the Globally Harmonized
System and OSHA Hazard
Communication Standard may be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(o). It is a
significant new use to use the substance
in any manner that may generate a
spray, mist, vapor, or aerosol containing
the substance unless the concentration
of the substance is less than 5.7% by
weight.
(iv) Disposal. Requirements as
specified in § 721.85(a)(1), (b)(1), and
(c)(1).
(v) Release to water. Requirements as
specified in § 721.90(a)(1), (b)(1), and
(c)(1).
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (k) are applicable
to manufacturers, importers, and
processors of this substance.
E:\FR\FM\17DEP1.SGM
17DEP1
ddrumheller on DSK120RN23PROD with PROPOSALS1
102070
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
§ 721.12065 Modified Silsesquioxane,
alkoxy-terminated (generic).
§ 721.12066 Vegetable oil, polymer with
pimelin ketone, oxymethylene and
polymethylenepolyphenylene isocyanate
(generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as modified silsesquioxane,
alkoxy-terminated (PMN P–22–175) is
subject to reporting under this section
for the significant new uses described in
paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (3) through (6), (b), and
(c). When determining which persons
are reasonably likely to be exposed as
required for § 721.63(a)(1) and (4),
engineering control measures (e.g.,
enclosure or confinement of the
operation, general and local ventilation)
or administrative control measures (e.g.,
workplace policies and procedures)
shall be considered and implemented to
prevent exposure, where feasible. For
purposes of § 721.63(a)(5), respirators
must provide a National Institute for
Occupational Safety and Health
(NIOSH) assigned protection factor
(APF) of at least 10. For purposes of
§ 721.63(b), the concentration is set at
1.0%.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (f), (g)(1), (3), and (5). For
purposes of § 721.72(e), the
concentration is set at 1.0%. For
purposes of § 721.72(g)(1), this
substance may cause: skin irritation, eye
irritation, and specific target organ
toxicity. For purposes of § 721.72(g)(3),
this substance may be: toxic to aquatic
life. Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(f). It is a significant
new use to use the substance unless the
concentration of the substance does not
exceed 10% by weight in formulation.
(iv) Release to water. Requirements as
specified in § 721.90(a)(4), (b)(4), and
(c)(4), where N=7.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i), and (k) are
applicable to manufacturers, importers,
and processors of this substance.
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as vegetable oil, polymer
with pimelin ketone, oxymethylene and
polymethylenepolyphenylene
isocyanate (PMN P–23–18) is subject to
reporting under this section for the
significant new uses described in
paragraph (a)(2) of this section. The
requirements of this section do not
apply to quantities of the substance after
they have been completely reacted or
cured.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1) and (3), and (c). When
determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (d), (f), (g)(1), and (5). For
purposes of § 721.72(g)(1), this
substance may cause: acute toxicity,
skin irritation, eye irritation, respiratory
sensitization, skin sensitization, genetic
toxicity, carcinogenicity, reproductive
toxicity, and specific target organ
toxicity. Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(o). It is a
significant new use to manufacture,
process, or use the substance in any
manner that results in inhalation
exposure to the substance.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i) are applicable to
manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
PO 00000
Frm 00055
Fmt 4702
Sfmt 4702
provisions of § 721.185 apply to this
section.
§ 721.12067 Silsesquioxanes, 3mercaptopropyl, polymers with silicic acid
(H4SiO4) tetra-Et ester, [(trimethylsilyl)oxy]terminated.
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
as silsesquioxanes, 3-mercaptopropyl,
polymers with silicic acid (H4SiO4)
tetra-Et ester, [(trimethylsilyl)oxy]terminated (PMN P–23–20; CASRN
2796383–42–9) is subject to reporting
under this section for the significant
new uses described in paragraph (a)(2)
of this section. The requirements of this
section do not apply to quantities of the
substance after they have been
completely reacted or cured.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (3), and (c). When
determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (d), (f), (g)(1), (3), and (5). For
purposes of § 721.72(g)(1), this
substance may cause: skin sensitization
and specific target organ toxicity. For
purposes of § 721.72(g)(3), this
substance may be: toxic to aquatic life.
Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(k). It is a
significant new use to manufacture,
process, or use the substance in any
manner that results inhalation exposure.
(iv) Release to water. Requirements as
specified in § 721.90(a)(4), (b)(4), and
(c)(4), where N=3.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i), and (k) are
applicable to manufacturers, importers,
and processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
E:\FR\FM\17DEP1.SGM
17DEP1
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
ddrumheller on DSK120RN23PROD with PROPOSALS1
§ 721.12068 Castor oil, polymer with
dicyclopentadiene, maleic anhydride, 2methyl-1,3-propanediol, 3a,4,7,7atetrahydro-2-(2-hydroxyethyl)-1H-isoindole1,3(2H)-dione and triethylene glycol.
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
as castor oil, polymer with
dicyclopentadiene, maleic anhydride, 2methyl-1,3-propanediol, 3a,4,7,7atetrahydro-2-(2-hydroxyethyl)-1Hisoindole-1,3(2H)-dione and triethylene
glycol (PMN P–23–36; CASRN
2794200–69–2) is subject to reporting
under this section for the significant
new uses described in paragraph (a)(2)
of this section. The requirements of this
section do not apply to quantities of the
substance after they have been
completely reacted or cured.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (3), (b), and (c). When
determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible. For purposes
of § 721.63(b), the concentration is set at
1.0%.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (f), (g)(1), (3), and (5). For
purposes of § 721.72(e), the
concentration is set at 1.0%. For
purposes of § 721.72(g)(1), this
substance may cause: skin irritation, eye
irritation, and specific target organ
toxicity. For purposes of § 721.72(g)(3),
this substance may be: toxic to aquatic
life. Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(o), (y)(1), and (2).
It is a significant new use to
manufacture or process the substance in
a manner that generates a vapor, mist,
aerosol, or dust.
(iv) Release to water. Requirements as
specified in § 721.90(a)(4), (b)(4), and
(c)(4), where N=27.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i), and (k) are
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
applicable to manufacturers, importers,
and processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
§ 721.12069 Monoaromatic cyclic alkylene
sulfonium fluoroalkyl sulfonic acid salt
(generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as monoaromatic cyclic
alkylene sulfonium fluoroalkyl sulfonic
acid salt (PMN P–23–37) is subject to
reporting under this section for the
significant new uses described in
paragraph (a)(2) of this section. The
requirements of this section do not
apply to quantities of the substance after
they have been completely reacted or
adhered (during photolithographic
processes) onto a semiconductor wafer
surface or similar manufactured article
used in the production of
semiconductor technologies.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (2)(i) and (iii), (3), and (c).
When determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (d), (f), (g)(1), (2)(i) through (iii),
(v), (3)(i) and (ii), and (5). For purposes
of § 721.72(g)(1), this substance may
cause: acute toxicity, skin irritation,
skin sensitization, genetic toxicity, and
specific target organ toxicity.
Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(f), (k), and (t). It is
a significant new use to import the
substance other than in solution, or in
sealed containers weighing 5 kilograms
or less. It is a significant new use to
modify the processing or use of the
substance in any way that generates
dust, mist, or aerosol in a non-enclosed
process. It is a significant new use to
manufacture the substance longer than
18 months.
(b) Specific requirements. The
provisions of Subpart A of this part
PO 00000
Frm 00056
Fmt 4702
Sfmt 4702
102071
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i) are applicable to
manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
§ 721.12070 Monoaromatic cyclic alkylene
sulfonium fluoroalkyl sulfonic acid salt
(generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as monoaromatic cyclic
alkylene sulfonium fluoroalkyl sulfonic
acid salt (PMN P–23–44) is subject to
reporting under this section for the
significant new uses described in
paragraph (a)(2) of this section. The
requirements of this section do not
apply to quantities of the substance after
they have been completely reacted or
adhered (during photolithographic
processes) onto a semiconductor wafer
surface or similar manufactured article
used in the production of
semiconductor technologies.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (2)(i) and (iii), (3), and (c).
When determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (d), (f), (g)(1), (2)(i) through (iii),
(v), (3)(i) and (ii), and (5). For purposes
of § 721.72(g)(1), this substance may
cause: acute toxicity, skin irritation,
serious eye damage, reproductive
toxicity, skin sensitization, genetic
toxicity, and specific target organ
toxicity. Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(f), (k), and (t). It is
a significant new use to import the
substance other than in solution, or in
sealed containers weighing 5 kilograms
or less. It is a significant new use to
modify the processing or use of the
substance in any way that generates
E:\FR\FM\17DEP1.SGM
17DEP1
102072
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
dust, mist, or aerosol in a non-enclosed
process. It is a significant new use to
manufacture the substance longer than
18 months.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i) are applicable to
manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
ddrumheller on DSK120RN23PROD with PROPOSALS1
§ 721.12071 Aromatic sulfonium tricyclo
fluoroalkyl sulfonic acid salt (generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as aromatic sulfonium
tricyclo fluoroalkyl sulfonic acid salt
(PMN P–23–80) is subject to reporting
under this section for the significant
new uses described in paragraph (a)(2)
of this section. The requirements of this
section do not apply to quantities of the
substance after they have been
completely reacted or adhered (during
photolithographic processes) onto a
semiconductor wafer surface or similar
manufactured article used in the
production of semiconductor
technologies.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (2)(i) and (iii), (3), and (c).
When determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (d), (f), (g)(1), (2)(i) through (iii),
(v), (3)(i) and (ii), and (5). For purposes
of § 721.72(g)(1), this substance may
cause: acute toxicity, skin irritation,
serious eye damage, skin sensitization,
genetic toxicity, and specific target
organ toxicity. Alternative hazard and
warning statements that meet the
criteria of the Globally Harmonized
System and OSHA Hazard
Communication Standard may be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(f), (k), and (t). It is
a significant new use to import the
substance other than in solution, or in
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
sealed containers weighing 5 kilograms
or less. It is a significant new use to
modify the processing or use of the
substance in any way that generates
dust, mist, or aerosol in a non-enclosed
process. It is a significant new use to
manufacture the substance longer than
18 months.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i) are applicable to
manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
§ 721.12072 Aromatic dibenzothiophenium
fluoroalkyl carbopolycycle sulfonic acid salt
(generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as aromatic
dibenzothiophenium fluoroalkyl
carbopolycycle sulfonic acid salt (PMN
P–23–93) is subject to reporting under
this section for the significant new uses
described in paragraph (a)(2) of this
section. The requirements of this section
do not apply to quantities of the
substance after they have been
completely reacted or adhered (during
photolithographic processes) onto a
semiconductor wafer surface or similar
manufactured article used in the
production of semiconductor
technologies.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (2)(i) and (iii), (3), and (c).
When determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (d), (f), (g)(1), (2)(i) through (iii),
(v), (3)(i) and (ii), and (5). For purposes
of § 721.72(g)(1), this substance may
cause: acute toxicity, skin irritation,
serious eye damage, reproductive
toxicity, skin sensitization, genetic
toxicity, and specific target organ
toxicity. Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
PO 00000
Frm 00057
Fmt 4702
Sfmt 4702
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(f), (k), and (t). It is
a significant new use to import the
substance other than in solution, or in
sealed containers weighing 5 kilograms
or less. It is a significant new use to
modify the processing or use of the
substance in any way that generates
dust, mist, or aerosol in a non-enclosed
process. It is a significant new use to
manufacture the substance longer than
18 months.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i) are applicable to
manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
§ 721.12073 Alkanediol, substituted,
polymer with diisocyanatoalkane,
substituted heterocycle-modified (generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as alkanediol, substituted,
polymer with diisocyanatoalkane,
substituted heterocycle-modified (PMN
P–23–64) is subject to reporting under
this section for the significant new uses
described in paragraph (a)(2) of this
section. The requirements of this section
do not apply to quantities of the
substance after they have been
completely reacted or cured.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (3), and (c). When
determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (d), (f), (g)(1), and (5). For
purposes of § 721.72(g)(1), this
substance may cause: skin sensitization
and specific target organ toxicity.
Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
E:\FR\FM\17DEP1.SGM
17DEP1
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(o), and (y)(1) and
(2). It is a significant new use to
manufacture or process the substance in
a manner that generates a vapor, mist,
aerosol, or dust.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i) are applicable to
manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
ddrumheller on DSK120RN23PROD with PROPOSALS1
§ 721.12074 Halosubstituted
carbopolycycle, polymer with substituted
carbomonocycles and oxybis[alkanol]
(generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as halosubstituted
carbopolycycle, polymer with
substituted carbomonocycles and
oxybis[alkanol] (PMN P–23–72) is
subject to reporting under this section
for the significant new uses described in
paragraph (a)(2) of this section. The
requirements of this section do not
apply to quantities of the substance after
they have been completely reacted or
cured.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (3) through (6), (b), and
(c). When determining which persons
are reasonably likely to be exposed as
required for § 721.63(a)(1) and (4),
engineering control measures (e.g.,
enclosure or confinement of the
operation, general and local ventilation)
or administrative control measures (e.g.,
workplace policies and procedures)
shall be considered and implemented to
prevent exposure, where feasible. For
purposes of § 721.63(a)(5), respirators
must provide a National Institute for
Occupational Safety and Health
(NIOSH) assigned protection factor
(APF) of at least 10. For purposes of
§ 721.63(b), the concentration is set at
0.1%.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (f), (g)(1), (3), and (5). For
purposes of § 721.72(e), the
concentration is set at 0.1%. For
purposes of § 721.72(g)(1), this
substance may cause: genetic toxicity,
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
carcinogenicity, and specific target
organ toxicity. For purposes of
§ 721.72(g)(3), this substance may be:
toxic to aquatic life. Alternative hazard
and warning statements that meet the
criteria of the Globally Harmonized
System and OSHA Hazard
Communication Standard may be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(o). It is a
significant new use to process for use or
use the substance other than in an
enclosed roll-coating lithographic
printing machine. It is a significant new
use to process for use or use the
substance to a final formulation for
coating application that exceeds 40% by
weight.
(iv) Disposal. Requirements as
specified in § 721.85(a)(2), (b)(2), and
(c)(2).
(v) Release to water. Requirements as
specified in § 721.90(a)(1), (b)(1), and
(c)(1).
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (k) are applicable
to manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
§ 721.12075 Polymer of
benzenedicarboxylic acid, substitutedbenzenedicarboxylic acid, branchedalkyldiol, alkyldiol and triisocyanate
(generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as polymer of
benzenedicarboxylic acid, substitutedbenzenedicarboxylic acid, branchedalkyldiol, alkyldiol and triisocyanate
(PMN P–23–94) is subject to reporting
under this section for the significant
new uses described in paragraph (a)(2)
of this section. The requirements of this
section do not apply to quantities of the
substance after they have been
completely reacted or cured.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (3), and (c). When
determining which persons are
reasonably likely to be exposed as
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
PO 00000
Frm 00058
Fmt 4702
Sfmt 4702
102073
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (d), (f), (g)(1), and (5). For
purposes of § 721.72(g)(1), this
substance may cause: skin sensitization,
respiratory sensitization, and specific
target organ toxicity. Alternative hazard
and warning statements that meet the
criteria of the Globally Harmonized
System and OSHA Hazard
Communication Standard may be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(o). It is a
significant new use to manufacture,
process, or use the substance in any
manner that results inhalation exposure.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i) are applicable to
manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
§ 721.12076 Sulfonium, tricarbocyclic-,
alkylcarbomonocyclic-polyfluoroheteropolycyclic-alkyl sulfonate (1:1),
polymer with alkylaryl and carbomonocyclic
alkylalkanoate, di-Me 2,2′-(1,2diazenediyl)bis[2-alkylalkanoate]-initiated
(generic).
(a) Chemical substance and
significant new uses subject to reporting.
(1) The chemical substance identified
generically as sulfonium, tricarbocyclic-,
alkylcarbomonocyclic-polyfluoroheteropolycyclic-alkyl sulfonate (1:1),
polymer with alkylaryl and
carbomonocyclic alkylalkanoate, di-Me
2,2′-(1,2-diazenediyl)bis[2alkylalkanoate]-initiated (PMN P–23–
172) is subject to reporting under this
section for the significant new uses
described in paragraph (a)(2) of this
section. The requirements of this section
do not apply to quantities of the
substance after they have been
completely reacted or adhered (during
photolithographic processes) onto a
semiconductor wafer surface or similar
manufactured article used in the
production of semiconductor
technologies.
(2) The significant new uses are:
(i) Protection in the workplace.
Requirements as specified in
§ 721.63(a)(1), (2)(i) and (iii), (3), and (c).
When determining which persons are
reasonably likely to be exposed as
E:\FR\FM\17DEP1.SGM
17DEP1
102074
Federal Register / Vol. 89, No. 242 / Tuesday, December 17, 2024 / Proposed Rules
required for § 721.63(a)(1), engineering
control measures (e.g., enclosure or
confinement of the operation, general
and local ventilation) or administrative
control measures (e.g., workplace
policies and procedures) shall be
considered and implemented to prevent
exposure, where feasible.
(ii) Hazard communication.
Requirements as specified in § 721.72(a)
through (d), (f), (g)(1), (2)(i) through (iii),
(v), (3)(i) and (ii), and (5). For purposes
of § 721.72(g)(1), this substance may
cause: acute toxicity, skin irritation,
serious eye damage, skin sensitization,
genetic toxicity, reproductive toxicity,
and specific target organ toxicity.
Alternative hazard and warning
statements that meet the criteria of the
Globally Harmonized System and OSHA
Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and
consumer activities. Requirements as
specified in § 721.80(f), (k), and (t). It is
a significant new use to import the
substance other than in solution, or in
sealed containers weighing 5 kilograms
or less. It is a significant new use to
modify the processing of the substance
in any way that generates dust, mist, or
aerosol in a non-enclosed process. It is
a significant new use to manufacture the
substance longer than 18 months.
(b) Specific requirements. The
provisions of Subpart A of this part
apply to this section except as modified
by this paragraph (b).
(1) Recordkeeping. Recordkeeping
requirements as specified in
§ 721.125(a) through (i) are applicable to
manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain
notification requirements. The
provisions of § 721.185 apply to this
section.
[FR Doc. 2024–29275 Filed 12–16–24; 8:45 am]
BILLING CODE 6560–50–P
DEPARTMENT OF THE INTERIOR
Fish and Wildlife Service
50 CFR Part 17
ddrumheller on DSK120RN23PROD with PROPOSALS1
[Docket No. FWS–R7–ES–2024–0117;
FXES1111090FEDR–256–FF09E21000]
RIN 1018–BI15
Endangered and Threatened Wildlife
and Plants; Endangered Species
Status for Suckley’s Cuckoo Bumble
Bee
Fish and Wildlife Service,
Interior.
ACTION: Proposed rule.
AGENCY:
VerDate Sep<11>2014
18:38 Dec 16, 2024
Jkt 265001
We, the U.S. Fish and
Wildlife Service (Service), propose to
list the Suckley’s cuckoo bumble bee
(Bombus suckleyi), an invertebrate
species from North America, as an
endangered species under the
Endangered Species Act of 1973, as
amended (Act). This determination also
serves as our 12-month finding on a
petition to list the Suckley’s cuckoo
bumble bee. After a review of the best
available scientific and commercial
information, we find that listing the
species is warranted. Accordingly, we
propose to list the species as an
endangered species under the Act. If we
finalize this rule as proposed, it would
add this species to the List of
Endangered and Threatened Wildlife
and extend the Act’s protections to the
species. Due to the current lack of data
sufficient to perform required analyses,
we conclude that the designation of
critical habitat for the species is not
determinable at this time.
DATES: We will accept comments
received or postmarked on or before
February 18, 2025. Comments submitted
electronically using the Federal
eRulemaking Portal (see ADDRESSES,
below) must be received by 11:59 p.m.
eastern time on the closing date. We
must receive requests for a public
hearing, in writing, at the address
shown in FOR FURTHER INFORMATION
CONTACT by January 31, 2025.
ADDRESSES: You may submit comments
by one of the following methods:
(1) Electronically: Go to the Federal
eRulemaking Portal:
https://www.regulations.gov. In the
Search box, enter FWS–R7–ES–2024–
0117, which is the docket number for
this rulemaking. Then, click on the
Search button. On the resulting page, in
the panel on the left side of the screen,
under the Document Type heading,
check the Proposed Rule box to locate
this document. You may submit a
comment by clicking on ‘‘Comment.’’
(2) By hard copy: Submit by U.S. mail
to: Public Comments Processing, Attn:
FWS–R7–ES–2024–0117, U.S. Fish and
Wildlife Service, MS: PRB/3W, 5275
Leesburg Pike, Falls Church, VA 22041–
3803.
We request that you send comments
only by the methods described above.
We will post all comments on https://
www.regulations.gov. This generally
means that we will post any personal
information you provide us (see
Information Requested, below, for more
information).
Availability of supporting materials:
Supporting materials, such as the
species status assessment report, are
SUMMARY:
PO 00000
Frm 00059
Fmt 4702
Sfmt 4702
available at https://www.regulations.gov
at Docket No. FWS–R7–ES–2024–0117.
FOR FURTHER INFORMATION CONTACT:
Mike Daigneault, Acting Field
Supervisor, Southern Alaska Fish and
Wildlife Field Office, 4700 BLM Road,
Anchorage, AK 99507; telephone 907–
271–1467. Individuals in the United
States who are deaf, deafblind, hard of
hearing, or have a speech disability may
dial 711 (TTY, TDD, or TeleBraille) to
access telecommunications relay
services. Individuals outside the United
States should use the relay services
offered within their country to make
international calls to the point-ofcontact in the United States. Please see
Docket No. FWS–R7–ES–2024–0117 on
https://www.regulations.gov for a
document that summarizes this
proposed rule.
SUPPLEMENTARY INFORMATION:
Executive Summary
Why we need to publish a rule. Under
the Act, a species warrants listing if it
meets the definition of an endangered
species (in danger of extinction
throughout all or a significant portion of
its range) or a threatened species (likely
to become an endangered species within
the foreseeable future throughout all or
a significant portion of its range). If we
determine that a species warrants
listing, we must list the species
promptly and designate the species’
critical habitat to the maximum extent
prudent and determinable. We have
determined that Suckley’s cuckoo
bumble bee meets the Act’s definition of
an endangered species; therefore, we are
proposing to list it as such. Listing a
species as an endangered or threatened
species can be completed only by
issuing a rule through the
Administrative Procedure Act
rulemaking process (5 U.S.C. 551 et
seq.).
What this document does. We
propose to list Suckley’s cuckoo bumble
bee as an endangered species under the
Act.
The basis for our action. Under the
Act, we may determine that a species is
an endangered or a threatened species
because of any of five factors: (A) The
present or threatened destruction,
modification, or curtailment of its
habitat or range; (B) overutilization for
commercial, recreational, scientific, or
educational purposes; (C) disease or
predation; (D) the inadequacy of
existing regulatory mechanisms; or (E)
other natural or manmade factors
affecting its continued existence. We
have determined that Suckley’s cuckoo
bumble bee meets the Act’s definition of
an endangered species due to threats
E:\FR\FM\17DEP1.SGM
17DEP1
Agencies
[Federal Register Volume 89, Number 242 (Tuesday, December 17, 2024)]
[Proposed Rules]
[Pages 102046-102074]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-29275]
-----------------------------------------------------------------------
ENVIRONMENTAL PROTECTION AGENCY
40 CFR Part 721
[EPA-HQ-OPPT-2024-0079; FRL-12386-01-OCSPP]
RIN 2070-AB27
Significant New Use Rules on Certain Chemical Substances (24-
3.5e)
AGENCY: Environmental Protection Agency (EPA).
ACTION: Proposed rule.
-----------------------------------------------------------------------
SUMMARY: EPA is proposing significant new use rules (SNURs) under the
Toxic Substances Control Act (TSCA) for certain chemical substances
that were the subject of premanufacture notices (PMNs) and are also
subject to an Order issued by EPA pursuant to TSCA. The SNURs require
persons who intend to manufacture (defined by statute to include
import) or process any of these chemical substances for an activity
that is proposed as a significant new use by this rulemaking to notify
EPA at least 90 days before commencing that activity. The required
notification initiates EPA's evaluation of the conditions of that use
for that chemical substance. In addition, the manufacture or processing
for the significant new use may not commence until EPA has conducted a
review of the required notification, made an appropriate determination
regarding that notification, and taken such actions as required by that
determination.
DATES: Comments must be received on or before January 16, 2025.
ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPPT-2024-0079, at https://www.regulations.gov.
Follow the online instructions for submitting comments. Do not submit
electronically any information you consider to be Confidential Business
Information (CBI) or other information whose disclosure is restricted
by statute. Additional instructions on commenting and visiting the
docket, along with more information about dockets generally, is
available at https://www.epa.gov/dockets.
FOR FURTHER INFORMATION CONTACT:
For technical information: Jordan Garbin, New Chemicals Division
(7405M), Office of Pollution Prevention and Toxics, Environmental
Protection
[[Page 102047]]
Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460-0001; telephone
number: (202) 564-4156; email address: [email protected].
For general information on SNURs: William Wysong, New Chemicals
Division (7405M), Office of Pollution Prevention and Toxics,
Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington,
DC 20460-0001; telephone number: (202) 564-4163; email address:
[email protected].
For general information on TSCA: The TSCA-Hotline, ABVI-Goodwill,
422 South Clinton Ave., Rochester, NY 14620; telephone number: (202)
554-1404; email address: [email protected].
SUPPLEMENTARY INFORMATION:
I. Executive Summary
A. What is the Agency's authority for taking this action?
TSCA section 5(a)(2) (15 U.S.C. 2604(a)(2)) authorizes EPA to
determine that a use of a chemical substance is a ``significant new
use.'' EPA must make this determination by rule after considering all
relevant factors, including the factors in TSCA section 5(a)(2) (see
also the discussion in Unit II.).
B. What action is the Agency taking?
EPA is proposing SNURs for the chemical substances discussed in
Unit III. These SNURs, if finalized as proposed, would require persons
who intend to manufacture or process any of these chemical substances
for an activity that is designated as a significant new use to notify
EPA at least 90 days before commencing that activity.
C. Does this action apply to me?
1. General Applicability
This action applies to you if you manufacture, process, or use the
chemical substances contained in this proposed rule. The following list
of North American Industrial Classification System (NAICS) codes is not
intended to be exhaustive, but rather provides a guide to help readers
determine whether this document applies to them. Potentially affected
entities may include:
Manufacturers or processors of one or more subject
chemical substances (NAICS codes 325 and 324110), e.g., chemical
manufacturing and petroleum refineries.
2. Applicability to Importers and Exporters
This action may also apply to certain entities through pre-existing
import certification and export notification requirements under TSCA
(https://www.epa.gov/tsca-import-export-requirements).
Chemical importers are subject to TSCA section 13 (15 U.S.C. 2612),
the requirements in 19 CFR 12.118 through 12.127, 19 CFR 127.28, and
the EPA policy in support of import certification at 40 CFR part 707,
subpart B. Chemical importers must certify that the shipment of the
chemical substance complies with all applicable rules and orders under
TSCA, including regulations issued under TSCA sections 5, 6, 7 and
Title IV.
Pursuant to 40 CFR 721.20, any persons who export or intend to
export a chemical substance that is the subject of this proposed rule
on or after January 16, 2025 are subject to TSCA section 12(b) (15
U.S.C. 2611(b)) and must comply with the export notification
requirements in 40 CFR part 707, subpart D.
D. What are the incremental economic impacts of this action?
EPA has evaluated the potential costs of establishing SNUN
reporting requirements for potential manufacturers (including
importers) and processors of the chemical substances subject to these
proposed SNURs. This analysis, which is available in the docket, is
briefly summarized here.
1. Estimated Costs for SNUN Submissions
If a SNUN is submitted, costs are an estimated $45,000 per SNUN
submission for large business submitters and $14,500 for small business
submitters. These estimates include the cost to prepare and submit the
SNUN (including registration for EPA's Central Data Exchange (CDX)),
and the payment of a user fee. Businesses that submit a SNUN would be
subject to either a $37,000 user fee required by 40 CFR
700.45(c)(2)(ii) and (d), or, if they are a small business as defined
at 13 CFR 121.201, a reduced user fee of $6,480 (40 CFR
700.45(c)(1)(ii) and (d)) per fiscal year 2022. The costs of submission
for SNUNs will not be incurred by any company unless a company decides
to pursue a significant new use as defined in these SNURs.
Additionally, these estimates reflect the costs and fees as they are
known at the time of this rulemaking.
2. Estimated Costs for Export Notifications
EPA has also evaluated the potential costs associated with the
export notification requirements under TSCA section 12(b) and the
implementing regulations at 40 CFR part 707, subpart D. For persons
exporting a substance that is the subject of a SNUR, a one-time notice
to EPA must be provided for the first export or intended export to a
particular country. The total costs of export notification will vary by
chemical, depending on the number of required notifications (i.e., the
number of countries to which the chemical is exported). While EPA is
unable to make any estimate of the likely number of export
notifications for the chemical substances covered by these SNURs, as
stated in the accompanying economic analysis, the estimated cost of the
export notification requirement on a per unit basis is approximately
$106.
E. What should I consider as I prepare my comments for EPA?
1. Submitting CBI
Do not submit CBI to EPA through email or https://www.regulations.gov. If you wish to include CBI in your comment, please
follow the applicable instructions at https://www.epa.gov/dockets/commenting-epa-dockets#rules and clearly mark the information that you
claim to be CBI. Information so marked will not be disclosed except in
accordance with procedures set forth in 40 CFR parts 2 and 703.
2. Tips for Preparing Your Comments
When preparing and submitting your comments, see the commenting
tips at https://www.epa.gov/dockets/commenting-epa-dockets.
II. Background
This unit provides general information about SNURs. For additional
information about EPA's new chemical program go to https://www.epa.gov/reviewing-new-chemicals-under-toxic-substances-control-act-tsca.
A. Significant New Use Determination Factors
TSCA section 5(a)(2) states that EPA's determination that a use of
a chemical substance is a significant new use must be made after
consideration of all relevant factors, including:
The projected volume of manufacturing and processing of a
chemical substance.
The extent to which a use changes the type or form of
exposure of human beings or the environment to a chemical substance.
The extent to which a use increases the magnitude and
duration of exposure of human beings or the environment to a chemical
substance.
The reasonably anticipated manner and methods of
manufacturing,
[[Page 102048]]
processing, distribution in commerce, and disposal of a chemical
substance.
In determining what would constitute a significant new use for the
chemical substances that are the subject of these SNURs, EPA considered
relevant information about the toxicity of the chemical substances, and
potential human exposures and environmental releases that may be
associated with the substances, in the context of the four bulleted
TSCA section 5(a)(2) factors listed in this unit and discussed in Unit
III.
These proposed SNURs include PMN substances that are subject to
orders issued under TSCA section 5(e)(1)(A), as required by the
determinations made under TSCA section 5(a)(3)(B). The TSCA orders
require protective measures to limit exposures or otherwise mitigate
the potential unreasonable risk. The proposed SNURs identify as
significant new uses any manufacturing, processing, use, distribution
in commerce, or disposal that does not conform to the restrictions
imposed by the underlying TSCA orders, consistent with TSCA section
5(f)(4).
B. Rationale and Objectives of the SNURs
1. Rationale
Under TSCA, no person may manufacture a new chemical substance or
manufacture or process a chemical substance for a significant new use
until EPA makes a determination as described in TSCA section 5(a) and
takes any required action. The issuance of a SNUR is not a risk
determination itself, only a notification requirement for ``significant
new uses,'' so that the Agency has the opportunity to review the SNUN
for the significant new use and make a TSCA section 5(a)(3) risk
determination.
During review of the PMNs submitted that are the subject to these
proposed SNURs, EPA concluded that regulation was warranted under TSCA
section 5(e), pending the development of information sufficient to make
reasoned evaluations of the health or environmental effects of the
chemical substances. Based on the findings outlined in Unit III., TSCA
section 5(e) Orders requiring the use of appropriate exposure controls
were negotiated with the PMN submitters. As a general matter, EPA
believes it is necessary to follow the TSCA Orders with a SNUR that
identifies the absence of those protective measures as significant new
uses to ensure that all manufacturers and processors--not just the
original submitter--are held to the same standard.
2. Objectives
EPA is proposing these SNURs because the Agency wants:
To identify as significant new uses any manufacturing,
processing, use, distribution in commerce, or disposal that does not
conform to the restrictions imposed by the underlying TSCA Orders,
consistent with TSCA section 5(f)(4).
To have an opportunity to review and evaluate data
submitted in a SNUN before the submitter begins manufacturing or
processing a listed chemical substance for the described significant
new use.
To be obligated to make a determination under TSCA section
5(a)(3) regarding the use described in the SNUN, under the conditions
of use. The Agency will either determine under TSCA section 5(a)(3)(C)
that the significant new use is not likely to present an unreasonable
risk, including an unreasonable risk to a potentially exposed or
susceptible subpopulation identified as relevant by the Administrator
under the conditions of use, or make a determination under TSCA section
5(a)(3)(A) or (B) and take the required regulatory action associated
with the determination, before manufacture or processing for the
significant new use of the chemical substance can occur.
Issuance of a proposed SNUR for a chemical substance does not
signify that the chemical substance is listed on the TSCA Chemical
Substance Inventory (TSCA Inventory). Guidance on how to determine if a
chemical substance is on the TSCA Inventory is available at https://www.epa.gov/tsca-inventory.
C. Significant New Uses Claimed as CBI
EPA is proposing to establish certain significant new uses which
have been claimed as CBI subject to Agency confidentiality regulations
at 40 CFR part 2 and 40 CFR part 703. Absent a final determination or
other disposition of the confidentiality claim under these regulations,
EPA is required to keep this information confidential. EPA promulgated
a procedure at 40 CFR 721.11 to deal with the situation where a
specific significant new use is CBI. Under these procedures. a
manufacturer or processor may request EPA to identify the confidential
significant new use under the rule. The manufacturer or processor must
show that it has a bona fide intent to manufacture or process the
chemical substance. If EPA concludes that the person has shown a bona
fide intent to manufacture or process the chemical substance, EPA will
identify the confidential significant new use to that person. Since
most of the chemical identities of the chemical substances subject to
these SNURs are also CBI, manufacturers and processors can combine the
bona fide submission under the procedure in 40 CFR 721.11 into a single
step.
D. Applicability of General Provisions
General provisions for SNURs appear in 40 CFR part 721, subpart A.
These provisions describe persons subject to SNURs, recordkeeping
requirements, exemptions to reporting requirements, and applicability
of the rule to uses occurring before the effective date of the rule.
Pursuant to 40 CFR 721.1(c), persons subject to SNURs must comply with
the same requirements and EPA regulatory procedures as submitters of
PMNs under TSCA section 5(a)(1)(A). In particular, these requirements
include the information submission requirements of TSCA sections 5(b)
and 5(d)(1), the exemptions authorized by TSCA sections 5(h)(1),
5(h)(2), 5(h)(3), and 5(h)(5) and the regulations at 40 CFR part 720.
In addition, provisions relating to user fees appear at 40 CFR part
700.
Once EPA receives a SNUN, EPA must either determine that the
significant new use is not likely to present an unreasonable risk of
injury under the conditions of use for the chemical substance or take
such regulatory action as is associated with an alternative
determination under TSCA section 5 before the manufacture (including
import) or processing for the significant new use can commence. If EPA
determines that the significant new use of the chemical substance is
not likely to present an unreasonable risk, EPA is required under TSCA
section 5(g) to make public, and submit for publication in the Federal
Register, a statement of EPA's findings.
As discussed in Unit I.C.2., persons who export or intend to export
a chemical substance identified in a proposed or final SNUR are subject
to the export notification provisions of TSCA section 12(b), and
persons who import a chemical substance identified in a final SNUR are
subject to the TSCA section 13 import certification requirements. See
also https://www.epa.gov/tsca-import-export-requirements.
E. Applicability of the Proposed SNURs to Uses Occurring Before the
Effective Date of the Final Rule
To establish a significant new use, EPA must determine that the use
is not ongoing. The chemical substances subject to this proposed rule
have undergone premanufacture review and
[[Page 102049]]
received determinations under TSCA section 5(a)(3)(C). TSCA Orders have
been issued for these chemical substances and the PMN submitters are
required by the TSCA Orders to submit a SNUN before undertaking
activities that would be designated as significant new uses in these
SNURs. Additionally, the identities of many of the chemical substances
subject to this proposed rule have been claimed as confidential per 40
CFR 720.85, further reducing the likelihood that another party would
manufacture or process the substances for an activity that would be
designated as a significant new use. Based on this, the Agency believes
that it is highly unlikely that any of the significant new uses
identified in Unit III. are ongoing.
When the chemical substances identified in Unit III. are added to
the TSCA Inventory, EPA recognizes that, before the rule is effective,
other persons might engage in a use that has been identified as a
significant new use. Persons who begin manufacture or processing of the
chemical substances for a significant new use identified on or after
the designated cutoff date specified in Unit III.A. would have to cease
any such activity upon the effective date of the final rule. To resume
their activities, these persons would have to first comply with all
applicable SNUR notification requirements and EPA would have to take
action under TSCA section 5 allowing manufacture or processing to
proceed.
F. Important Information About SNUN Submissions
1. SNUN Submissions
SNUNs must be submitted on EPA Form No. 7710-25, generated using e-
PMN software, and submitted to the Agency in accordance with the
procedures set forth in 40 CFR 720.40 and 721.25. E-PMN software is
available electronically at https://www.epa.gov/reviewing-new-chemicals-under-toxic-substances-control-act-tsca.
2. Development and Submission of Information
EPA recognizes that TSCA section 5 does not require development of
any particular new information (e.g., generating test data) before
submission of a SNUN. There is an exception: If a person is required to
submit information for a chemical substance pursuant to a rule, order
or consent agreement under TSCA section 4, then TSCA section 5(b)(1)(A)
requires such information to be submitted to EPA at the time of
submission of the SNUN.
In the absence of a rule, TSCA order, or consent agreement under
TSCA section 4 covering the chemical substance, persons are required
only to submit information in their possession or control and to
describe any other information known to or reasonably ascertainable by
them (see 40 CFR 720.50). However, upon review of PMNs and SNUNs, the
Agency has the authority to require appropriate testing. To assist with
EPA's analysis of the SNUN, submitters are encouraged, but not
required, to provide the potentially useful information identified for
the chemical substance in Unit III.C.
EPA strongly encourages persons, before performing any testing, to
consult with the Agency pertaining to protocol selection. Furthermore,
pursuant to TSCA section 4(h), which pertains to reduction of testing
in vertebrate animals, EPA encourages consultation with the Agency on
the use of alternative test methods and strategies (also called New
Approach Methodologies, or NAMs), if available, to generate the
recommended test data. EPA encourages dialog with Agency
representatives to help determine how best the submitter can meet both
the data needs and the objective of TSCA section 4(h). For more
information on alternative test methods and strategies to reduce
vertebrate animal testing, visit https://www.epa.gov/assessing-and-managing-chemicals-under-tsca/alternative-test-methods-and-strategies-reduce.
The potentially useful information described in Unit III. may not
be the only means of providing information to evaluate the chemical
substance associated with the significant new uses. However, submitting
a SNUN without any test data may increase the likelihood that EPA will
take action under TSCA sections 5(e) or 5(f). EPA recommends that
potential SNUN submitters contact EPA early enough so that they will be
able to conduct the appropriate tests.
SNUN submitters should be aware that EPA will be better able to
evaluate SNUNs that provide detailed information on the human exposure
and environmental release that may result from the significant new use
of the chemical substances.
III. Chemical Substances Subject to These Proposed SNURs
A. What is the designated cutoff date for ongoing uses?
EPA designates December 17, 2024 as the cutoff date for determining
whether the new use is ongoing. This designation is explained in more
detail in Unit II.E.
B. What information is provided for each chemical substance?
For each chemical substance identified in Unit III.C., EPA provides
the following information:
PMN number (the proposed CFR citation assigned in the
regulatory text section of the proposed rule).
Chemical name (generic name, if the specific name is
claimed as CBI).
Chemical Abstracts Service Registry Number (CASRN) (if
assigned for non-confidential chemical identities).
Basis for the action (effective date of and basis for the
TSCA Order).
Potentially useful information.
The regulatory text section of the proposed rule specifies the
activities designated as significant new uses. Certain new uses,
including production volume limits and other uses designated in the
proposed rules, may be claimed as CBI.
These proposed rules include PMN substances that are subject to
orders issued under TSCA section 5(e)(1)(A), as required by the
determinations made under TSCA section 5(a)(3)(B). Those TSCA Orders
require protective measures to limit exposures or otherwise mitigate
the potential unreasonable risk. The proposed SNURs identify as
significant new uses any manufacturing, processing, use, distribution
in commerce, or disposal that does not conform to the restrictions
imposed by the underlying TSCA Orders, consistent with TSCA section
5(f)(4).
C. Which chemical substances are subject to these proposed rules?
The substances subject to the proposed rules in this document are
as follows:
PMN Number (Proposed CFR Citation): P-18-127 (40 CFR 721.12043)
Chemical Name: Heptane, 2-methoxy-2-methyl-.
CASRN: 76589-16-7.
Effective Date of TSCA Order: December 15, 2023.
Basis for TSCA Order: The PMN states that the use will be as a
fragrance for household and consumer products, mainly laundry
detergents. Based on submitted test data on the PMN substance, EPA has
identified concerns for skin sensitization. Based on comparison to
analogous chemical substances, EPA has also identified concerns for
systemic and developmental effects. Based on submitted test data on the
PMN substance, EPA predicts toxicity to
[[Page 102050]]
aquatic organisms may occur at concentrations that exceed 210 ppb. The
Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and
5(e)(1)(A)(ii)(I), based on a finding that in the absence of sufficient
information to permit a reasoned evaluation, the substance may present
an unreasonable risk of injury to human health and the environment. To
protect against these risks, the Order requires:
Manufacture of the PMN substance only by import into the
United States in a solution of no greater than 5% by weight (i.e., no
domestic manufacture);
Processing of the PMN substance only in a solution of no
greater than 5% by weight of the PMN substance;
Processing for use or use of the PMN substance in consumer
products only if the concentration of the PMN substance is less than 1%
by weight;
No release of the PMN substance, or any waste stream
containing the PMN substance, in surface water concentrations that
exceed 210 ppb;
Use of personal protective equipment where there is a
potential for dermal exposure; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of
developmental toxicity, specific target organ toxicity, and pulmonary
effects testing may be potentially useful to characterize the health
and environmental effects of the PMN substance. Although the Order does
not require these tests, the Order's restrictions remain in effect
until the Order is modified or revoked by EPA based on submission of
this or other relevant information.
PMN Number (Proposed CFR Citation): P-18-325 (40 CFR 721.12044)
Chemical Name: Benzenesulfonic acid, alkyl-, compd. with 1,1'-
iminobis[2-propanol] (1:1) (generic).
CASRN: Not available.
Effective Date of TSCA Order: January 9, 2024.
Basis for TSCA Order: The PMN states that the use will be as an
industrial crosslinking catalyst. Based on the structure of the anion,
EPA identified concerns for lung toxicity (surfactant effects). Based
on test data for the neutral form of the cation and analogues for the
anion, EPA also identified concerns for skin and eye irritation, and
systemic and reproductive effects. Based on comparison to analogous
anionic surfactants, EPA predicts toxicity to aquatic organisms may
occur at concentrations that exceed 0.4 ppb. The Order was issued under
TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a
finding that in the absence of sufficient information to permit a
reasoned evaluation, the substance may present an unreasonable risk of
injury to human health and the environment. To protect against these
risks, the Order requires:
No manufacture, processing, or use of the PMN substance in
any manner that results in inhalation exposure to the PMN substance;
No processing for use or use of the PMN substance other
than as an industrial cross-linking catalyst;
No release of the PMN substances, or any waste stream
containing the PMN substances, into waters of the United States;
Use of personal protective equipment where there is a
potential for dermal exposure; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of skin
irritation/corrosion, eye irritation/corrosion, pulmonary effects,
specific target organ toxicity, and aquatic toxicity testing may be
potentially useful to characterize the health and environmental effects
of the PMN substance. Although the Order does not require these tests,
the Order's restrictions remain in effect until the Order is modified
or revoked by EPA based on submission of this or other relevant
information.
PMN Number (Proposed CFR Citation): P-20-14 (40 CFR 721.12045)
Chemical Name: Sugars, polymer with alkanetriamine (generic).
CASRN: Not available.
Effective Date of TSCA Order: January 27, 2023.
Basis for TSCA Order: The PMN states that the generic (non-
confidential) use will be as a water resistant resin additive. Based on
comparison to analogous chemical substances, EPA has identified
concerns for systemic effects (body weight). Based on potential
chelation to nutrient metals, EPA has also identified concerns for
developmental and systemic effects. Based on submitted test data on the
PMN substance, EPA predicts toxicity to aquatic organisms may occur at
concentrations that exceed 191 ppb. The Order was issued under TSCA
sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding
that in the absence of sufficient information to permit a reasoned
evaluation, the substance may present an unreasonable risk of injury to
human health and the environment. To protect against these risks, the
Order requires:
No use of the PMN substance in a consumer product;
No release of the PMN substance, or any waste stream
containing the PMN substance, in surface water concentrations that
exceed 191 ppb;
Use of personal protective equipment where there is a
potential for dermal exposure; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of
reproductive toxicity and specific target organ toxicity testing may be
potentially useful to characterize the health and environmental effects
of the PMN substance. Although the Order does not require these tests,
the Order's restrictions remain in effect until the Order is modified
or revoked by EPA based on submission of this or other relevant
information.
PMN Number (Proposed CFR Citation): P-21-86 (40 CFR 721.12046)
Chemical Name: Isooctadecanamide, N,N-bis(2-ethylhexyl)-.
CASRN: 1616494-50-8.
Effective Date of TSCA Order: February 6, 2024.
Basis for TSCA Order: The PMN states that the generic (non-
confidential) use will be as an automotive engine
[[Page 102051]]
additive. Based on test data for the metabolite, EPA has identified
concerns for systemic effects. The Order was issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that in the
absence of sufficient information to permit a reasoned evaluation, the
substance may present an unreasonable risk of injury to human health.
To protect against these risks, the Order requires:
No processing for use of the PMN substance in a consumer
product where the concentration of the PMN substance in the consumer
product formulation exceeds the confidential percentage listed in the
Order;
No use of the PMN substance in a consumer product where
the concentration of the PMN substance exceeds the confidential
percentage listed in the Order;
Use of personal protective equipment where there is a
potential for dermal exposure; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of
metabolism or pharmacokinetics and specific target organ toxicity
testing may be potentially useful to characterize the health effects of
the PMN substance. Although the Order does not require these tests, the
Order's restrictions remain in effect until the Order is modified or
revoked by EPA based on submission of this or other relevant
information.
PMN Number (Proposed CFR Citation): P-21-164 (40 CFR 721.12047)
Chemical Name: 2-Butanone, oxime, reaction products with
trimethoxymethylsilane.
CASRN: 2639393-45-4.
Effective Date of TSCA Order: November 13, 2023.
Basis for TSCA Order: The PMN states that the use will be as a
crosslinker for waterproofing. Based on comparison to analogous
chemical substances, EPA has identified concerns for irritation to skin
and eyes and systemic effects. Based on test data for hydrolysis
products, EPA has also identified concerns for acute toxicity, skin
irritation, eye corrosion, respiratory tract irritation and corrosion,
skin sensitization, systemic effects, developmental effects,
neurotoxicity and carcinogenicity. Based on test data for hydrolysis
products, EPA predicts toxicity to aquatic organisms may occur at
concentrations that exceed 102 ppb. The Order was issued under TSCA
sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding
that in the absence of sufficient information to permit a reasoned
evaluation, the substance may present an unreasonable risk of injury to
human health and the environment. To protect against these risks, the
Order requires:
No use of the PMN substance unless at 4% or less by weight
in formulation;
No loading or unloading of the PMN substance for
manufacture, processing, or use unless under a gas (e.g., nitrogen)
blanket;
Application of the PMN substance for use only by roll,
brush, or dip coating;
Use of personal protective equipment where there is a
potential for dermal exposure;
Use of a NIOSH-certified combination particulate and gas/
vapor respirator with an APF of at least 50 where there is a potential
for inhalation exposure;
Disposal of the PMN substance, or waste streams containing
the PMN substance, only by incineration;
No release of the PMN substance, or any waste stream
containing the PMN substance, into waters of the United States; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of acute
toxicity, carcinogenicity, eye damage, pulmonary effects, skin
irritation, specific target organ toxicity, and aquatic toxicity
testing may be potentially useful to characterize the health and
environmental effects of the PMN substance. Although the Order does not
require these tests, the Order's restrictions remain in effect until
the Order is modified or revoked by EPA based on submission of this or
other relevant information.
PMN Number (Proposed CFR Citation): P-21-170 (40 CFR 721.12048)
Chemical Name: 2,6-Bis(dialkyl)-4-[2-(1-alkyl-4(1H)-
pyridinylidene)alkylidene]-2,5-cycloalkyladien-1-one (generic).
CASRN: Not available.
Effective Date of TSCA Order: January 27, 2024.
Basis for TSCA Order: The PMN states that the use will be as a
color indicator for frying oil breakdown. Based on comparison to
analogous chemical substances, EPA has identified concerns for
irritation to skin and eyes, skin sensitization, neurotoxicity,
systemic effects (respiratory tract, lung, liver, kidney, spleen, and
body weight effects), reproductive and developmental effects,
genotoxicity, carcinogenicity, and acute toxicity (mortality). Based on
OECD Toolbox results, EPA identified concerns for skin sensitization
and based on information provided in the SDS, EPA has also identified
concerns for acute toxicity and irritation to skin, eyes, and
respiratory tract. Based on comparison to analogous chemical
substances, EPA predicts toxicity to aquatic organisms may occur at
concentrations that exceed 1 ppb. The Order was issued under TSCA
sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding
that in the absence of sufficient information to permit a reasoned
evaluation, the substance may present an unreasonable risk of injury to
human health and the environment. To protect against these risks, the
Order requires:
Manufacture of the PMN substance only below an annual
volume of 10 kg;
No manufacture, processing, or use of the PMN substance
resulting in releases to air except with the use of a HEPA filtration
system;
No processing for use or use of the PMN substance other
than as a color indicator for frying oil breakdown;
No processing for use or use of the PMN substance where
the concentration of the PMN substance in the final product exceeds
0.008%;
No release of the PMN substance, or any waste stream
containing the PMN substance, into waters of the United States;
Use of a NIOSH-certified particulate respirator with an
APF of at least 10 where there is a potential for inhalation exposure;
Use of personal protective equipment where there is a
potential for dermal exposure; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
[[Page 102052]]
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of
biodegradation, bioaccumulation, log P, and aquatic toxicity testing
may be potentially useful to characterize the physical/chemical
properties and environmental fate/effects of the PMN substance.
Although the Order does not require these tests, the Order's
restrictions remain in effect until the Order is modified or revoked by
EPA based on submission of this or other relevant information.
PMN Number (Proposed CFR Citation): P-21-184 (40 CFR 721.12049)
Chemical Name: Fatty acids, soya, reaction products with ammonia-
ethanolamine reaction by-products.
CASRN: 2378512-59-3.
Effective Date of TSCA Order: November 16, 2023.
Basis for TSCA Order: The PMN states that the generic (non-
confidential) use will be in asphalt emulsion applications. Based on
comparison to analogous chemical substances, EPA has identified
concerns for acute toxicity, skin and eye irritation/corrosion, skin
sensitization, point-of-contact effects, lung effects, and systemic
effects. Based on the surfactant-like properties of the PMN substance
and its use as an emulsifier, EPA has also identified concerns for lung
effects (surfactancy). Based on information in the SDS, EPA has also
identified concerns for skin irritation, eye corrosion, and respiratory
irritation. Based on comparison to analogous aliphatic amines, EPA
predicts toxicity to aquatic organisms may occur at concentrations that
exceed 2 ppb. The Order was issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that in the
absence of sufficient information to permit a reasoned evaluation, the
substance may present an unreasonable risk of injury to human health
and the environment. To protect against these risks, the Order
requires:
No manufacture, processing, or use of the PMN substance in
any manner that results in the generation of vapor, mist, dust, or
aerosol;
No processing for use or use of the PMN substance in a
consumer product;
Use of personal protective equipment where there is a
potential for dermal exposure;
No release of the PMN substance, or any waste stream
containing the PMN substance, in surface water concentrations that
exceed 2 ppb; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of acute
toxicity, specific target organ toxicity, pulmonary effects, skin
irritation/corrosion, eye damage, neurotoxicity, skin sensitization,
and aquatic toxicity testing may be potentially useful to characterize
the health and environmental effects of the PMN substance. Although the
Order does not require these tests, the Order's restrictions remain in
effect until the Order is modified or revoked by EPA based on
submission of this or other relevant information.
PMN Numbers (Proposed CFR Citations): P-22-3 (40 CFR 721.12050), P-22-4
(40 CFR 721.12051), P-22-5 (40 CFR 721.12052), and P-22-6 (40 CFR
721.12053)
Chemical Names: 1,5-Pentanediamine, 2-methyl-, hydrochloride (1:2)
(P-22-3), 1,5-Pentanediamine, 2-methyl-, hydrochloride (1:1) (P-22-4),
Formic acid, compd. with 2-methyl-1,5- pentanediamine (2:1) (P-22-5),
and Formic acid, compd. with 2-methyl-1,5-pentanediamine (1:1) (P-22-
6).
CASRNs: 34813-63-3 (P-22-3), 1840915-04-9 (P-22-4), 1836131-73-7
(P-22-5), and 1836131-75-9 (P-22-6).
Effective Date of TSCA Order: December 4, 2023.
Basis for TSCA Order: The PMNs state that the uses will be as clay
stabilizers for oil and gas fracking. Based on submitted test data on
the P-22-3 substance, comparison to analogous chemical substances,
structure and expected acidity or basicity of components, physical/
chemical properties of components, and information provided in the SDS,
EPA has identified concerns for acute toxicity, irritation or corrosion
to skin, eyes, and respiratory tract, and systemic effects. Based on
submitted test data for the P-22-3 substance, EPA predicts toxicity to
aquatic organisms may occur at concentrations that exceed 570 ppb. The
Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and
5(e)(1)(A)(ii)(I), based on a finding that in the absence of sufficient
information to permit a reasoned evaluation, the substances may present
an unreasonable risk of injury to human health and the environment. To
protect against these risks, the Order requires:
No processing for use or use of the PMN substances in
consumer products;
No manufacture, processing, or use of the PMN substances
in any manner that results in inhalation exposure to the PMN
substances;
Use of personal protective equipment where there is a
potential for dermal exposure;
No release of the PMN substances, or any waste stream
containing the PMN substances, in surface water concentrations that
exceed 570 ppb combined; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of eye
irritation/corrosion, skin irritation/corrosion, specific target organ
toxicity, pulmonary effects, and aquatic toxicity testing may be
potentially useful to characterize the health and environmental effects
of the PMN substances. Although the Order does not require these tests,
the Order's restrictions remain in effect until the Order is modified
or revoked by EPA based on submission of this or other relevant
information.
PMN Number (Proposed CFR Citation): P-22-11 (40 CFR 721.12054)
Chemical Name: Alkadiene, homopolymer, hydroxy-terminated, bis[N-
[2-[(1-oxo-2-propen-1- yl)oxylethyl]carbamates] (generic).
CASRN: Not available.
Effective Date of TSCA Order: November 27, 2023.
Basis for TSCA Order: The PMN states that the generic (non-
confidential) use will be as a functionalized rubber in the resin side
of two component epoxy
[[Page 102053]]
modified acrylic adhesive and as a functionalized rubber in the resin
side of two component acrylic adhesive. Based on test data on one or
both of the two components in the formulation, EPA has identified
concerns for skin sensitization, and systemic, reproductive, and
developmental effects. Based on the weight of the scientific evidence,
EPA has also identified concerns for respiratory sensitization. Based
on information in the SDS, EPA has also identified concerns for skin
sensitization and reproductive toxicity. The Order was issued under
TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a
finding that in the absence of sufficient information to permit a
reasoned evaluation, the substance may present an unreasonable risk of
injury to human health. To protect against these risks, the Order
requires:
No use of the PMN substance in a consumer product;
No manufacture, processing, or use of the PMN substance in
any manner that results in inhalation exposure;
Use of personal protective equipment where there is a
potential for dermal exposure; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of skin
sensitization, developmental toxicity, reproductive toxicity, and
specific target organ toxicity testing may be potentially useful to
characterize the health effects of the PMN substance. Although the
Order does not require these tests, the Order's restrictions remain in
effect until the Order is modified or revoked by EPA based on
submission of this or other relevant information.
PMN Number (Proposed CFR Citation): P-22-25 (40 CFR 721.12055)
Chemical Name: Oxirane, 2-(chloromethyl)-, homopolymer, ether with
dialkyl-alkanediol (2:1) (generic).
CASRN: Not available.
Effective Date of TSCA Order: February 20, 2024.
Basis for TSCA Order: The PMN states that the use will be as a
chemical intermediate. Based on comparison to analogous chemical
substances and structural alerts, EPA has identified concerns for acute
toxicity, irritation to the respiratory tract, skin, and eyes, systemic
effects, genetic toxicity, and carcinogenicity. The Order was issued
under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a
finding that in the absence of sufficient information to permit a
reasoned evaluation, the substance may present an unreasonable risk of
injury to human health. To protect against these risks, the Order
requires:
No exceedance of the confidential annual production volume
listed in the Order;
No manufacture, processing, or use of the PMN substance in
any manner that results in the generation of a vapor, mist, dust, or
aerosol;
Use of the PMN substance only as a chemical intermediate;
Disposal of the PMN substance, or waste streams containing
the PMN substance, only by hazardous waste incineration;
No release of the PMN substance, or any waste stream
containing the PMN substance, into waters of the United States;
Use of personal protective equipment where there is a
potential for dermal exposure; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of acute
toxicity, specific target organ toxicity, pulmonary effects, eye
irritation, skin irritation, genetic toxicity, and carcinogenicity
testing may be potentially useful to characterize the health effects of
the PMN substance. Although the Order does not require these tests, the
Order's restrictions remain in effect until the Order is modified or
revoked by EPA based on submission of this or other relevant
information.
PMN Number (Proposed CFR Citation): P-22-49 (40 CFR 721.12056)
Chemical Name: Aryl, polymer with formaldehyde, glycidyl ether,
reaction products with amino alkyl-alkane diamine, cyclohexanediamine
and alkylene (alkylcyclohexanamine) (generic).
CASRN: Not available.
Effective Date of TSCA Order: January 11, 2024.
Basis for TSCA Order: The PMN states that the use will be as a
hardener in coatings for oil and gas, power, and chemical/petrochemical
industries for tank and pipe linings and for asset protection, in
coatings in wastewater applications industries for tank and pipe
linings and for asset protection, in coatings used in manufacturing
industries for tank and pipe linings and for asset protection, and in
OEM automotive and heavy industrial machinery coatings. Based on
submitted test data on the PMN substance, EPA has identified concerns
for acute toxicity. Based on residual data, EPA has also identified
concerns for irritation to the skin, eye, and respiratory tract, skin
and respiratory sensitization, systemic, developmental, and
reproductive effects, corrosion to all tissues, and genetic toxicity.
Based on submitted test data on the PMN substance and comparison to
analogous polycationic polymers, EPA predicts toxicity to aquatic
organisms may occur at concentrations that exceed 2 ppb. The Order was
issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence of sufficient information to
permit a reasoned evaluation, the substance may present an unreasonable
risk of injury to human health or the environment. To protect against
these risks, the Order requires:
No release of the PMN substance, or any waste stream
containing the PMN substance, in surface water concentrations that
exceed 2 ppb;
Use of a NIOSH-certified particulate respirator with an
APF of at least 1,000 where there is a potential for inhalation
exposure;
No use of the PMN substance in a consumer product;
Use of personal protective equipment where there is a
potential for dermal exposure; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has
[[Page 102054]]
determined that the results of skin irritation, skin corrosion, eye
irritation, eye corrosion, specific target organ toxicity, pulmonary
effects, and aquatic toxicity testing may be potentially useful to
characterize the health and environmental effects of the PMN substance.
Although the Order does not require these tests, the Order's
restrictions remain in effect until the Order is modified or revoked by
EPA based on submission of this or other relevant information.
PMN Number (Proposed CFR Citation): P-22-50 (40 CFR 721.12057)
Chemical Name: Alkene, alkoxy-, polymer with alkoxyalkene
(generic).
CASRN: Not available.
Effective Date of TSCA Order: January 8, 2024.
Basis for TSCA Order: The PMN states that the generic (non-
confidential) use will be as a lubricant. Based on comparison to
analogous chemical substances, EPA has identified concerns for skin,
eye, and respiratory tract irritation and systemic effects. Based on
comparison to analogous neutral organics, EPA predicts toxicity to
aquatic organisms may occur at concentrations that exceed 32 ppb. The
Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and
5(e)(1)(A)(ii)(I), based on a finding that in the absence of sufficient
information to permit a reasoned evaluation, the substance may present
an unreasonable risk of injury to human health and the environment. To
protect against these risks, the Order requires:
No processing for use or use of the PMN substance in a
consumer product;
No manufacture, processing, or use of the PMN substance in
any manner that results in inhalation exposure to the PMN substance;
No processing for use or use of the PMN substance other
than for the confidential use listed in the Order;
No release of the PMN substance, or any waste stream
containing the PMN substance, into waters of the United States;
Use of personal protective equipment where there is a
potential for dermal exposure; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of
specific target organ toxicity, skin irritation, eye irritation,
pulmonary effects, and aquatic toxicity testing may be potentially
useful to characterize the health and environmental effects of the PMN
substance. Although the Order does not require these tests, the Order's
restrictions remain in effect until the Order is modified or revoked by
EPA based on submission of this or other relevant information.
PMN Number (Proposed CFR Citation): P-22-58 (40 CFR 721.12058)
Chemical Name: Methanesulfonamide, 1,1,1-trifluoro-N-
[(trifluoromethyl)sulfonyl]-, sodium salt (1:1).
CASRN: 91742-21-1.
Effective Date of TSCA Order: February 13, 2024.
Basis for TSCA Order: The PMN states that the generic (non-
confidential) use will be as a process chemical. Based on submitted
test data on the PMN substance, EPA has identified concerns for acute
toxicity and serious eye damage. Based on comparison to analogous
chemical substances, EPA has also identified concerns for respiratory
tract and skin irritation, neurotoxicity, systemic, reproductive, and
developmental effects. Based on comparison to analogous chemical
substances, EPA has also identified concerns for respiratory, systemic,
and neurological effects for the potential incineration product of the
anion. Based on submitted test data on the PMN substance and comparison
to analogous substances, EPA predicts toxicity to aquatic organisms may
occur at concentrations that exceed 140 ppb. The Order was issued under
TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a
finding that in the absence of sufficient information to permit a
reasoned evaluation, the substance may present an unreasonable risk of
injury to human health and the environment. To protect against these
risks, the Order requires:
No manufacture of the PMN substance other than in an
enclosed process;
No processing or use of the PMN substance other than in a
manner that does not generate a vapor, mist, dust, or aerosol that
results in inhalation exposure to workers;
No use of the PMN substance other than for the
confidential use listed in the Order;
No use of the PMN substance other than in the form of a
liquid;
No release of the PMN substance, or any waste stream
containing the PMN substance, in surface water concentrations that
exceed 100 ppb;
Use of a NIOSH-certified combination particulate and gas/
vapor respirator with an APF of at least 50 where there is a potential
for inhalation exposure;
Use of personal protective equipment where there is a
potential for dermal exposure; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of
specific target organ toxicity, pulmonary effects, reproductive
toxicity, developmental toxicity, neurotoxicity, sediment toxicity, and
aquatic toxicity testing may be potentially useful to characterize the
health and environmental effects of the PMN substance. Although the
Order does not require these tests, the Order's restrictions remain in
effect until the Order is modified or revoked by EPA based on
submission of this or other relevant information.
PMN Number (Proposed CFR Citation): P-22-75 (40 CFR 721.12059)
Chemical Name: 1H-Isoindole-1,3(2H)-dione, 3a,4,7,7a-tetrahydro-2-
(2-hydroxyethyl)-.
CASRN: 15458-48-7.
Effective Date of TSCA Order: January 19, 2024.
Basis for TSCA Order: The PMN states that the use will be as a
monomer used to produce an unsaturated polyester resin. Based on
comparison to analogous chemical substances, EPA has identified
concerns for acute toxicity, skin and eye irritation, and systemic
effects. Based on comparison to analogous imides, EPA predicts toxicity
to aquatic organisms may occur at concentrations that exceed 21 ppb.
The Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and
5(e)(1)(A)(ii)(I), based on a finding that in the absence of sufficient
information to permit a reasoned evaluation, the substance may present
an unreasonable risk of injury to human health and the environment. To
protect against these risks, the Order requires:
[[Page 102055]]
Manufacture of the PMN substance only at or below an
annual volume of 3,000 kg;
No domestic manufacture of the PMN substance (i.e., import
only);
No use of the PMN substance other than as a monomer used
to produce an unsaturated polyester resin;
Use of personal protective equipment where there is a
potential for dermal exposure; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of acute
toxicity, eye irritation, skin irritation, pulmonary effects, specific
target organ toxicity, and aquatic toxicity testing may be potentially
useful to characterize the health and environmental effects of the PMN
substance. Although the Order does not require these tests, the Order's
restrictions remain in effect until the Order is modified or revoked by
EPA based on submission of this or other relevant information.
PMN Number (Proposed CFR Citation): P-22-78 (40 CFR 721.12060)
Chemical Name: Oxirane, 2-methyl-, polymer with oxirane, mono-
isoalkyl ethers, phosphates, salt (generic).
CASRN: Not available.
Effective Date of TSCA Order: November 27, 2023.
Basis for TSCA Order: The PMN states that the use will be as a
dispersing agent for pesticide formulations. Based on structure, EPA
has identified concerns for lung effects (surfactancy). Based on
comparison to analogous chemical substances, EPA has also identified
concerns for skin irritation and systemic effects. Based on comparison
to analogous anionic surfactants, EPA predicts toxicity to aquatic
organisms may occur at concentrations that exceed 23 ppb. The Order was
issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence of sufficient information to
permit a reasoned evaluation, the substance may present an unreasonable
risk of injury to human health and the environment. To protect against
these risks, the Order requires:
No processing for use or use of the PMN substance other
than as a dispersing agent for pesticide formulations;
No manufacture or processing of the PMN substance in any
manner that results in the generation of a vapor, mist, dust, or
aerosol;
Use of personal protective equipment where there is a
potential for dermal exposure;
No release of the PMN substance, or any waste stream
containing the PMN substance, in surface water concentrations that
exceed 23 ppb; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of
pulmonary effects, skin irritation, specific target organ toxicity, and
aquatic toxicity testing may be potentially useful to characterize the
health and environmental effects of the PMN substance. Although the
Order does not require these tests, the Order's restrictions remain in
effect until the Order is modified or revoked by EPA based on
submission of this or other relevant information.
PMN Number (Proposed CFR Citation): P-22-80 (40 CFR 721.12061)
Chemical Name: Poly(oxy-1,2-ethanediyl), .alpha.-(2-
aminoethyl)-.omega.-(2-aminoethoxy)- and Poly(oxy-1,2-ethanediyl),
.alpha.,.alpha.',-(iminodi-2,1- ethanediyl)bis[.omega.-(2-
aminoethoxy)-.
CASRNs: 24991-53-5 and 90350-34-8.
Effective Date of TSCA Order: December 1, 2023.
Basis for TSCA Order: The PMN states that the use will be as an
industrial intermediate used in the manufacture of polyamides as a
monomer. Based on the pH of the PMN substance, EPA has identified
concerns for skin, eye, and respiratory tract corrosion. Based on
comparison to analogous chemical substances, EPA has also identified
concerns for acute toxicity and skin sensitization. Based on comparison
to analogous polycationic polymers, EPA predicts toxicity to aquatic
organisms may occur at concentrations that exceed 0.7 ppb. The Order
was issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence of sufficient information to
permit a reasoned evaluation, the substance may present an unreasonable
risk of injury to human health and the environment. To protect against
these risks, the Order requires:
No manufacture, processing, or use of the PMN substance in
any manner that results in inhalation exposure;
No release of the PMN substance, or any waste stream
containing the PMN substance, in surface water concentrations that
exceed 0.7 ppb;
Use of personal protective equipment where there is a
potential for dermal exposure; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of acute
toxicity, skin corrosion, eye corrosion, pulmonary effects, skin
sensitization, and aquatic toxicity testing may be potentially useful
to characterize the health and environmental effects of the PMN
substance. Although the Order does not require these tests, the Order's
restrictions remain in effect until the Order is modified or revoked by
EPA based on submission of this or other relevant information.
PMN Number (Proposed CFR Citation): P-22-82 (40 CFR 721.12062)
Chemical Name: Alkenoic acid, alkyl, carbopolycyclic alkyl ester,
polymer with trihalo (trihaloalkyl) alkyl alkyl alkenoate (generic).
CASRN: Not available.
Effective Date of TSCA Order: November 3, 2023.
Basis for TSCA Order: The PMN states that the generic (non-
confidential) use will be as a component of photoresist. Based on test
data on the degradation product and an analogue of the degradation
product, EPA has identified concerns for neurotoxicity, reproductive,
developmental, and systemic effects. Based on the potential
incineration product, EPA has also identified concerns for systemic
effects, and neurotoxicity. The Order was issued under TSCA sections
[[Page 102056]]
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that in the
absence of sufficient information to permit a reasoned evaluation, the
substance may present an unreasonable risk of injury to human health.
To protect against these risks, the Order requires:
No manufacture of the PMN substance other than by import
into the United States (i.e., no domestic manufacture) in a liquid
formulation;
No processing or use of the PMN substance other than in a
liquid formulation;
Use of the PMN substance only for the confidential use
listed in the Order;
No release of the PMN substance, or any waste stream
containing the PMN substance, into waters of the United States;
Disposal of the PMN substance, or waste streams containing
the PMN substance, only by incineration;
Use of personal protective equipment where there is a
potential for dermal exposure; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of
pulmonary effects, reproductive and developmental effects, and
neurotoxicity testing may be potentially useful to characterize the
health effects of the PMN substance. Although the Order does not
require these tests, the Order's restrictions remain in effect until
the Order is modified or revoked by EPA based on submission of this or
other relevant information.
PMN Number (Proposed CFR Citation): P-22-121 (40 CFR 721.12063)
Chemical Name: Polychloroalkene (generic).
CASRN: Not available.
Effective Date of TSCA Order: February 6, 2024.
Basis for TSCA Order: The PMN states that the generic (non-
confidential) use will be as a process intermediate. Based on submitted
test data on the PMN substance and information in the SDS, EPA has
identified concerns for acute toxicity (oral) and skin sensitization.
Based on test data for analogues, EPA identified concerns for acute
toxicity (oral, inhalation), skin irritation, eye corrosion,
respiratory irritation, genotoxicity, carcinogenicity, and systemic
effects. Based on submitted acute test data and comparison to analogous
chemical substances, EPA predicts toxicity to aquatic organisms may
occur at concentrations that exceed 0.15 ppb. The Order was issued
under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a
finding that in the absence of sufficient information to permit a
reasoned evaluation, the substance may present an unreasonable risk of
injury to human health and the environment. To protect against these
risks, the Order requires:
No domestic manufacture of the PMN substance (i.e., import
only);
No processing, use, loading, or unloading of the PMN
substance unless under a gas (e.g., nitrogen) blanket or in a closed
system except that sampling may occur outside the closed system
resulting in exposures;
No use of the PMN substance other than for the
confidential use listed in the Order;
Use of a NIOSH-certified combination particulate and gas/
vapor respirator with an APF of at least 50 where there is a potential
for inhalation exposure;
Use of personal protective equipment where there is a
potential for dermal exposure;
No release of the PMN substance, or any waste stream
containing the PMN substance, in surface water concentrations that
exceed 0.15 ppb; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results
carcinogenicity, eye irritation/corrosion, genetic toxicity, pulmonary
effects, skin irritation, specific target organ toxicity,
toxicokinetics, and aquatic toxicity testing may be potentially useful
to characterize the health and environmental effects of the PMN
substance. Although the Order does not require these tests, the Order's
restrictions remain in effect until the Order is modified or revoked by
EPA based on submission of this or other relevant information.
PMN Number (Proposed CFR Citation): P-22-145 (40 CFR 721.12064)
Chemical Name: Alkanoic acid, trialkyl-, diester with
carbomonocycle bis(alkyleneoxy)]bis[alkanediol] (generic).
CASRN: Not available.
Effective Date of TSCA Order: February 21, 2024.
Basis for TSCA Order: The PMN states that the use will be as a
reactive-diluent in a polyol component of a 2K (Isocyanate-Polyol)
Urethane coating system for interior concrete floor sealant or
interior/exterior paver sealer. Based on the physical/chemical
properties of the PMN substance (as described in the New Chemical
Program's PBT category at 64 FR 60194; November 1999) and test data on
structurally similar substances, the PMN substance is a potentially
persistent, bioaccumulative, and toxic (PBT) chemical. EPA estimates
that the PMN substance will persist in the environment for more than
six months and estimates a bioconcentration factor of greater than or
equal to 5,000. Based on test data for a potential hydrolysis product,
EPA has identified concerns for acute toxicity and systemic,
reproductive, and developmental effects. Based on comparison to
analogous esters, EPA predicts toxicity to aquatic organisms may occur
at concentrations that exceed 0.14 ppb. The Order was issued under TSCA
sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding
that in the absence of sufficient information to permit a reasoned
evaluation, the substance may present an unreasonable risk of injury to
human health and the environment. To protect against these risks, the
Order requires:
No use of the PMN substance in any manner that generates a
spray, mist, vapor, or aerosol containing the PMN substance unless the
concentration of the PMN substance is less than 5.7% by weight;
No processing for use or use of the PMN substance in a
consumer product;
No release of the PMN substance, or any waste stream
containing the PMN substance, into waters of the United States;
Disposal of the PMN substance, or waste streams containing
the PMN substance, only by incineration;
Use of personal protective equipment where there is a
potential for dermal exposure; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
[[Page 102057]]
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of acute
toxicity, reproductive toxicity, developmental toxicity, specific
target organ toxicity, toxicokinetics, and aquatic toxicity testing may
be potentially useful to characterize the health and environmental
effects of the PMN substance. Although the Order does not require these
tests, the Order's restrictions remain in effect until the Order is
modified or revoked by EPA based on submission of this or other
relevant information.
PMN Number (Proposed CFR Citation): P-22-175 (40 CFR 721.12065)
Chemical Name: Modified Silsesquioxane, alkoxy-terminated
(generic).
CASRN: Not available.
Effective Date of TSCA Order: January 30, 2024.
Basis for TSCA Order: The PMN states that the use will be as a
curable binder resin for composite stone articles (engineered stone).
Based on comparison to analogous alkoxysilanes and other analogous
chemical substances, EPA has identified concerns for lung toxicity.
Based on the reactivity of the PMN substance and the low molecular
weight fraction content, EPA has also identified concerns for
irritation to the skin, eyes, and respiratory tract. Based on
comparison with analogous chemical substances, EPA has also identified
concerns for hematological effects (i.e., increased neutrophils,
eosinophils, lymphocytes) associated with lung toxicity. Based on
comparison to analogous alkoxysilanes, EPA predicts toxicity to aquatic
organisms may occur at concentrations that exceed 7 ppb. The Order was
issued under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I),
based on a finding that in the absence of sufficient information to
permit a reasoned evaluation, the substance may present an unreasonable
risk of injury to human health and the environment. To protect against
these risks, the Order requires:
No domestic manufacture of the PMN substance (i.e., import
only);
Use of the PMN substance only if the concentration of the
PMN substance does not exceed 10% by weight in formulation;
Use of a NIOSH-certified respirator with an APF of at
least 10 where there is a potential for inhalation exposure;
No release of the PMN substance, or any waste stream
containing the PMN substance, in surface water concentrations that
exceed 7 ppb;
Use of personal protective equipment where there is a
potential for dermal exposure; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of skin
irritation, eye irritation, specific target organ toxicity, and aquatic
toxicity testing may be potentially useful to characterize the health
and environmental effects of the PMN substance. Although the Order does
not require these tests, the Order's restrictions remain in effect
until the Order is modified or revoked by EPA based on submission of
this or other relevant information.
PMN Number (Proposed CFR Citation): P-23-18 (40 CFR 721.12066)
Chemical Name: Vegetable oil, polymer with pimelin ketone,
oxymethylene and polymethylenepolyphenylene isocyanate (generic).
CASRN: Not applicable.
Effective Date of TSCA Order: February 23, 2024.
Basis for TSCA Order: The PMN states that the use will be as an
industrial adhesive. Based on the weight of the scientific evidence,
EPA has identified concerns for skin and respiratory sensitization and
lung toxicity for the PMN substance and the low molecular weight
fraction. Based on test data for residuals and comparison to analogous
chemical substances of the residuals, EPA has also identified acute
toxicity, irritation to the skin, eyes, and respiratory tract, skin
sensitization, respiratory sensitization, neurotoxicity, lung effects,
systemic effects, reproductive and developmental effects, genetic
toxicity, and carcinogenicity for the residuals. The Order was issued
under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a
finding that in the absence of sufficient information to permit a
reasoned evaluation, the substance may present an unreasonable risk of
injury to human health. To protect against these risks, the Order
requires:
No manufacture, processing, or use of the PMN substance in
any manner that results in inhalation exposure to the PMN substance;
No processing for use or use of the PMN substance in a
consumer product;
Use of personal protective equipment where there is a
potential for dermal exposure; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of skin
irritation, skin sensitization, and pulmonary effects testing may be
potentially useful to characterize the health effects of the PMN
substance. Although the Order does not require these tests, the Order's
restrictions remain in effect until the Order is modified or revoked by
EPA based on submission of this or other relevant information.
PMN Number (Proposed CFR Citation): P-23-20 (40 CFR 721.12067)
Chemical Name: Silsesquioxanes, 3-mercaptopropyl, polymers with
silicic acid (H4SiO4) tetra-Et ester, [(trimethylsilyl)oxy]-terminated.
CASRN: 2796383-42-9.
Effective Date of TSCA Order: November 21, 2023.
Basis for TSCA Order: The PMN states that the generic (non-
confidential) use will be as an additive/intermediate. Based on
comparison to analogous chemical substances and alkoxysilanes, EPA has
identified concerns for lung effects. Based on analogue data for the
hydrolysis product, EPA has also identified concerns for skin
sensitization and systemic effects. Based on comparison to analogous
alkoxysilanes and thiols, EPA predicts toxicity to aquatic organisms
may occur at concentrations that exceed 3 ppb. The Order was issued
under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a
finding that in the absence of sufficient information to permit a
reasoned evaluation, the substance may
[[Page 102058]]
present an unreasonable risk of injury to human health and the
environment. To protect against these risks, the Order requires:
Use of the PMN substance only for the confidential use
listed in the Order;
No manufacture, processing, or use of the PMN substance in
any manner that results in inhalation exposure to the PMN substance;
Use of personal protective equipment where there is a
potential for dermal exposure;
No release of the PMN substance, or any waste stream
containing the PMN substance, in surface water concentrations that
exceed 3 ppb; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of
specific target organ toxicity, pulmonary effects, skin sensitization,
and aquatic toxicity testing may be potentially useful to characterize
the health and environmental effects of the PMN substance. Although the
Order does not require these tests, the Order's restrictions remain in
effect until the Order is modified or revoked by EPA based on
submission of this or other relevant information.
PMN Number (Proposed CFR Citation): P-23-36 (40 CFR 721.12068).
Chemical Name: Castor oil, polymer with dicyclopentadiene, maleic
anhydride, 2-methyl-1,3-propanediol, 3a,4,7,7a-tetrahydro-2-(2-
hydroxyethyl)-1H-isoindole-1,3(2H)-dione and triethylene glycol.
CASRN: 2794200-69-2.
Effective Date of TSCA Order: January 19, 2024.
Basis for TSCA Order: The PMN states that the use will be as a
resin used in an electrical insulation coating to insulate electrical
components (motors) in automobiles. Based on test data for the expected
hydrolysis product and an analogue of the expected hydrolysis product,
EPA has identified concerns for skin irritation, eye irritation,
systemic effects, and reproductive/developmental effects. Based on
comparison to analogous nonionic polymers, EPA predicts toxicity to
aquatic organisms may occur at concentrations that exceed 27 ppb. The
Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and
5(e)(1)(A)(ii)(I), based on a finding that in the absence of sufficient
information to permit a reasoned evaluation, the substance may present
an unreasonable risk of injury to human health and the environment. To
protect against these risks, the Order requires:
No processing for use or use of the PMN substance in a
consumer product;
No manufacture, processing, or use of the PMN substance in
any manner that generates a vapor, mist, dust, or aerosol;
Use of personal protective equipment where there is a
potential for dermal exposure;
No release of the PMN substance, or any waste stream
containing the PMN substance, in surface water concentrations that
exceed 27 ppb; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of skin
irritation, eye irritation, specific target organ toxicity,
toxicokinetics, and aquatic toxicity testing may be potentially useful
to characterize the health and environmental effects of the PMN
substance. Although the Order does not require these tests, the Order's
restrictions remain in effect until the Order is modified or revoked by
EPA based on submission of this or other relevant information.
PMN Numbers (Proposed CFR Citations): P-23-37 (40 CFR 721.12069), P-23-
44 (40 CFR 721.12070), P-23-80 (40 CFR 721.12071), and P-23-93 (40 CFR
721.12072)
Chemical Names: Monoaromatic cyclic alkylene sulfonium fluoroalkyl
sulfonic acid salt (generic) (P-23-37 and P-23-44), Aromatic sulfonium
tricyclo fluoroalkyl sulfonic acid salt (generic) (P-23-80), and
Aromatic dibenzothiophenium fluoroalkyl carbopolycycle sulfonic acid
salt (generic) (P-23-93).
CASRNs: Not available.
Effective Date of TSCA Order: December 22, 2023.
Basis for TSCA Order: The PMNs state that the generic (non-
confidential) use of the PMN substances will be as photoacid generators
(PAGs) for use in electronics industry. Based on the physical/chemical
properties of the PMN substances (as described in the New Chemical
Program's PBT category at 64 FR 60194; November 1999) and test data on
structurally similar substances, the PMN substance are potentially
persistent, bioaccumulative, and toxic (PBT) chemicals. EPA estimates
that the PMN substances will persist in the environment for more than
six months and have unknown bioaccumulation. Based on comparison to
analogous chemical compounds, EPA has identified concerns for acute
toxicity, irritation to the skin and respiratory tract, neurological
effects, and systemic effects for the cation of the PMN substances, as
well as eye corrosion for P-23-44, P-23-80, and P-23-93. Based on
comparison to analogous chemical substances, EPA has also identified
concerns for genetic toxicity for the PMN substances, and skin
sensitization and portal-of-entry (respiratory) effects for P-23-93.
Based on the photoreactivity of the PMN substances, EPA has also
identified concerns for photosensitization. Based on comparison to
analogous compounds, EPA has also identified concerns for systemic and
reproductive effects for the anion of P-23-44 and P-23-93. Based on
data on a potential incineration product, EPA identified concerns for
local and systemic effects via inhalation exposure. Based on a lack of
scientific data, there is unknown toxicity to aquatic organisms. The
Order was issued under TSCA sections 5(a)(3)(B)(ii)(I) and
5(e)(1)(A)(ii)(I), based on a finding that in the absence of sufficient
information to permit a reasoned evaluation, the substances may present
an unreasonable risk of injury to human health or the environment. To
protect against these risks, the Order requires:
No manufacture of the PMN substances beyond the time
limits specified in the Order without submittal to EPA the results of
certain testing described in the Testing section of the Order;
Use of personal protective equipment where there is a
potential for dermal exposure;
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS;
No modification of the processing or use of the PMN
substances in any way that generates a vapor, dust, mist, or aerosol in
a non-enclosed process;
[[Page 102059]]
Use of the PMN substances only for the confidential uses
listed in the Order;
No domestic manufacture of the PMN substances (i.e.,
import only);
Import of the PMN substances only in solution or in sealed
containers weighing 5 kilograms or less; and
No exceedance of the confidential annual importation
volumes listed the Order.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information about the physical/chemical properties, fate,
bioaccumulation, environmental hazard, and human health effects of the
PMN substances may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. The submitter has agreed not to exceed the
time limits specified in the Order without performing the required Tier
I and Tier II testing outlined in the Testing section of the Order.
PMN Number (Proposed CFR Citation): P-23-64 (40 CFR 721.12073)
Chemical Name: Alkanediol, substituted, polymer with
diisocyanatoalkane, substituted heterocycle-modified (generic).
CASRN: Not available.
Effective Date of TSCA Order: February 21, 2024.
Basis for TSCA Order: The PMN states that the generic (non-
confidential) use will be as a component in aerospace coatings. Based
on comparison to analogous chemical substances, EPA has identified
concerns for pulmonary effects, systemic effects, and skin
sensitization. The Order was issued under TSCA sections
5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding that in the
absence of sufficient information to permit a reasoned evaluation, the
substance may present an unreasonable risk of injury to human health.
To protect against these risks, the Order requires:
No processing for use or use of the PMN substance in
consumer products;
No manufacture, processing, or use of the PMN substance in
any manner that results in the generation of a vapor, mist, dust, or
aerosol;
Use of personal protective equipment where there is a
potential for dermal exposure; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of
pulmonary effects and specific target organ toxicity testing may be
potentially useful to characterize the health effects of the PMN
substance. Although the Order does not require these tests, the Order's
restrictions remain in effect until the Order is modified or revoked by
EPA based on submission of this or other relevant information.
PMN Number (Proposed CFR Citation): P-23-72 (40 CFR 721.12074)
Chemical Name: Halosubstituted carbopolycycle, polymer with
substituted carbomonocycles and oxybis[alkanol] (generic).
CASRN: Not available.
Effective Date of TSCA Order: February 22, 2024.
Basis for TSCA Order: The PMN states that the use will be as a UV
resin for offset lithographic printing on plastic substrates. Based on
the physical/chemical properties of the PMN substance (as described in
the New Chemical Program's PBT category at 64 FR 60194; November 1999)
and test data on structurally similar substances, the PMN substance is
a potentially persistent, bioaccumulative, and toxic (PBT) chemical.
EPA estimates that the PMN substance will persist in the environment
for more than six months and estimates a bioaccumulation factor of
greater than or equal to 5,000. Based on test data for hydrolysis
products of the low molecular weight fraction of the PMN substance, EPA
has identified concerns for genetic toxicity, carcinogenicity, and
systemic, reproductive, and developmental effects. Based on comparison
to analogous esters, EPA predicts toxicity to aquatic organisms may
occur at concentrations that exceed 0.4 ppb. The Order was issued under
TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a
finding that in the absence of sufficient information to permit a
reasoned evaluation, the substance may present an unreasonable risk of
injury to human health and the environment. To protect against these
risks, the Order requires:
No processing for use or use of the PMN substance in a
consumer product;
No processing for use or use of the PMN substance other
than in an enclosed roll-coating lithographic printing machine;
No processing for use or use of the PMN substance in a
final coating formulation that exceeds 40% by weight;
Disposal of the PMN substance only by landfill;
No release of the PMN substance, or any waste stream
containing the PMN substance, into waters of the United States;
Use of a NIOSH-certified respirator with an APF of at
least 10 where there is a potential for inhalation exposure;
Use of personal protective equipment where there is a
potential for dermal exposure; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of
carcinogenicity, developmental toxicity, genetic toxicity, reproductive
toxicity, specific target organ toxicity, toxicokinetics, and aquatic
toxicity testing may be potentially useful to characterize the health
and environmental effects of the PMN substance. Although the Order does
not require these tests, the Order's restrictions remain in effect
until the Order is modified or revoked by EPA based on submission of
this or other relevant information.
PMN Number (Proposed CFR Citation): P-23-94 (40 CFR 721.12075)
Chemical Name: Polymer of benzenedicarboxylic acid, substituted-
benzenedicarboxylic acid, branched-alkyldiol, alkyldiol and
triisocyanate (generic).
CASRN: Not available.
Effective Date of TSCA Order: January 9, 2024.
Basis for TSCA Order: The PMN states that the use will be as a
reactive polymer for use in surface pre-treatment. Based on test data
for the feedstock residual, EPA has identified concerns for lung
effects for the residual. Based on OECD QSAR Toolbox results and the
structural alert for diisocyanates, EPA has also identified
[[Page 102060]]
concerns for dermal and respiratory sensitization. The Order was issued
under TSCA sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a
finding that in the absence of sufficient information to permit a
reasoned evaluation, the substance may present an unreasonable risk of
injury to human health. To protect against these risks, the Order
requires:
No processing for use or use of the PMN substance in a
consumer product;
No manufacture, processing, or use of the PMN substance in
any manner that results in inhalation exposure to the PMN substance;
Use of personal protective equipment where there is a
potential for dermal exposure; and
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. EPA has determined that the results of
specific target organ toxicity, pulmonary effects, and skin
sensitization testing may be potentially useful to characterize the
health effects of the PMN substance. Although the Order does not
require these tests, the Order's restrictions remain in effect until
the Order is modified or revoked by EPA based on submission of this or
other relevant information.
PMN Number (Proposed CFR Citation): P-23-172 (40 CFR 721.12076)
Chemical Name: Sulfonium, tricarbocyclic-, alkylcarbomonocyclic-
polyfluoro-heteropolycyclic-alkyl sulfonate (1:1), polymer with
alkylaryl and carbomonocyclic alkylalkanoate, di-Me 2,2'-(1,2-
diazenediyl)bis[2-alkylalkanoate]-initiated (generic).
CASRN: Not available.
Effective Date of TSCA Order: January 29, 2024.
Basis for TSCA Order: The PMN states that the generic (non-
confidential) use of the PMN substance will be for photolithography.
Based on the physical/chemical properties of the PMN substance (as
described in the New Chemical Program's PBT category at 64 FR 60194;
November 1999) and test data on structurally similar substances, the
PMN substance is a potentially persistent, bioaccumulative, and toxic
(PBT) chemical. EPA estimates that the PMN substance will persist in
the environment for more than six months and estimates unknown
bioaccumulation. Based on comparison to analogous sulfonium compounds,
EPA has identified concerns for acute toxicity, irritation to the skin
and respiratory tract, eye corrosion, neurological effects, and
systemic effects for the sulfonium cation. Based on comparison to
analogous chemical substances, EPA has also identified concerns for
genetic toxicity. Based on the photoreactivity of the PMN substance,
EPA has also identified concerns for photosensitization. Based on a
potential incineration product (trifluroacetate), EPA has also
identified concerns for local, neurological, developmental and systemic
effects via inhalation exposure. The Order was issued under TSCA
sections 5(a)(3)(B)(ii)(I) and 5(e)(1)(A)(ii)(I), based on a finding
that in the absence of sufficient information to permit a reasoned
evaluation, the substance may present an unreasonable risk of injury to
human health or the environment. To protect against these risks, the
Order requires:
No manufacture of the PMN substance beyond the time limits
specified in the Order without submittal to EPA the results of certain
testing described in the Testing section of the Order;
Use of personal protective equipment where there is a
potential for dermal exposure;
Establishment of a hazard communication program, including
human health precautionary statements on each label and in the SDS;
No modification of the processing of the PMN substance in
any way that generates a vapor, dust, mist, or aerosol in a non-
enclosed process;
Use of the PMN substance only for the confidential use
listed in the Order;
No domestic manufacture of the PMN substance (i.e., import
only);
Import of the PMN substance only in solution or in sealed
containers weighing 5 kilograms or less; and
No exceedance of the confidential annual importation
volume listed the Order.
The proposed SNUR would designate as a ``significant new use'' the
absence of these protective measures.
Potentially Useful Information: EPA has determined that certain
information about the physical/chemical properties, fate,
bioaccumulation, environmental hazard, and human health effects of the
PMN substance may be potentially useful in support of a request by the
PMN submitter to modify the Order, or if a manufacturer or processor is
considering submitting a SNUN for a significant new use that will be
designated by this SNUR. The submitter has agreed not to exceed the
time limits specified in the Order without performing the required Tier
I and Tier II testing outlined in the Testing section of the Order.
IV. Statutory and Executive Order Reviews
Additional information about these statutes and Executive Orders
can be found at https://www.epa.gov/laws-regulations-and-executive-orders.
A. Executive Order 12866: Regulatory Planning and Review and Executive
Order 14094: Modernizing Regulatory Review
This action proposes to establish SNURs for new chemical substances
that were the subject of PMNs. The Office of Management and Budget
(OMB) has exempted these types of actions from review under Executive
Order 12866 (58 FR 51735, October 4, 1993), as amended by Executive
Order 14094 (88 FR 21879, April 11, 2023).
B. Paperwork Reduction Act (PRA)
According to the PRA (44 U.S.C. 3501 et seq.), an agency may not
conduct or sponsor, and a person is not required to respond to a
collection of information that requires OMB approval under PRA, unless
it has been approved by OMB and displays a currently valid OMB control
number. The OMB control numbers for EPA's regulations in title 40 of
the CFR, after appearing in the Federal Register, are listed in 40 CFR
part 9, and included on the related collection instrument or form, if
applicable.
The information collection requirements related to SNURs have
already been approved by OMB pursuant to PRA under OMB control number
2070-0038 (EPA ICR No. 1188). This action does not impose any burden
requiring additional OMB approval. If an entity were to submit a SNUN
to the Agency, the annual burden is estimated to average between 30 and
170 hours per submission. This burden estimate includes the time needed
to review instructions, search existing data sources, gather and
maintain the data needed, and complete, review, and submit the required
SNUN.
EPA always welcomes your feedback on the burden estimates. Send any
comments about the accuracy of the burden estimate, and any suggested
methods for improving the collection instruments or instruction or
minimizing respondent burden,
[[Page 102061]]
including through the use of automated collection techniques.
C. Regulatory Flexibility Act (RFA)
I certify that this action will not have a significant economic
impact on a substantial number of small entities under the RFA (5
U.S.C. 601 et seq.). The requirement to submit a SNUN applies to any
person (including small or large entities) who intends to engage in any
activity described in the final rule as a ``significant new use.''
Because these uses are ``new,'' based on all information currently
available to EPA, EPA has concluded that no small or large entities
presently engage in such activities.
A SNUR requires that any person who intends to engage in such
activity in the future must first notify EPA by submitting a SNUN.
Although some small entities may decide to pursue a significant new use
in the future, EPA cannot presently determine how many, if any, there
may be. However, EPA's experience to date is that, in response to the
promulgation of SNURs covering over 1,000 chemicals, the Agency
receives only a small number of notices per year. For example, the
number of SNUNs received was 16 in Federal fiscal year (FY) FY2018,
five in FY2019, seven in FY2020, 13 in FY2021, 11 in FY2022, and 15 in
FY2023, and only a fraction of these submissions were from small
businesses.
In addition, the Agency currently offers relief to qualifying small
businesses by reducing the SNUN submission fee from $37,000 to $6,480.
This lower fee reduces the total reporting and recordkeeping cost of
submitting a SNUN to about $14,500 per SNUN submission for qualifying
small firms. Therefore, the potential economic impacts of complying
with these proposed SNURs are not expected to be significant or
adversely impact a substantial number of small entities. In a SNUR that
published in the Federal Register of June 2, 1997 (62 FR 29684) (FRL-
5597-1), the Agency presented its general determination that SNURs are
not expected to have a significant economic impact on a substantial
number of small entities, which was provided to the Chief Counsel for
Advocacy of the Small Business Administration.
D. Unfunded Mandates Reform Act (UMRA)
This action does not contain an unfunded mandate of $100 million or
more (in 1995 dollars) in any one year as described in UMRA, 2 U.S.C.
1531-1538, and does not significantly or uniquely affect small
governments. Based on EPA's experience with proposing and finalizing
SNURs, State, local, and Tribal governments have not been impacted by
SNURs, and EPA does not have any reasons to believe that any State,
local, or Tribal government will be impacted by these SNURs. In
addition, the estimated costs of this action to the private sector do
not exceed $183 million or more in any one year (the 1995 dollars are
adjusted to 2023 dollars for inflation using the GDP implicit price
deflator). The estimated costs for this action are discussed in Unit
I.D.
E. Executive Order 13132: Federalism
This action will not have federalism implications as specified in
Executive Order 13132 (64 FR 43255, August 10, 1999), because it is not
expected to have a substantial direct effect on States, on the
relationship between the national government and the States, or on the
distribution of power and responsibilities among the various levels of
government. Accordingly, the requirements of Executive Order 13132 do
not apply to this action.
F. Executive Order 13175: Consultation and Coordination With Indian
Tribal Governments
This action will not have Tribal implications as specified in
Executive Order 13175 (65 FR 67249, November 9, 2000), because it is
not expected to have substantial direct effects on Indian Tribes,
significantly or uniquely affect the communities of Indian Tribal
governments and does not involve or impose any requirements that affect
Indian Tribes. Accordingly, the requirements of Executive Order 13175
do not apply to this action.
G. Executive Order 13045: Protection of Children From Environmental
Health Risks and Safety Risks
This action is not subject to Executive Order 13045 (62 FR 19885,
April 23, 1997), because it does not concern an environmental health or
safety risk. Since this action does not concern a human health risk,
EPA's 2021 Policy on Children's Health also does not apply. Although
the establishment of these SNURs do not address an existing children's
environmental health concern because the chemical uses involved are not
ongoing uses, SNURs require that persons notify EPA at least 90 days
before commencing manufacture (defined by statute to include import) or
processing of any of these chemical substances for an activity that is
designated as a significant new use by this rulemaking. This
notification allows EPA to assess the intended uses to identify
potential risks and take appropriate actions before the activities
commence.
H. Executive Order 13211: Actions Concerning Regulations That
Significantly Affect Energy Supply, Distribution, or Use
This action is not a ``significant energy action'' as defined in
Executive Order 13211 (66 FR 28355, May 22, 2001), because it is not
likely to have a significant adverse effect on the supply,
distribution, or use of energy.
I. National Technology Transfer and Advancement Act (NTTAA)
This action does not involve any technical standards subject to
NTTAA section 12(d) (15 U.S.C. 272 note).
J. Executive Order 12898: Federal Actions To Address Environmental
Justice in Minority Populations and Low-Income Populations and
Executive Order 14096: Revitalizing Our Nation's Commitment to
Environmental Justice for All
EPA believes that this type of action does not concern human health
or environmental conditions and therefore cannot be evaluated with
respect to the potentially disproportionate and adverse effects on
communities with environmental justice concerns in accordance with
Executive Orders 12898 (59 FR 7629, February 16, 1994) and 14096 (88 FR
25251, April 26, 2023). Although this action does not concern human
health or environmental conditions, the premanufacture notifications
required by these SNURs will allow EPA to assess the intended uses to
identify potential disproportionate risks and take appropriate actions
before the activities commence.
List of Subjects in 40 CFR part 721
Environmental protection, Chemicals, Hazardous substances,
Reporting and recordkeeping requirements.
Kevin DeBell,
Acting Director, Office of Pollution Prevention and Toxics.
Therefore, for the reasons stated in the preamble, EPA proposes to
amend 40 CFR chapter I as follows:
PART 721--SIGNIFICANT NEW USES OF CHEMICAL SUBSTANCES
0
1. The authority citation for part 721 continues to read as follows:
Authority: 15 U.S.C. 2604, 2607, and 2625(c).
[[Page 102062]]
0
2. Add Sec. Sec. 721.12043 through 721.12076 to Subpart E to read as
follows:
Subpart E--Significant New Uses for Specific Chemical Substances
Sec.
* * * * *
721.12043 Heptane, 2-methoxy-2-methyl-.
721.12044 Benzenesulfonic acid, alkyl-, compd. with 1,1'-iminobis[2-
propanol] (1:1) (generic).
721.12045 Sugars, polymer with alkanetriamine (generic).
721.12046 Isooctadecanamide, N,N-bis(2-ethylhexyl)-.
721.12047 2-Butanone, oxime, reaction products with
trimethoxymethylsilane.
721.12048 2,6-Bis(dialkyl)-4-[2-(1-alkyl-4(1H)-
pyridinylidene)alkylidene]-2,5-cycloalkyladien-1-one (generic).
721.12049 Fatty acids, soya, reaction products with ammonia-
ethanolamine reaction by-products.
721.12050 1,5-Pentanediamine, 2-methyl-, hydrochloride (1:2).
721.12051 1,5-Pentanediamine, 2-methyl-, hydrochloride (1:1).
721.12052 Formic acid, compd. with 2-methyl-1,5- pentanediamine
(2:1).
721.12053 Formic acid, compd. with 2-methyl-1,5-pentanediamine
(1:1).
721.12054 Alkadiene, homopolymer, hydroxy-terminated, bis[N-[2-[(1-
oxo-2-propen-1-yl)oxylethyl]carbamates] (generic).
721.12055 Oxirane, 2-(chloromethyl)-, homopolymer, ether with
dialkyl-alkanediol (2:1) (generic).
721.12056 Aryl, polymer with formaldehyde, glycidyl ether, reaction
products with amino alkyl-alkane diamine, cyclohexanediamine and
alkylene (alkylcyclohexanamine) (generic).
721.12057 Alkene, alkoxy-, polymer with alkoxyalkene (generic).
721.12058 Methanesulfonamide, 1,1,1-trifluoro-N-
[(trifluoromethyl)sulfonyl]-, sodium salt (1:1).
721.12059 1H-Isoindole-1,3(2H)-dione, 3a,4,7,7a-tetrahydro-2-(2-
hydroxyethyl).
721.12060 Oxirane, 2-methyl-, polymer with oxirane, mono-isoalkyl
ethers, phosphates, salt (generic).
721.12061 Poly(oxy-1,2-ethanediyl), .alpha.-(2-aminoethyl)-.omega.-
(2-aminoethoxy)- and Poly(oxy-1,2-ethanediyl), .alpha.,.alpha.',-
(iminodi-2,1- ethanediyl)bis[.omega.-(2-aminoethoxy)-.
721.12062 Alkenoic acid, alkyl, carbopolycyclic alkyl ester, polymer
with trihalo (trihaloalkyl) alkyl alkyl alkenoate (generic).
721.12063 Polychloroalkene (generic).
721.12064 Alkanoic acid, trialkyl-, diester with carbomonocycle
bis(alkyleneoxy)]bis[alkanediol] (generic).
721.12065 Modified Silsesquioxane, alkoxy-terminated (generic).
721.12066 Vegetable oil, polymer with pimelin ketone, oxymethylene
and polymethylenepolyphenylene isocyanate (generic).
721.12067 Silsesquioxanes, 3-mercaptopropyl, polymers with silicic
acid (H4SiO4) tetra-Et ester, [(trimethylsilyl)oxy]-terminated.
721.12068 Castor oil, polymer with dicyclopentadiene, maleic
anhydride, 2-methyl-1,3-propanediol, 3a,4,7,7a-tetrahydro-2-(2-
hydroxyethyl)-1H-isoindole-1,3(2H)-dione and triethylene glycol.
721.12069 Monoaromatic cyclic alkylene sulfonium fluoroalkyl
sulfonic acid salt (generic).
721.12070 Monoaromatic cyclic alkylene sulfonium fluoroalkyl
sulfonic acid salt (generic).
721.12071 Aromatic sulfonium tricyclo fluoroalkyl sulfonic acid salt
(generic).
721.12072 Aromatic dibenzothiophenium fluoroalkyl carbopolycycle
sulfonic acid salt (generic).
721.12073 Alkanediol, substituted, polymer with diisocyanatoalkane,
substituted heterocycle-modified (generic).
721.12074 Halosubstituted carbopolycycle, polymer with substituted
carbomonocycles and oxybis[alkanol] (generic).
721.12075 Polymer of benzenedicarboxylic acid, substituted-
benzenedicarboxylic acid, branched-alkyldiol, alkyldiol and
triisocyanate (generic).
721.12076 Sulfonium, tricarbocyclic-, alkylcarbomonocyclic-
polyfluoro-heteropolycyclic-alkyl sulfonate (1:1), polymer with
alkylaryl and carbomonocyclic alkylalkanoate, di-Me 2,2'-(1,2-
diazenediyl)bis[2-alkylalkanoate]-initiated (generic).
* * * * *
Sec. 721.12043 Heptane, 2-methoxy-2-methyl-.
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified as Heptane, 2-methoxy-2-
methyl- (PMN P-18-127; CASRN 76589-16-7) is subject to reporting under
this section for the significant new uses described in paragraph (a)(2)
of this section.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (3), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (f), (g)(1), (3), and (5). For purposes of Sec.
721.72(g)(1), this substance may cause: skin sensitization and specific
target organ toxicity. For purposes of Sec. 721.72(g)(3), this
substance may be: toxic to aquatic life. Alternative hazard and warning
statements that meet the criteria of the Globally Harmonized System and
OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(f). It is a significant new use to
manufacture the substance unless by import into the United States in a
solution of no greater than 5% by weight (i.e., no domestic
manufacture). It is a significant new use to process the substance
unless in a solution of no greater than 5% by weight of the substance.
It is a significant new use to process for use or use the substance in
consumer products unless the concentration of the substance is less
than 1% by weight.
(iv) Release to water. Requirements as specified in Sec.
721.90(a)(4), (b)(4), and (c)(4), where N=210.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i), and (k) are applicable to manufacturers,
importers, and processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12044 Benzenesulfonic acid, alkyl-, compd. with 1,1'-
iminobis[2-propanol] (1:1) (generic).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified generically as
benzenesulfonic acid, alkyl-, compd. with 1,1'-iminobis[2-propanol]
(1:1) (PMN P-18-325) is subject to reporting under this section for the
significant new uses described in paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1) and (3), (b), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible. For purposes of
Sec. 721.63(b), the concentration is set at 1.0%.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (f), and (g)(1), (3) and (5). For
[[Page 102063]]
purposes of Sec. 721.72(e), the concentration is set at 1.0%. For
purposes of Sec. 721.72(g)(1), this substance may cause: skin
irritation, eye irritation, and specific target organ toxicity. For
purposes Sec. 721.72(g)(3), this substance may be: toxic to aquatic
life. Alternative hazard and warning statements that meet the criteria
of the Globally Harmonized System and OSHA Hazard Communication
Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(k). It is a significant new use to
manufacture, process, or use the substance in any manner that results
in inhalation exposure to the substance. It is a significant new use to
process for use or use the substance other than as an industrial cross-
linking catalyst.
(iv) Release to water. Requirements as specified in Sec.
721.90(a)(1), (b)(1), and (c)(1).
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i), and (k) are applicable to manufacturers,
importers, and processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12045 Sugars, polymer with alkanetriamine (generic).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified generically as sugars,
polymer with alkanetriamine (PMN P-20-14) is subject to reporting under
this section for the significant new uses described in paragraph (a)(2)
of this section. The requirements of this section do not apply to
quantities of the substance after they have been completely reacted or
cured.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1) and (3), (b), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible. For purposes of
Sec. 721.63(b), the concentration is set at 1.0%.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (f), (g)(1), (3), and (5). For purposes of Sec.
721.72(e), the concentration is set at 1.0%. For purposes of Sec.
721.72(g)(1), this substance may cause: reproductive toxicity and
specific target organ toxicity. For purposes of Sec. 721.72(g)(3),
this substance may be: toxic to aquatic life. Alternative hazard and
warning statements that meet the criteria of the Globally Harmonized
System and OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(o).
(iv) Release to water. Requirements as specified in Sec.
721.90(a)(4), (b)(4), and (c)(4), where N=191.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i), and (k) are applicable to manufacturers,
importers, and processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12046 Isooctadecanamide, N,N-bis(2-ethylhexyl)-.
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified as isooctadecanamide, N,N-
bis(2-ethylhexyl)- (PMN P-21-86; CASRN 1616494-50-8) is subject to
reporting under this section for the significant new uses described in
paragraph (a)(2) of this section. The requirements of this section do
not apply to quantities of the substance after they have been entrained
in a polymer.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1) and (3), (b), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible. For purposes of
Sec. 721.63(b), the concentration is set at 1.0%.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (f), (g)(1), and (5). For purposes of Sec.
721.72(e), the concentration is set at 1.0%. For purposes of Sec.
721.72(g)(1), this substance may cause: specific target organ toxicity.
Alternative hazard and warning statements that meet the criteria of the
Globally Harmonized System and OSHA Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and consumer activities. It is a
significant new use to process the substance for use in a consumer
product where the concentration of the substance in the consumer
product formulation exceeds the confidential percentage listed in the
Order. It is a significant new use to use the substance in a consumer
product where the concentration of the substance exceeds the
confidential percentage listed in the Order.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12047 2-Butanone, oxime, reaction products with
trimethoxymethylsilane.
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified as 2-butanone, oxime,
reaction products with trimethoxymethylsilane (PMN P-21-164; CASRN
2639393-45-4) is subject to reporting under this section for the
significant new uses described in paragraph (a)(2) of this section. The
requirements of this section do not apply to quantities of the
substance after they have been completely reacted or cured.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (3) through (6), and (c). When determining which persons
are reasonably likely to be exposed as required for Sec. 721.63(a)(1)
and (4), engineering control measures (e.g., enclosure or confinement
of the operation, general and local ventilation) or administrative
control measures (e.g., workplace policies and procedures) shall be
considered and implemented to prevent exposure, where feasible. For
purposes of Sec. 721.63(a)(5), respirators must provide a National
Institute for Occupational Safety and Health (NIOSH) assigned
protection factor (APF) of at least 50.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a)
[[Page 102064]]
through (d), (f), (g)(1), (3), and (5). For purposes of Sec.
721.72(g)(1), this substance may cause: acute toxicity,
carcinogenicity, serious eye damage, reproductive toxicity, skin
irritation, skin sensitization, and specific target organ toxicity. For
purposes of Sec. 721.72(g)(3), this substance may be: toxic to aquatic
life. Alternative hazard and warning statements that meet the criteria
of the Globally Harmonized System and OSHA Hazard Communication
Standard may be used.
(iii) Industrial, commercial, and consumer activities. It is a
significant new use to load or unload the substance for manufacture,
processing, or use in any manner unless under a gas (e.g. nitrogen)
blanket. It is a significant new use to use the substance unless at 4%
or less by weight in formulation. It is a significant new use to apply
the substance for use unless by roll, brush, or dip coating.
(iv) Disposal. Requirements as specified in Sec. 721.85(a)(1),
(b)(1), and (c)(1).
(v) Release to water. Requirements as specified in Sec.
721.90(a)(1), (b)(1), and (c)(1).
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (k) are applicable to manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12048 2,6-Bis(dialkyl)-4-[2-(1-alkyl-4(1H)-
pyridinylidene)alkylidene]-2,5-cycloalkyladien-1-one (generic).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified generically as 2,6-
bis(dialkyl)-4-[2-(1-alkyl-4(1H)-pyridinylidene)alkylidene]-2,5-
cycloalkyladien-1-one (generic) (PMN P-21-170) is subject to reporting
under this section for the significant new uses described in paragraph
(a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (3) through (6), and (c). When determining which persons
are reasonably likely to be exposed as required for Sec. 721.63(a)(1)
and (4), engineering control measures (e.g., enclosure or confinement
of the operation, general and local ventilation) or administrative
control measures (e.g., workplace policies and procedures) shall be
considered and implemented to prevent exposure, where feasible. For
purposes of Sec. 721.63(a)(5), respirators must provide a National
Institute for Occupational Safety and Health (NIOSH) assigned
protection factor (APF) of at least 10.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (f), (g)(1), (3), and (5). For purposes of Sec.
721.72(g)(1), this substance may cause: acute toxicity, skin
irritation, eye irritation, skin sensitization, genetic toxicity,
carcinogenicity, reproductive toxicity, and specific target organ
toxicity. For purposes of Sec. 721.72(g)(3), this substance may be:
toxic to aquatic life. Alternative hazard and warning statements that
meet the criteria of the Globally Harmonized System and OSHA Hazard
Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(k), (t). It is a significant new use to
manufacture the substance in excess of an annual volume of 10 kg. It is
a significant new use to process for use or use the substance other
than as a color indicator for frying oil breakdown. It is a significant
new use to manufacture, process, or use the substance in any manner
that results in the release of the substance to air except with the use
of a HEPA filtration system.
(iv) Release to water. Requirements as specified in Sec.
721.90(a)(1), (b)(1), and (c)(1).
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i), and (k) are applicable to manufacturers,
importers, and processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12049 Fatty acids, soya, reaction products with ammonia-
ethanolamine reaction by-products.
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified as fatty acids, soya,
reaction products with ammonia-ethanolamine reaction by-products (PMN
P-21-184; CASRN 2378512-59-3) is subject to reporting under this
section for the significant new uses described in paragraph (a)(2) of
this section.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (3), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (f), (g)(1), (3), and (5). For purposes of Sec.
721.72(g)(1), this substance may cause: acute toxicity, skin corrosion,
skin irritation, serious eye damage, eye irritation, skin
sensitization, and specific target organ toxicity. For purposes of
Sec. 721.72(g)(3), this substance may be: toxic to aquatic life.
Alternative hazard and warning statements that meet the criteria of the
Globally Harmonized System and OSHA Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(o), and (y)(1) and (2). It is a
significant new use to manufacture, process, or use the substance in
any manner that results in the generation of vapor, mist, aerosol, or
dust.
(iv) Release to water. Requirements as specified in Sec.
721.90(a)(4), (b)(4), and (c)(4), where N=2.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i), and (k) are applicable to manufacturers,
importers, and processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12050 1,5-Pentanediamine, 2-methyl-, hydrochloride (1:2).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified as 1,5-pentanediamine, 2-
methyl-, hydrochloride (1:2) (PMN P-22-3; CASRN 34813-63-3) is subject
to reporting under this section for the significant new uses described
in paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (3), (b), and (c). When determining which persons are
[[Page 102065]]
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible. For purposes of
Sec. 721.63(b), the concentration is set at 1.0%.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (f), (g)(1), (3), and (5). For purposes of Sec.
721.72(e), the concentration is set at 1.0%. For purposes of Sec.
721.72(g)(1), this substance may cause: acute toxicity, skin
irritation, and eye irritation. For purposes of Sec. 721.72(g)(3),
this substance may be: toxic to aquatic life. Alternative hazard and
warning statements that meet the criteria of the Globally Harmonized
System and OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(o). It is a significant new use to
manufacture, process, or use the substance in any manner that results
in inhalation exposure to the substance.
(iv) Release to water. Requirements as specified in Sec.
721.90(a)(4), (b)(4), and (c)(4), where N=570 of P-22-3, P-22-4, P-22-
5, and P-22-6 combined.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i), and (k) are applicable to manufacturers,
importers, and processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12051 1,5-Pentanediamine, 2-methyl-, hydrochloride (1:1).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified as 1,5-pentanediamine, 2-
methyl-, hydrochloride (1:1) (PMN P-22-4; CASRN 1840915-04-9) is
subject to reporting under this section for the significant new uses
described in paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (3), (b), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible. For purposes of
Sec. 721.63(b), the concentration is set at 1.0%.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (f), (g)(1), (3), and (5). For purposes of Sec.
721.72(e), the concentration is set at 1.0%. For purposes of Sec.
721.72(g)(1), this substance may cause: acute toxicity, skin
irritation, eye irritation, serious eye damage, skin corrosion, and
specific target organ toxicity. For purposes of Sec. 721.72(g)(3),
this substance may be: toxic to aquatic life. Alternative hazard and
warning statements that meet the criteria of the Globally Harmonized
System and OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(o). It is a significant new use to
manufacture, process, or use the substance in any manner that results
in inhalation exposure to the substance.
(iv) Release to water. Requirements as specified in Sec.
721.90(a)(4), (b)(4), and (c)(4), where N=570 of P-22-3, P-22-4, P-22-
5, and P-22-6 combined.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i), and (k) are applicable to manufacturers,
importers, and processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12052 Formic acid, compd. with 2-methyl-1,5- pentanediamine
(2:1).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified as formic acid, compd. with
2-methyl-1,5- pentanediamine (2:1) (PMN P-22-5; CASRN 1836131-73-7) is
subject to reporting under this section for the significant new uses
described in paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1) and (3), (b), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible. For purposes of
Sec. 721.63(b), the concentration is set at 1.0%.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (f), (g)(1), (3), and (5). For purposes of Sec.
721.72(e), the concentration is set at 1.0%. For purposes of Sec.
721.72(g)(1), this substance may cause: acute toxicity, skin
irritation, eye irritation, and specific target organ toxicity. For
purposes of Sec. 721.72(g)(3), this substance may be: toxic to aquatic
life. Alternative hazard and warning statements that meet the criteria
of the Globally Harmonized System and OSHA Hazard Communication
Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(o). It is a significant new use to
manufacture, process, or use the substance in any manner that results
in inhalation exposure to the substance.
(iv) Release to water. Requirements as specified in Sec.
721.90(a)(4), (b)(4), and (c)(4), where N=570 of P-22-3, P-22-4, P-22-
5, and P-22-6 combined.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i), and (k) are applicable to manufacturers,
importers, and processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12053 Formic acid, compd. with 2-methyl-1,5-pentanediamine
(1:1).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified as formic acid, compd. with
2-methyl-1,5-pentanediamine (1:1) (PMN P-22-6; CASRN 1836131-75-9) is
subject to reporting under this section for the significant new uses
described in paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1) and (3), (b), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general
[[Page 102066]]
and local ventilation) or administrative control measures (e.g.,
workplace policies and procedures) shall be considered and implemented
to prevent exposure, where feasible. For purposes of Sec. 721.63(b),
the concentration is set at 1.0%.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (f), (g)(1), (3), and (5). For purposes of Sec.
721.72(e), the concentration is set at 1.0%. For purposes of Sec.
721.72(g)(1), this substance may cause: acute toxicity, skin corrosion,
skin irritation, serious eye damage, eye irritation, and specific
target organ toxicity. For purposes of Sec. 721.72(g)(3), this
substance may be: toxic to aquatic life. Alternative hazard and warning
statements that meet the criteria of the Globally Harmonized System and
OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(o). It is a significant new use to
manufacture, process, or use the substance in any manner that results
in inhalation exposure to the substance.
(iv) Release to water. Requirements as specified in Sec.
721.90(a)(4), (b)(4), and (c)(4), where N=570 of P-22-3, P-22-4, P-22-
5, and P-22-6 combined.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i), and (k) are applicable to manufacturers,
importers, and processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12054 Alkadiene, homopolymer, hydroxy-terminated, bis[N-[2-
[(1-oxo-2-propen-1- yl)oxylethyl]carbamates] (generic).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified generically as alkadiene,
homopolymer, hydroxy-terminated, bis[N-[2-[(1-oxo-2-propen-1-
yl)oxylethyl]carbamates] (PMN P-22-11) is subject to reporting under
this section for the significant new uses described in paragraph (a)(2)
of this section.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (3), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (f), (g)(1), and (5). For purposes of Sec.
721.72(g)(1), this substance may cause: skin sensitization, respiratory
sensitization, reproductive toxicity, and specific target organ
toxicity. Alternative hazard and warning statements that meet the
criteria of the Globally Harmonized System and OSHA Hazard
Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(o). It is a significant new use to
manufacture, process, or use the substance in any manner that results
in inhalation exposure to the substance.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12055 Oxirane, 2-(chloromethyl)-, homopolymer, ether with
dialkyl-alkanediol (2:1) (generic).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified generically as oxirane, 2-
(chloromethyl)-, homopolymer, ether with dialkyl-alkanediol (2:1) (PMN
P-22-25) is subject to reporting under this section for the significant
new uses described in paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (3), (b), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible. For purposes of
Sec. 721.63(b), the concentration is set at 0.1%.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (f), (g)(1), and (5). For purposes of Sec.
721.72(e), the concentration is set at 0.1%. For purposes of Sec.
721.72(g)(1), this substance may cause: acute toxicity, skin
irritation, eye irritation, genetic toxicity, carcinogenicity, and
specific target organ toxicity. Alternative hazard and warning
statements that meet the criteria of the Globally Harmonized System and
OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(g), (t), (y)(1), and (2). It is a
significant new use to manufacture, process, or use the substance in
any manner that generates a vapor, mist, aerosol, or dust.
(iv) Disposal. It is a significant new use to dispose of the
substance, or waste streams containing the substance, other than by
hazardous waste incineration.
(v) Release to water. Requirements as specified in Sec.
721.90(a)(1), (b)(1), and (c)(1).
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (k) are applicable to manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12056 Aryl, polymer with formaldehyde, glycidyl ether,
reaction products with amino alkyl-alkane diamine, cyclohexanediamine
and alkylene (alkylcyclohexanamine) (generic).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified generically as aryl, polymer
with formaldehyde, glycidyl ether, reaction products with amino alkyl-
alkane diamine, cyclohexanediamine and alkylene (alkylcyclohexanamine)
(PMN P-22-49) is subject to reporting under this section for the
significant new uses described in paragraph (a)(2) of this section. The
requirements of this section do not apply to quantities of the
substance after they have been completely reacted or cured.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (3) through (6), and (c). When determining which persons
are reasonably likely to be exposed as required for Sec. 721.63(a)(1)
and (4), engineering control measures (e.g.,
[[Page 102067]]
enclosure or confinement of the operation, general and local
ventilation) or administrative control measures (e.g., workplace
policies and procedures) shall be considered and implemented to prevent
exposure, where feasible. For purposes of Sec. 721.63(a)(5),
respirators must provide a National Institute for Occupational Safety
and Health (NIOSH) assigned protection factor (APF) of at least 1,000.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (f), (g)(1), (3), and (5). For purposes of Sec.
721.72(g)(1), this substance may cause: acute toxicity, skin
irritation, eye irritation, skin corrosion, serious eye damage,
respiratory sensitization, skin sensitization, genetic toxicity,
reproductive toxicity, and specific target organ toxicity. For purposes
of Sec. 721.72(g)(3), this substance may be: toxic to aquatic life.
Alternative hazard and warning statements that meet the criteria of the
Globally Harmonized System and OSHA Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(o).
(iv) Release to water. Requirements as specified in Sec.
721.90(a)(4), (b)(4), and (c)(4), where N=2.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i), and (k) are applicable to manufacturers,
importers, and processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12057 Alkene, alkoxy-, polymer with alkoxyalkene (generic).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified generically as alkene,
alkoxy-, polymer with alkoxyalkene (PMN P-22-50) is subject to
reporting under this section for the significant new uses described in
paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1) and (3), (b), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible. For purposes of
Sec. 721.63(b), the concentration is set at 1.0%.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (f), (g)(1), (3), and (5). For purposes of Sec.
721.72(e), the concentration is set at 1.0%. For purposes of Sec.
721.72(g)(1), this substance may cause: skin irritation, eye
irritation, and specific target organ toxicity. For purposes of Sec.
721.72(g)(3), this substance may be: toxic to aquatic life. Alternative
hazard and warning statements that meet the criteria of the Globally
Harmonized System and OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(k) and (o). It is a significant new use to
manufacture, process, or use the substance in any manner that results
in inhalation exposure to the substance.
(iv) Release to water. Requirements as specified in Sec.
721.90(a)(1), (b)(1), and (c)(1).
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i), and (k) are applicable to manufacturers,
importers, and processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12058 Methanesulfonamide, 1,1,1-trifluoro-N-
[(trifluoromethyl)sulfonyl]-, sodium salt (1:1).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified as Methanesulfonamide, 1,1,1-
trifluoro-N-[(trifluoromethyl)sulfonyl]-, sodium salt (1:1) (PMN P-22-
58; CASRN 91742-21-1) is subject to reporting under this section for
the significant new uses described in paragraph (a)(2) of this section.
The requirements of this section do not apply to quantities of the
substance after they have been incorporated into an article.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (3) through (6), (b), and (c). When determining which
persons are reasonably likely to be exposed as required for Sec.
721.63(a)(1) and (4), engineering control measures (e.g., enclosure or
confinement of the operation, general and local ventilation) or
administrative control measures (e.g., workplace policies and
procedures) shall be considered and implemented to prevent exposure,
where feasible. For purposes of Sec. 721.63(a)(5), respirators must
provide a National Institute for Occupational Safety and Health (NIOSH)
assigned protection factor (APF) of at least 50. For purposes of Sec.
721.63(b), the concentration is set at 1.0%.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (f), (g)(1), (3), and (5). For purposes of Sec.
721.72(e), the concentration is set at 1.0%. For purposes of Sec.
721.72(g)(1), this substance may cause: acute toxicity, serious eye
damage, skin irritation, reproductive toxicity, and specific target
organ toxicity. For purposes of Sec. 721.72(g)(3), this substance may
be: toxic to aquatic life. Alternative hazard and warning statements
that meet the criteria of the Globally Harmonized System and OSHA
Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(b), (k), (v)(2), and (y)(1) and (2). It is
a significant new use to process the substance in a manner that
generates a vapor, mist, aerosol, or dust that results in inhalation to
workers.
(iv) Release to water. Requirements as specified in Sec.
721.90(a)(4), (b)(4), and (c)(4), where N=100.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i), and (k) are applicable to manufacturers,
importers, and processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12059 1H-Isoindole-1,3(2H)-dione, 3a,4,7,7a-tetrahydro-2-(2-
hydroxyethyl)-.
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified as 1H-Isoindole-1,3(2H)-
dione, 3a,4,7,7a-tetrahydro-2-(2-hydroxyethyl)- (PMN P-22-75; CASRN
15458-48-7) is subject to reporting under this section for the
significant new uses described in paragraph (a)(2) of this section. The
requirements of this section do not apply to quantities of the
substance after they have been completely reacted or cured.
(2) The significant new uses are:
[[Page 102068]]
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (3), (b), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible. For purposes of
Sec. 721.63(b), the concentration is set at 1.0%.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (f), (g)(1), (3), and (5). For purposes of Sec.
721.72(e), the concentration is set at 1.0%. For purposes of Sec.
721.72(g)(1), this substance may cause: acute toxicity, skin
irritation, eye irritation, and specific target organ toxicity. For
purposes of Sec. 721.72(g)(3), this substance may be: toxic to aquatic
life. Alternative hazard and warning statements that meet the criteria
of the Globally Harmonized System and OSHA Hazard Communication
Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(f), (k), and (t). It is a significant new
use to manufacture the substance in excess of an annual volume of 3,000
kg. It is a significant new use to use the substance other than as a
monomer used to produce an unsaturated polyester resin.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12060 Oxirane, 2-methyl-, polymer with oxirane, mono-
isoalkyl ethers, phosphates, salt (generic).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified generically as oxirane, 2-
methyl-, polymer with oxirane, mono-isoalkyl ethers, phosphates, salt
(PMN P-22-78) is subject to reporting under this section for the
significant new uses described in paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1) and (3), (b), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible. For purposes of
Sec. 721.63(b), the concentration is set at 1.0%.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (f), (g)(1), (3), and (5). For purposes of Sec.
721.72(e), the concentration is set at 1.0%. For purposes of Sec.
721.72(g)(1), this substance may cause: skin irritation and specific
target organ toxicity. For purposes of Sec. 721.72(g)(3), this
substance may be: toxic to aquatic life. Alternative hazard and warning
statements that meet the criteria of the Globally Harmonized System and
OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(k). It is a significant new use to
manufacture or process the substance in a manner that generates a
vapor, mist, aerosol, or dust. It is a significant new use to process
for use or use the substance other than as a dispersing agent for
pesticide formulations.
(iv) Release to water. Requirements as specified in Sec.
721.90(a)(4), (b)(4), and (c)(4), where N=23.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i), and (k) are applicable to manufacturers,
importers, and processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12061 Poly(oxy-1,2-ethanediyl), .alpha.-(2-
aminoethyl)-.omega.-(2-aminoethoxy)- and Poly(oxy-1,2-ethanediyl),
.alpha.,.alpha.',-(iminodi-2,1- ethanediyl)bis[.omega.-(2-
aminoethoxy)-.
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified as poly(oxy-1,2-ethanediyl),
.alpha.-(2-aminoethyl)-.omega.-(2-aminoethoxy)- and poly(oxy-1,2-
ethanediyl), .alpha.,.alpha.',-(iminodi-2,1- ethanediyl)bis[.omega.-(2-
aminoethoxy)- (PMN P-22-80; CAS Nos. 24991-53-5 and 90350-34-8) is
subject to reporting under this section for the significant new uses
described in paragraph (a)(2) of this section. The requirements of this
section do not apply to quantities of the substance after they have
been completely reacted or destroyed.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (3), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (f), (g)(1), (3), and (5). For purposes of Sec.
721.72(g)(1), this substance may cause: acute toxicity, skin corrosion,
serious eye damage, and skin sensitization. For purposes of Sec.
721.72(g)(3), this substance may be: toxic to aquatic life. Alternative
hazard and warning statements that meet the criteria of the Globally
Harmonized System and OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. It is a
significant new use to manufacture, process, or use the substance in
any manner that results in inhalation exposure to the substance.
(iv) Release to water. Requirements as specified in Sec.
721.90(a)(4), (b)(4), and (c)(4), where N=0.7.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i), and (k) are applicable to manufacturers,
importers, and processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12062 Alkenoic acid, alkyl, carbopolycyclic alkyl ester,
polymer with trihalo (trihaloalkyl) alkyl alkyl alkenoate (generic).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified generically as alkenoic acid,
alkyl, carbopolycyclic alkyl ester, polymer with trihalo (trihaloalkyl)
alkyl alkyl alkenoate (PMN P-22-82) is subject to reporting under this
section for the significant new uses described in
[[Page 102069]]
paragraph (a)(2) of this section. The requirements of this section do
not apply to quantities of the substance after they have been entrained
in dried photoresist.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (3), (b), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible. For purposes of
Sec. 721.63(b), the concentration is set at 1.0%.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (f), (g)(1), and (5). For purposes of Sec.
721.72(e), the concentration is set at 1.0%. For purposes of Sec.
721.72(g)(1), this substance may cause: reproductive toxicity and
specific target organ toxicity. Alternative hazard and warning
statements that meet the criteria of the Globally Harmonized System and
OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(f), (k), (v)(1), (2) and (4), (w)(1), (2)
and (4), and (x)(1), (2) and (4). It is a significant new use to
manufacture the substance other than by import into the United States
(i.e., no domestic manufacture) in a liquid formulation.
(iv) Disposal. Requirements as specified in Sec. 721.85(a)(1),
(b)(1), and (c)(1).
(v) Release to water. Requirements as specified in Sec.
721.90(a)(1), (b)(1), and (c)(1).
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (k) are applicable to manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12063 Polychloroalkene (generic).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified generically as
polychloroalkene (PMN P-22-121) is subject to reporting under this
section for the significant new uses described in paragraph (a)(2) of
this section. The requirements of this section do not apply to
quantities of the substance after they have been completely reacted.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (3) through (6), and (c). When determining which persons
are reasonably likely to be exposed as required for Sec. 721.63(a)(1)
and (4), engineering control measures (e.g., enclosure or confinement
of the operation, general and local ventilation) or administrative
control measures (e.g., workplace policies and procedures) shall be
considered and implemented to prevent exposure, where feasible. For
purposes of Sec. 721.63(a)(5), respirators must provide a National
Institute for Occupational Safety and Health (NIOSH) assigned
protection factor (APF) of at least 50.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (f), (g)(1), (3), and (5). For purposes of Sec.
721.72(g)(1), this substance may cause: acute toxicity, skin
irritation, serious eye damage, skin sensitization, genetic toxicity,
carcinogenicity, and specific target organ toxicity. For purposes of
Sec. 721.72(g)(3), this substance may be: toxic to aquatic life.
Alternative hazard and warning statements that meet the criteria of the
Globally Harmonized System and OSHA Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(f) and (k). It is a significant new use to
process, use, load, or unload the substance unless under a gas (e.g.,
nitrogen) blanket or in a closed system except that sampling may occur
outside the closed system resulting in exposures.
(iv) Release to water. Requirements as specified in Sec.
721.90(a)(4), (b)(4), and (c)(4), where N=0.15.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i), and (k) are applicable to manufacturers,
importers, and processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12064 Alkanoic acid, trialkyl-, diester with carbomonocycle
bis(alkyleneoxy)]bis[alkanediol] (generic).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified generically as alkanoic acid,
trialkyl-, diester with carbomonocycle bis(alkyleneoxy)]bis[alkanediol]
(PMN P-22-145) is subject to reporting under this section for the
significant new uses described in paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (3), (b), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible. For purposes of
Sec. 721.63(b), the concentration is set at 1.0%.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (f), (g)(1), (3), and (5). For purposes of Sec.
721.72(e), the concentration is set at 1.0%. For purposes of Sec.
721.72(g)(1), this substance may cause: acute toxicity, reproductive
toxicity, and specific target organ toxicity. For purposes of Sec.
721.72(g)(3), this substance may be: toxic to aquatic life. Alternative
hazard and warning statements that meet the criteria of the Globally
Harmonized System and OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(o). It is a significant new use to use the
substance in any manner that may generate a spray, mist, vapor, or
aerosol containing the substance unless the concentration of the
substance is less than 5.7% by weight.
(iv) Disposal. Requirements as specified in Sec. 721.85(a)(1),
(b)(1), and (c)(1).
(v) Release to water. Requirements as specified in Sec.
721.90(a)(1), (b)(1), and (c)(1).
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (k) are applicable to manufacturers, importers, and
processors of this substance.
[[Page 102070]]
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12065 Modified Silsesquioxane, alkoxy-terminated (generic).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified generically as modified
silsesquioxane, alkoxy-terminated (PMN P-22-175) is subject to
reporting under this section for the significant new uses described in
paragraph (a)(2) of this section.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (3) through (6), (b), and (c). When determining which
persons are reasonably likely to be exposed as required for Sec.
721.63(a)(1) and (4), engineering control measures (e.g., enclosure or
confinement of the operation, general and local ventilation) or
administrative control measures (e.g., workplace policies and
procedures) shall be considered and implemented to prevent exposure,
where feasible. For purposes of Sec. 721.63(a)(5), respirators must
provide a National Institute for Occupational Safety and Health (NIOSH)
assigned protection factor (APF) of at least 10. For purposes of Sec.
721.63(b), the concentration is set at 1.0%.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (f), (g)(1), (3), and (5). For purposes of Sec.
721.72(e), the concentration is set at 1.0%. For purposes of Sec.
721.72(g)(1), this substance may cause: skin irritation, eye
irritation, and specific target organ toxicity. For purposes of Sec.
721.72(g)(3), this substance may be: toxic to aquatic life. Alternative
hazard and warning statements that meet the criteria of the Globally
Harmonized System and OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(f). It is a significant new use to use the
substance unless the concentration of the substance does not exceed 10%
by weight in formulation.
(iv) Release to water. Requirements as specified in Sec.
721.90(a)(4), (b)(4), and (c)(4), where N=7.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i), and (k) are applicable to manufacturers,
importers, and processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12066 Vegetable oil, polymer with pimelin ketone,
oxymethylene and polymethylenepolyphenylene isocyanate (generic).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified generically as vegetable oil,
polymer with pimelin ketone, oxymethylene and
polymethylenepolyphenylene isocyanate (PMN P-23-18) is subject to
reporting under this section for the significant new uses described in
paragraph (a)(2) of this section. The requirements of this section do
not apply to quantities of the substance after they have been
completely reacted or cured.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1) and (3), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (f), (g)(1), and (5). For purposes of Sec.
721.72(g)(1), this substance may cause: acute toxicity, skin
irritation, eye irritation, respiratory sensitization, skin
sensitization, genetic toxicity, carcinogenicity, reproductive
toxicity, and specific target organ toxicity. Alternative hazard and
warning statements that meet the criteria of the Globally Harmonized
System and OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(o). It is a significant new use to
manufacture, process, or use the substance in any manner that results
in inhalation exposure to the substance.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12067 Silsesquioxanes, 3-mercaptopropyl, polymers with
silicic acid (H4SiO4) tetra-Et ester, [(trimethylsilyl)oxy]-terminated.
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified as silsesquioxanes, 3-
mercaptopropyl, polymers with silicic acid (H4SiO4) tetra-Et ester,
[(trimethylsilyl)oxy]-terminated (PMN P-23-20; CASRN 2796383-42-9) is
subject to reporting under this section for the significant new uses
described in paragraph (a)(2) of this section. The requirements of this
section do not apply to quantities of the substance after they have
been completely reacted or cured.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (3), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (f), (g)(1), (3), and (5). For purposes of Sec.
721.72(g)(1), this substance may cause: skin sensitization and specific
target organ toxicity. For purposes of Sec. 721.72(g)(3), this
substance may be: toxic to aquatic life. Alternative hazard and warning
statements that meet the criteria of the Globally Harmonized System and
OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(k). It is a significant new use to
manufacture, process, or use the substance in any manner that results
inhalation exposure.
(iv) Release to water. Requirements as specified in Sec.
721.90(a)(4), (b)(4), and (c)(4), where N=3.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i), and (k) are applicable to manufacturers,
importers, and processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
[[Page 102071]]
Sec. 721.12068 Castor oil, polymer with dicyclopentadiene, maleic
anhydride, 2-methyl-1,3-propanediol, 3a,4,7,7a-tetrahydro-2-(2-
hydroxyethyl)-1H-isoindole-1,3(2H)-dione and triethylene glycol.
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified as castor oil, polymer with
dicyclopentadiene, maleic anhydride, 2-methyl-1,3-propanediol,
3a,4,7,7a-tetrahydro-2-(2-hydroxyethyl)-1H-isoindole-1,3(2H)-dione and
triethylene glycol (PMN P-23-36; CASRN 2794200-69-2) is subject to
reporting under this section for the significant new uses described in
paragraph (a)(2) of this section. The requirements of this section do
not apply to quantities of the substance after they have been
completely reacted or cured.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (3), (b), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible. For purposes of
Sec. 721.63(b), the concentration is set at 1.0%.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (f), (g)(1), (3), and (5). For purposes of Sec.
721.72(e), the concentration is set at 1.0%. For purposes of Sec.
721.72(g)(1), this substance may cause: skin irritation, eye
irritation, and specific target organ toxicity. For purposes of Sec.
721.72(g)(3), this substance may be: toxic to aquatic life. Alternative
hazard and warning statements that meet the criteria of the Globally
Harmonized System and OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(o), (y)(1), and (2). It is a significant
new use to manufacture or process the substance in a manner that
generates a vapor, mist, aerosol, or dust.
(iv) Release to water. Requirements as specified in Sec.
721.90(a)(4), (b)(4), and (c)(4), where N=27.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i), and (k) are applicable to manufacturers,
importers, and processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12069 Monoaromatic cyclic alkylene sulfonium fluoroalkyl
sulfonic acid salt (generic).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified generically as monoaromatic
cyclic alkylene sulfonium fluoroalkyl sulfonic acid salt (PMN P-23-37)
is subject to reporting under this section for the significant new uses
described in paragraph (a)(2) of this section. The requirements of this
section do not apply to quantities of the substance after they have
been completely reacted or adhered (during photolithographic processes)
onto a semiconductor wafer surface or similar manufactured article used
in the production of semiconductor technologies.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), (3), and (c). When determining which
persons are reasonably likely to be exposed as required for Sec.
721.63(a)(1), engineering control measures (e.g., enclosure or
confinement of the operation, general and local ventilation) or
administrative control measures (e.g., workplace policies and
procedures) shall be considered and implemented to prevent exposure,
where feasible.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (f), (g)(1), (2)(i) through (iii), (v), (3)(i)
and (ii), and (5). For purposes of Sec. 721.72(g)(1), this substance
may cause: acute toxicity, skin irritation, skin sensitization, genetic
toxicity, and specific target organ toxicity. Alternative hazard and
warning statements that meet the criteria of the Globally Harmonized
System and OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(f), (k), and (t). It is a significant new
use to import the substance other than in solution, or in sealed
containers weighing 5 kilograms or less. It is a significant new use to
modify the processing or use of the substance in any way that generates
dust, mist, or aerosol in a non-enclosed process. It is a significant
new use to manufacture the substance longer than 18 months.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12070 Monoaromatic cyclic alkylene sulfonium fluoroalkyl
sulfonic acid salt (generic).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified generically as monoaromatic
cyclic alkylene sulfonium fluoroalkyl sulfonic acid salt (PMN P-23-44)
is subject to reporting under this section for the significant new uses
described in paragraph (a)(2) of this section. The requirements of this
section do not apply to quantities of the substance after they have
been completely reacted or adhered (during photolithographic processes)
onto a semiconductor wafer surface or similar manufactured article used
in the production of semiconductor technologies.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), (3), and (c). When determining which
persons are reasonably likely to be exposed as required for Sec.
721.63(a)(1), engineering control measures (e.g., enclosure or
confinement of the operation, general and local ventilation) or
administrative control measures (e.g., workplace policies and
procedures) shall be considered and implemented to prevent exposure,
where feasible.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (f), (g)(1), (2)(i) through (iii), (v), (3)(i)
and (ii), and (5). For purposes of Sec. 721.72(g)(1), this substance
may cause: acute toxicity, skin irritation, serious eye damage,
reproductive toxicity, skin sensitization, genetic toxicity, and
specific target organ toxicity. Alternative hazard and warning
statements that meet the criteria of the Globally Harmonized System and
OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(f), (k), and (t). It is a significant new
use to import the substance other than in solution, or in sealed
containers weighing 5 kilograms or less. It is a significant new use to
modify the processing or use of the substance in any way that generates
[[Page 102072]]
dust, mist, or aerosol in a non-enclosed process. It is a significant
new use to manufacture the substance longer than 18 months.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12071 Aromatic sulfonium tricyclo fluoroalkyl sulfonic acid
salt (generic).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified generically as aromatic
sulfonium tricyclo fluoroalkyl sulfonic acid salt (PMN P-23-80) is
subject to reporting under this section for the significant new uses
described in paragraph (a)(2) of this section. The requirements of this
section do not apply to quantities of the substance after they have
been completely reacted or adhered (during photolithographic processes)
onto a semiconductor wafer surface or similar manufactured article used
in the production of semiconductor technologies.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), (3), and (c). When determining which
persons are reasonably likely to be exposed as required for Sec.
721.63(a)(1), engineering control measures (e.g., enclosure or
confinement of the operation, general and local ventilation) or
administrative control measures (e.g., workplace policies and
procedures) shall be considered and implemented to prevent exposure,
where feasible.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (f), (g)(1), (2)(i) through (iii), (v), (3)(i)
and (ii), and (5). For purposes of Sec. 721.72(g)(1), this substance
may cause: acute toxicity, skin irritation, serious eye damage, skin
sensitization, genetic toxicity, and specific target organ toxicity.
Alternative hazard and warning statements that meet the criteria of the
Globally Harmonized System and OSHA Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(f), (k), and (t). It is a significant new
use to import the substance other than in solution, or in sealed
containers weighing 5 kilograms or less. It is a significant new use to
modify the processing or use of the substance in any way that generates
dust, mist, or aerosol in a non-enclosed process. It is a significant
new use to manufacture the substance longer than 18 months.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12072 Aromatic dibenzothiophenium fluoroalkyl carbopolycycle
sulfonic acid salt (generic).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified generically as aromatic
dibenzothiophenium fluoroalkyl carbopolycycle sulfonic acid salt (PMN
P-23-93) is subject to reporting under this section for the significant
new uses described in paragraph (a)(2) of this section. The
requirements of this section do not apply to quantities of the
substance after they have been completely reacted or adhered (during
photolithographic processes) onto a semiconductor wafer surface or
similar manufactured article used in the production of semiconductor
technologies.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), (3), and (c). When determining which
persons are reasonably likely to be exposed as required for Sec.
721.63(a)(1), engineering control measures (e.g., enclosure or
confinement of the operation, general and local ventilation) or
administrative control measures (e.g., workplace policies and
procedures) shall be considered and implemented to prevent exposure,
where feasible.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (f), (g)(1), (2)(i) through (iii), (v), (3)(i)
and (ii), and (5). For purposes of Sec. 721.72(g)(1), this substance
may cause: acute toxicity, skin irritation, serious eye damage,
reproductive toxicity, skin sensitization, genetic toxicity, and
specific target organ toxicity. Alternative hazard and warning
statements that meet the criteria of the Globally Harmonized System and
OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(f), (k), and (t). It is a significant new
use to import the substance other than in solution, or in sealed
containers weighing 5 kilograms or less. It is a significant new use to
modify the processing or use of the substance in any way that generates
dust, mist, or aerosol in a non-enclosed process. It is a significant
new use to manufacture the substance longer than 18 months.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12073 Alkanediol, substituted, polymer with
diisocyanatoalkane, substituted heterocycle-modified (generic).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified generically as alkanediol,
substituted, polymer with diisocyanatoalkane, substituted heterocycle-
modified (PMN P-23-64) is subject to reporting under this section for
the significant new uses described in paragraph (a)(2) of this section.
The requirements of this section do not apply to quantities of the
substance after they have been completely reacted or cured.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (3), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (f), (g)(1), and (5). For purposes of Sec.
721.72(g)(1), this substance may cause: skin sensitization and specific
target organ toxicity. Alternative hazard and warning statements that
meet the criteria of the Globally Harmonized System and OSHA
[[Page 102073]]
Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(o), and (y)(1) and (2). It is a
significant new use to manufacture or process the substance in a manner
that generates a vapor, mist, aerosol, or dust.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12074 Halosubstituted carbopolycycle, polymer with
substituted carbomonocycles and oxybis[alkanol] (generic).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified generically as
halosubstituted carbopolycycle, polymer with substituted
carbomonocycles and oxybis[alkanol] (PMN P-23-72) is subject to
reporting under this section for the significant new uses described in
paragraph (a)(2) of this section. The requirements of this section do
not apply to quantities of the substance after they have been
completely reacted or cured.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (3) through (6), (b), and (c). When determining which
persons are reasonably likely to be exposed as required for Sec.
721.63(a)(1) and (4), engineering control measures (e.g., enclosure or
confinement of the operation, general and local ventilation) or
administrative control measures (e.g., workplace policies and
procedures) shall be considered and implemented to prevent exposure,
where feasible. For purposes of Sec. 721.63(a)(5), respirators must
provide a National Institute for Occupational Safety and Health (NIOSH)
assigned protection factor (APF) of at least 10. For purposes of Sec.
721.63(b), the concentration is set at 0.1%.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (f), (g)(1), (3), and (5). For purposes of Sec.
721.72(e), the concentration is set at 0.1%. For purposes of Sec.
721.72(g)(1), this substance may cause: genetic toxicity,
carcinogenicity, and specific target organ toxicity. For purposes of
Sec. 721.72(g)(3), this substance may be: toxic to aquatic life.
Alternative hazard and warning statements that meet the criteria of the
Globally Harmonized System and OSHA Hazard Communication Standard may
be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(o). It is a significant new use to process
for use or use the substance other than in an enclosed roll-coating
lithographic printing machine. It is a significant new use to process
for use or use the substance to a final formulation for coating
application that exceeds 40% by weight.
(iv) Disposal. Requirements as specified in Sec. 721.85(a)(2),
(b)(2), and (c)(2).
(v) Release to water. Requirements as specified in Sec.
721.90(a)(1), (b)(1), and (c)(1).
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (k) are applicable to manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12075 Polymer of benzenedicarboxylic acid, substituted-
benzenedicarboxylic acid, branched-alkyldiol, alkyldiol and
triisocyanate (generic).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified generically as polymer of
benzenedicarboxylic acid, substituted-benzenedicarboxylic acid,
branched-alkyldiol, alkyldiol and triisocyanate (PMN P-23-94) is
subject to reporting under this section for the significant new uses
described in paragraph (a)(2) of this section. The requirements of this
section do not apply to quantities of the substance after they have
been completely reacted or cured.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (3), and (c). When determining which persons are
reasonably likely to be exposed as required for Sec. 721.63(a)(1),
engineering control measures (e.g., enclosure or confinement of the
operation, general and local ventilation) or administrative control
measures (e.g., workplace policies and procedures) shall be considered
and implemented to prevent exposure, where feasible.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (f), (g)(1), and (5). For purposes of Sec.
721.72(g)(1), this substance may cause: skin sensitization, respiratory
sensitization, and specific target organ toxicity. Alternative hazard
and warning statements that meet the criteria of the Globally
Harmonized System and OSHA Hazard Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(o). It is a significant new use to
manufacture, process, or use the substance in any manner that results
inhalation exposure.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
Sec. 721.12076 Sulfonium, tricarbocyclic-, alkylcarbomonocyclic-
polyfluoro-heteropolycyclic-alkyl sulfonate (1:1), polymer with
alkylaryl and carbomonocyclic alkylalkanoate, di-Me 2,2'-(1,2-
diazenediyl)bis[2-alkylalkanoate]-initiated (generic).
(a) Chemical substance and significant new uses subject to
reporting.
(1) The chemical substance identified generically as sulfonium,
tricarbocyclic-, alkylcarbomonocyclic-polyfluoro-heteropolycyclic-alkyl
sulfonate (1:1), polymer with alkylaryl and carbomonocyclic
alkylalkanoate, di-Me 2,2'-(1,2-diazenediyl)bis[2-alkylalkanoate]-
initiated (PMN P-23-172) is subject to reporting under this section for
the significant new uses described in paragraph (a)(2) of this section.
The requirements of this section do not apply to quantities of the
substance after they have been completely reacted or adhered (during
photolithographic processes) onto a semiconductor wafer surface or
similar manufactured article used in the production of semiconductor
technologies.
(2) The significant new uses are:
(i) Protection in the workplace. Requirements as specified in Sec.
721.63(a)(1), (2)(i) and (iii), (3), and (c). When determining which
persons are reasonably likely to be exposed as
[[Page 102074]]
required for Sec. 721.63(a)(1), engineering control measures (e.g.,
enclosure or confinement of the operation, general and local
ventilation) or administrative control measures (e.g., workplace
policies and procedures) shall be considered and implemented to prevent
exposure, where feasible.
(ii) Hazard communication. Requirements as specified in Sec.
721.72(a) through (d), (f), (g)(1), (2)(i) through (iii), (v), (3)(i)
and (ii), and (5). For purposes of Sec. 721.72(g)(1), this substance
may cause: acute toxicity, skin irritation, serious eye damage, skin
sensitization, genetic toxicity, reproductive toxicity, and specific
target organ toxicity. Alternative hazard and warning statements that
meet the criteria of the Globally Harmonized System and OSHA Hazard
Communication Standard may be used.
(iii) Industrial, commercial, and consumer activities. Requirements
as specified in Sec. 721.80(f), (k), and (t). It is a significant new
use to import the substance other than in solution, or in sealed
containers weighing 5 kilograms or less. It is a significant new use to
modify the processing of the substance in any way that generates dust,
mist, or aerosol in a non-enclosed process. It is a significant new use
to manufacture the substance longer than 18 months.
(b) Specific requirements. The provisions of Subpart A of this part
apply to this section except as modified by this paragraph (b).
(1) Recordkeeping. Recordkeeping requirements as specified in Sec.
721.125(a) through (i) are applicable to manufacturers, importers, and
processors of this substance.
(2) Limitation or revocation of certain notification requirements.
The provisions of Sec. 721.185 apply to this section.
[FR Doc. 2024-29275 Filed 12-16-24; 8:45 am]
BILLING CODE 6560-50-P